97. 潰瘍性大腸炎 Disease details / Clinical trials / Drug dev / DR info


臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

薬物ごとの開発者(Primary Sponsor)、臨床試験情報(抜粋)です。
( L ) ASCORBATO DI CALCIO   
   ASTRAZENECA AB
      2021   Phase 2   EUCTR2021-001644-10-IT   Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
(-)-3-(4-Aminophenyl)-2-methoxypropionic acid   
   GIULIANI
      2012   -   EUCTR2011-003283-78-IT   Italy;
(R)-3-(1-oxo-propoxy)-4-(N,N,N-trimethyl amonium chloride)-butanoic acid   
   SIGMA-TAU
      2012   -   EUCTR2011-004765-32-IT   Belgium;Czech Republic;Italy;Netherlands;
   Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
      2012   Phase 3   EUCTR2011-004770-28-ES   Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
      2012   Phase 3   EUCTR2011-004765-32-BE   Belgium;Czech Republic;Italy;Netherlands;Slovakia;
      2012   -   EUCTR2011-004770-28-PL   Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
      2012   -   EUCTR2011-004770-28-LV   Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
      2012   -   EUCTR2011-004770-28-LT   Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
      2012   -   EUCTR2011-004770-28-HU   Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
      2012   -   EUCTR2011-004770-28-DE   Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
      2012   -   EUCTR2011-004770-28-AT   Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
      2012   -   EUCTR2011-004765-32-SK   Belgium;Czech Republic;Italy;Netherlands;Slovakia;
      2012   -   EUCTR2011-004765-32-NL   Belgium;Czech Republic;Israel;Italy;Netherlands;Russian Federation;
      2012   -   EUCTR2011-004765-32-CZ   Belgium;Czech Republic;Italy;Netherlands;
(S)-(-)-3-(4-Aminophenyl)-2-methoxypropionic Acid   
   PPM SERVICES SA
      2017   Phase 2   EUCTR2016-001684-36-LV   Bulgaria;Canada;France;Hungary;Italy;Latvia;Poland;Slovakia;Spain;Ukraine;United States;
      2017   Phase 2   EUCTR2016-001684-36-ES   Bulgaria;Canada;France;Hungary;Italy;Latvia;Poland;Slovakia;Spain;Ukraine;United States;
      2016   Phase 2   EUCTR2016-001684-36-SK   Bulgaria;Canada;France;Hungary;Italy;Latvia;Poland;Slovakia;Spain;Ukraine;United Kingdom;United States;
      2016   Phase 2   EUCTR2016-001684-36-HU   Bulgaria;Canada;Czech Republic;France;Hungary;Italy;Latvia;Poland;Slovakia;Spain;Ukraine;United Kingdom;United States;
      2016   Phase 2   EUCTR2016-001684-36-BG   Bulgaria;Canada;France;Hungary;Italy;Latvia;Poland;Slovakia;Spain;Ukraine;United Kingdom;United States;
(S)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5- yl)-2-isopropoxybenzonitrile hydrochloride   
   CELGENE INTERNATIONAL II SàRL
      2016   Phase 3   EUCTR2015-001600-64-IT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Mexico;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
(S)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxyben   
   Celgene International II Sàrl
      2015   Phase 3   EUCTR2015-001600-64-GB   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
(S)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile hydrochloride   
   CELGENE INTERNATIONAL II SàRL
      2015   Phase 3   EUCTR2015-000319-41-IT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
   Celgene International II Sàrl
      2018   Phase 3   EUCTR2015-001600-64-LV   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2015-001600-64-GR   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2015-001600-64-ES   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2015-001600-64-AT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2015-001600-64-HR   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-001600-64-NL   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-001600-64-BG   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-001600-64-SK   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Djibouti;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-001600-64-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-001600-64-BE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-000319-41-GB   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
   Celgene International II Sàrl (CIS II)
      2018   Phase 3   EUCTR2015-000319-41-LV   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2015-000319-41-GR   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2015-000319-41-ES   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2015-000319-41-AT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2015-000319-41-HR   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000319-41-NL   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-001600-64-DE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-000319-41-SK   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-000319-41-DE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-000319-41-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-000319-41-BE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2015-001600-64-PL   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2015-000319-41-PL   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2015-000319-41-BG   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
   Celgene International II Sárl (CIS II)
      2015   Phase 3   EUCTR2015-001600-64-HU   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-000319-41-HU   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Mexico;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
-aminosalicylic acid   
   National Center for Research Resources (NCRR)
      1996   Phase 2   NCT00004810   -
1.Remicade   
   Helse More og Romsdal Hospital Trust
      2016   Phase 4   EUCTR2016-001409-18-NO   Norway;
100   
   Essex Pharma GmbH
      2009   -   EUCTR2009-010065-23-DE   Germany;
14C]-RPC1063 Solution (0.1 mg/mL) for Oral Administration   
   Celgene International II Sàrl
      2016   Phase 1   EUCTR2016-003073-18-GB   United Kingdom;
15N2-tofacitinib   
   Theravance Biopharma
      2017   Phase 1   NCT03103412   United States;
2 x 10 mg Natura-alpha capsules   
   Natrogen Therapeutics International, Inc
      2010   Phase 2   NCT01216280   United States;
2'-Fucosyllactose   
   Children's Hospital Medical Center, Cincinnati
      2019   Phase 1/Phase 2   NCT03847467   United States;
23-valent polysaccharide pneumococcal vaccine (Pneumovax TM)   
   Cedars-Sinai Medical Center
      2005   -   NCT00829595   United States;
2L polyethylene glycol/ascorbic acid   
   American University of Beirut Medical Center
      2018   Phase 4   NCT03581149   Lebanon;
3-hydroxy-2-methyl-4H-pyrane-4-one iron (III) complex (3:1), Ferric (3-hydroxy-2-methyl-4-pyrone), Tris-maltol-iron (III), Tri=maltol-iron (III)   
   Iron Therapeutics (Switzerland) AG
      2012   -   EUCTR2010-023588-16-DE   Austria;Germany;Hungary;United Kingdom;
      2011   Phase 3   EUCTR2010-023588-16-GB   Austria;Germany;Hungary;United Kingdom;
      2011   -   EUCTR2010-023588-16-HU   Austria;Germany;Hungary;United Kingdom;
      2011   -   EUCTR2010-023588-16-AT   Austria;Germany;Hungary;United Kingdom;
331731-18-1   
   AbbVie Deutschland GmbH & Co. KG
      2019   Phase 3   EUCTR2013-001682-16-DK   Austria;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
      2017   Phase 3   EUCTR2015-001346-29-CZ   Austria;Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-001346-29-HU   Australia;Canada;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-001346-29-GB   Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Spain;Sweden;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-001346-29-ES   Australia;Belgium;Canada;Czech Republic;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-001346-29-BE   Australia;Belgium;Canada;Czech Republic;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-001346-29-SK   Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
      2015   Phase 3   EUCTR2013-001682-16-BE   Belgium;Canada;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Spain;Switzerland;United States;
      2014   Phase 3   EUCTR2013-003032-77-IT   Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;Switzerland;United Kingdom;United States;
      2014   Phase 3   EUCTR2013-003032-77-HU   Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States;
      2014   Phase 3   EUCTR2013-003032-77-GB   Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States;
      2014   Phase 3   EUCTR2013-001682-16-SK   Austria;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
      2014   Phase 3   EUCTR2013-001682-16-PL   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
      2014   Phase 3   EUCTR2013-001682-16-NL   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
      2014   Phase 3   EUCTR2013-001682-16-IT   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
      2014   Phase 3   EUCTR2013-001682-16-HU   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
      2014   Phase 3   EUCTR2013-001682-16-ES   Austria;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
      2014   Phase 3   EUCTR2013-001682-16-DE   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
      2014   Phase 3   EUCTR2013-001682-16-CZ   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
      2014   Phase 3   EUCTR2013-001682-16-AT   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
      -   Phase 3   EUCTR2015-001346-29-SE   Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Spain;Sweden;United Kingdom;United States;
      -   Phase 3   EUCTR2015-001346-29-PL   Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
      -   Phase 3   EUCTR2015-001346-29-AT   Austria;Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Spain;Sweden;United Kingdom;United States;
   AbbVie Inc.
      -   -   EUCTR2014-004559-29-Outside-EU/EEA   Japan;
   Abbvie Deutschland GmbH & Co. KG
      2015   Phase 3   EUCTR2013-003032-77-PL   Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States;
      2014   Phase 3   EUCTR2013-003032-77-SK   Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States;
      2014   Phase 3   EUCTR2013-003032-77-ES   Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;Switzerland;United Kingdom;United States;
      2014   Phase 3   EUCTR2013-003032-77-CZ   Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States;
      2014   Phase 3   EUCTR2013-003032-77-BE   Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;Switzerland;United Kingdom;United States;
      2014   Phase 3   EUCTR2013-003032-77-AT   Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States;
      -   Phase 3   EUCTR2013-003032-77-FR   Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;Switzerland;United Kingdom;United States;
42942019   
   UNIVERSITÀ CATTOLICA DEL SACRO CUORE- POLICLINICO A. GEMELLI
      2016   Phase 4   EUCTR2016-002061-54-IT   Italy;
5 ASA, enemas, suppositories, corticosteroids   
   Bausch Health Americas, Inc.
      2005   Phase 3   NCT00269438   United States;
5-ASA   
   Bausch Health Americas, Inc.
      2012   Phase 3   NCT01532648   Bulgaria;Canada;Czech Republic;Czechia;Estonia;Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;United States;
   Center for Diagnostic and Therapeutic Endoscopy,Keio University
      2015   -   JPRN-UMIN000018075   Japan;
   Centre Hospitalier Universitaire de Saint Etienne
      2016   Phase 3   NCT02665845   France;Greece;Israel;Italy;Korea, Republic of;Serbia;
   Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine
      2015   -   JPRN-UMIN000019310   Japan;
   Department of Gastroenterology, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China
      2014   Phase 1 study   ChiCTR-TRC-14004153   -
   Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University
      2017   -   JPRN-UMIN000026175   Japan;
   Ferring Pharmaceuticals
      2021   -   NCT04499495   Korea, Republic of;
   Friendship Hospital of Capital Medical University
      2008   Phase 1 study   ChiCTR-TRC-08000145   China;
5-ASA (5-Aminosalicylate)   
   Ferring Pharmaceuticals
      2007   Phase 3   NCT00603733   Canada;
5-ASA MMx   
   GIULIANI
      2004   -   EUCTR2004-000916-25-IT   Italy;
5-Aminosalicyclic acid   
   Asian Institute of Gastroenterology, India
      2016   Phase 3   NCT02683759   India;
5-Aminosalicylic acid (5-ASA)   
   Essex Pharma GmbH
      2009   -   EUCTR2009-010065-23-DE   Germany;
5-Aminosalicylic acid(5-ASA) and/or Prednisone   
   Guangzhou First People's Hospital
      2019   Phase 2/Phase 3   NCT03804931   China;
5-HTP   
   University Hospital, Ghent
      2018   Phase 2   NCT03574948   Belgium;
5-amino salicylic acid   
   Shire Pharmaceutical Development Ltd
      2009   -   EUCTR2004-004184-29-DK   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2008   Phase 3   EUCTR2004-004184-29-NL   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2007   -   EUCTR2004-004184-29-SE   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2007   -   EUCTR2004-004184-29-PT   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2005   Phase 3   EUCTR2004-004184-29-HU   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2005   Phase 3   EUCTR2004-004184-29-GB   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2005   -   EUCTR2004-004184-29-ES   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2005   -   EUCTR2004-004184-29-DE   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2005   -   EUCTR2004-004184-29-CZ   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
5-amino salicylic acid (5-ASA)   
   Shire Pharmaceutical Development Inc
      2004   -   EUCTR2004-000733-12-CZ   Czech Republic;
   Shire Pharmaceutical Development Inc.
      2005   -   EUCTR2004-000734-36-CZ   Czech Republic;
5-amino-2-hydroxybenzoic acid   
   Otsuka Maryland Research Institute, Inc.
      2004   -   EUCTR2004-000611-25-IE   Hungary;Ireland;
      2004   -   EUCTR2004-000611-25-HU   Hungary;Ireland;
5-aminosalicylate (Pentasa, Ferring)   
   VU University Medical Center
      2005   Phase 4   NCT00167882   Netherlands;
5-aminosalicylic acid   
   Department of Internal medicine, Division of Lower Gastroenterology, Hyogo College of Medicine
      2010   Phase 3   JPRN-UMIN000003785   Japan;
   Ferring Pharmaceuticals
      2021   -   NCT04499495   Korea, Republic of;
   Medizinische Universität Wien, Universitätsklinik für Innere Medizin 3, Abteilung für Gastroenterologie und Hepatologie
      2012   Phase 2   EUCTR2012-002023-15-AT   Austria;
   Merck Sharp & Dohme Corp.
      2009   Phase 3   NCT00984568   Germany;
   Sheba Medical Center
      2011   Phase 3   NCT01320436   Israel;
   Shire Pharmaceutical Development Ltd
      2009   -   EUCTR2004-004184-29-DK   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2008   Phase 3   EUCTR2004-004184-29-NL   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2007   -   EUCTR2004-004184-29-SE   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2007   -   EUCTR2004-004184-29-PT   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2005   Phase 3   EUCTR2004-004184-29-HU   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2005   Phase 3   EUCTR2004-004184-29-GB   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2005   -   EUCTR2004-004184-29-ES   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2005   -   EUCTR2004-004184-29-DE   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2005   -   EUCTR2004-004184-29-CZ   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
5-aminosalicylic acid (5-ASA)   
   Procter & Gamble Technical Centres Limited
      2006   -   EUCTR2006-001310-32-LT   Czech Republic;Estonia;Hungary;Latvia;Lithuania;
      2006   -   EUCTR2006-001310-32-HU   Czech Republic;Estonia;Hungary;Latvia;Lithuania;
      2006   -   EUCTR2006-001310-32-EE   Czech Republic;Estonia;Hungary;Latvia;Lithuania;
      2006   -   EUCTR2006-001310-32-CZ   Czech Republic;Estonia;Hungary;Latvia;Lithuania;
549-0261/F02-01   
   F. Hoffmann-La Roche Ltd
      2018   Phase 1   EUCTR2017-003649-10-GB   Belgium;Germany;Poland;Spain;United Kingdom;
      2018   Phase 1   EUCTR2017-003649-10-DE   Belgium;Germany;Poland;Spain;United Kingdom;United States;
      2018   Phase 1   EUCTR2017-003649-10-BE   Belgium;Germany;Poland;Spain;United Kingdom;
      -   Phase 1   EUCTR2017-003649-10-PL   Belgium;Germany;Poland;Spain;United Kingdom;United States;
6 mercaptopurine   
   Indiana University
      2015   -   NCT02413047   United States;
6-[2-(3,4-diethoxyphenyl)thiazol-4-yl] pyridine-2-carboxylic acid   
   Otsuka Maryland Research Institute, Inc.
      2004   -   EUCTR2004-000611-25-IE   Hungary;Ireland;
      2004   -   EUCTR2004-000611-25-HU   Hungary;Ireland;
A multistrain probiotic product (DSF)   
   Xijing Hospital of Digestive Diseases
      2019   -   NCT04006977   China;
A07DA03   
   Department of surgery, Odense University Hospital
      2014   Phase 4   EUCTR2014-004740-35-DK   Denmark;
A: 1 dosis   
   AB Biotics, SA
      2018   -   NCT03444311   Spain;
AB (antibiotics)   
   Shaare Zedek Medical Center
      2014   -   NCT02033408   Canada;Finland;Israel;Italy;Poland;Spain;
ABBV-006   
   ABBVIE DEUTSCHLAND GMBH & CO. KG
      2018   Phase 3   EUCTR2016-004676-22-IT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
   AbbVie Deutschland GmbH & Co. KG
      2021   Phase 3   EUCTR2016-004676-22-FR   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2016-004676-22-SI   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2016-004676-22-HR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2016-004676-22-DE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2016-004676-22-BG   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2016-004676-22-BE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2016-004676-22-SE   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2016-004676-22-PT   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2016-004676-22-NL   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2016-004676-22-LV   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2016-004676-22-LT   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2016-004676-22-GR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2016-004676-22-GB   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2016-004676-22-ES   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2016-004676-22-DK   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2016-004676-22-AT   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2016-004676-22-PL   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2016-004676-22-CZ   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
ABBV-066   
   ABBVIE DEUTSCHLAND GMBH & CO. KG
      2018   Phase 3   EUCTR2016-004676-22-IT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 2;Phase 3   EUCTR2016-004677-40-IT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
   AbbVie Deutschland GmbH & Co. KG
      2021   Phase 3   EUCTR2016-004676-22-FR   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 2;Phase 3   EUCTR2016-004677-40-FR   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2016-004676-22-SI   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2016-004676-22-HR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2016-004676-22-DE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2016-004676-22-BG   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2016-004676-22-BE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 2;Phase 3   EUCTR2016-004677-40-SI   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 2;Phase 3   EUCTR2016-004677-40-HR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 2;Phase 3   EUCTR2016-004677-40-BG   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2016-004676-22-SK   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2016-004676-22-SE   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2016-004676-22-PT   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2016-004676-22-NL   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2016-004676-22-LV   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2016-004676-22-LT   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2016-004676-22-GR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2016-004676-22-GB   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2016-004676-22-ES   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2016-004676-22-DK   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2016-004676-22-AT   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-SK   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-SE   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-PT   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-NL   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-LV   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-LT   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-GR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-ES   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-DK   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-DE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-BE   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 2;Phase 3   EUCTR2016-004677-40-AT   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2016-004676-22-PL   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2016-004676-22-CZ   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 2;Phase 3   EUCTR2016-004677-40-PL   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 2;Phase 3   EUCTR2016-004677-40-GB   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 2;Phase 3   EUCTR2016-004677-40-CZ   Argentina;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
ABBV-323   
   ABBVIE DEUTSCHLAND GMBH & CO. KG
      2019   Phase 2   EUCTR2018-000930-37-IT   Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States;
   AbbVie Deutschland GmbH & Co. KG
      2020   Phase 2   EUCTR2018-000930-37-HU   Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-000930-37-GB   Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-000930-37-FR   Canada;France;Germany;Hungary;Italy;Netherlands;Spain;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-000930-37-ES   Canada;France;Germany;Italy;Netherlands;Spain;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-000930-37-DE   Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States;
      2018   Phase 2   EUCTR2018-000930-37-NL   Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States;
ABBV-323 Dose A   
   AbbVie
      2019   Phase 2   NCT03695185   Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States;
ABBV-323 Dose B   
   AbbVie
      2019   Phase 2   NCT03695185   Canada;France;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Spain;United Kingdom;United States;
ABI-M201   
   Assembly Biosciences
      2019   Phase 1   NCT03923478   Canada;United States;
ABT-494   
   ABBVIE DEUTSCHLAND GMBH & CO. KG
      2019   Phase 3   EUCTR2016-000642-62-IT   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2016-000674-38-IT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
   AbbVie Deutschland GmbH & Co. KG
      2020   Phase 3   EUCTR2016-000642-62-SE   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2016-000642-62-FR   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2016-000642-62-SK   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2016-000642-62-PT   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2016-000642-62-PL   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2016-000642-62-NL   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2016-000642-62-LT   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2016-000642-62-IE   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2016-000642-62-HR   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2016-000642-62-GR   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2016-000642-62-GB   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2016-000642-62-ES   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2016-000642-62-DE   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2016-000642-62-CZ   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2016-000642-62-AT   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2016-000642-62-NO   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2016-000642-62-LV   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2016-000642-62-HU   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2016-000642-62-FI   Argentina;Australia;Austria;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 2;Phase 3   EUCTR2016-000641-31-BE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-000674-38-SE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-000674-38-PT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-000674-38-LT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-000674-38-IE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-000674-38-HR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-000674-38-FI   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-000674-38-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-000674-38-BE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2017   Phase 2;Phase 3   EUCTR2016-000641-31-SE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2017   Phase 2;Phase 3   EUCTR2016-000641-31-PT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2017   Phase 2;Phase 3   EUCTR2016-000641-31-LT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2017   Phase 2;Phase 3   EUCTR2016-000641-31-HR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2017   Phase 2;Phase 3   EUCTR2016-000641-31-FR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2017   Phase 2;Phase 3   EUCTR2016-000641-31-FI   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2017   Phase 2;Phase 3   EUCTR2016-000641-31-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2016-000674-38-SK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2016-000674-38-PL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2016-000674-38-NL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2016-000674-38-LV   Argentina;Australia;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Egypt;Estonia;European Union;Greece;Hungary;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;South Africa;Spain;Switzerland;Taiwan;Ukraine;United States;
      2016   Phase 3   EUCTR2016-000674-38-HU   Argentina;Australia;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Egypt;Estonia;European Union;Greece;Hungary;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;South Africa;Spain;Switzerland;Taiwan;Ukraine;United States;
      2016   Phase 3   EUCTR2016-000674-38-GR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2016-000674-38-GB   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2016-000674-38-ES   Argentina;Australia;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Egypt;Estonia;European Union;Greece;Hungary;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Malaysia;Mexico;Netherlands;New Zealand;Norway;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;South Africa;Spain;Switzerland;Taiwan;Ukraine;United States;
      2016   Phase 3   EUCTR2016-000674-38-EE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Greece;Hungary;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2016-000674-38-AT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 2;Phase 3   EUCTR2016-000641-31-SK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2016   Phase 2;Phase 3   EUCTR2016-000641-31-PL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2016   Phase 2;Phase 3   EUCTR2016-000641-31-NL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2016   Phase 2;Phase 3   EUCTR2016-000641-31-LV   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2016   Phase 2;Phase 3   EUCTR2016-000641-31-IE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2016   Phase 2;Phase 3   EUCTR2016-000641-31-HU   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2016   Phase 2;Phase 3   EUCTR2016-000641-31-GR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2016   Phase 2;Phase 3   EUCTR2016-000641-31-GB   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2016   Phase 2;Phase 3   EUCTR2016-000641-31-ES   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2016   Phase 2;Phase 3   EUCTR2016-000641-31-EE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2016   Phase 2;Phase 3   EUCTR2016-000641-31-AT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2016-000674-38-NO   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2016-000674-38-DE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 2;Phase 3   EUCTR2016-000641-31-NO   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      -   Phase 2;Phase 3   EUCTR2016-000641-31-DE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;Estonia;European Union;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Saudi Arabia;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
   AbbVie GK
      2018   Phase 3   JPRN-JapicCTI-184131   Japan, Asia except Japan, North America, South America, Europe, Oceania, Africa, -;
ABT-Humira   
   AbbVie Deutschland GmbH & Co. KG
      2009   Phase 3   EUCTR2007-004157-28-SE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
      2008   Phase 3   EUCTR2007-004157-28-NL   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
      2008   Phase 3   EUCTR2007-004157-28-HU   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
      2008   Phase 3   EUCTR2007-004157-28-DE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
      2008   Phase 3   EUCTR2007-004157-28-CZ   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
      2008   Phase 3   EUCTR2007-004157-28-BE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
      2008   Phase 3   EUCTR2007-004157-28-AT   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
   Abbott GmbH & Co. KG
      2009   Phase 3   EUCTR2007-004157-28-PT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;
      2008   Phase 3   EUCTR2007-004157-28-SK   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;
      2008   Phase 3   EUCTR2007-004157-28-FR   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;
ABX464   
   ABIVAX
      2022   Phase 2   EUCTR2021-004398-30-SI   Austria;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;
      2021   Phase 2   EUCTR2021-004398-30-SK   Austria;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;
      2021   Phase 2   EUCTR2021-004398-30-HU   Austria;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;
      2020   Phase 2   EUCTR2019-000733-39-GB   Austria;Belarus;Belgium;Canada;Czech Republic;France;Germany;Hungary;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;
      2020   Phase 2   EUCTR2019-000733-39-FR   Austria;Belarus;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Netherlands;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;
      2020   Phase 2   EUCTR2019-000733-39-DE   Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;
      2020   Phase 2   EUCTR2019-000733-39-AT   Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;
      2020   Phase 2   EUCTR2018-003558-26-GB   Austria;Belarus;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;United States;
      2019   Phase 2   EUCTR2019-000733-39-SK   Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;
      2019   Phase 2   EUCTR2019-000733-39-SI   Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;
      2019   Phase 2   EUCTR2019-000733-39-PL   Austria;Belarus;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Netherlands;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;
      2019   Phase 2   EUCTR2019-000733-39-ES   Austria;Belarus;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Netherlands;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;
      2019   Phase 2   EUCTR2018-003558-26-SK   Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-003558-26-SI   Austria;Belarus;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-003558-26-PL   Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-003558-26-HU   Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-003558-26-FR   Austria;Belarus;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Italy;Netherlands;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;
      2019   Phase 2   EUCTR2018-003558-26-DE   Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Ireland;Italy;Netherlands;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;
      2019   Phase 2   EUCTR2018-003558-26-CZ   Austria;Belarus;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Italy;Netherlands;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;
      2019   Phase 2   EUCTR2018-003558-26-BE   Austria;Belarus;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;United States;
      2018   Phase 2   EUCTR2017-003284-35-PL   Belgium;Hungary;Poland;Spain;
      2018   Phase 2   EUCTR2017-003284-35-HU   Belgium;Hungary;Poland;Spain;
      2018   Phase 2   EUCTR2017-003284-35-ES   Hungary;Spain;
      2018   Phase 2   EUCTR2017-000937-30-AT   Austria;Belgium;France;Germany;Hungary;Poland;Spain;
      2017   Phase 2   EUCTR2017-003284-35-BE   Belgium;Hungary;Poland;Spain;
      2017   Phase 2   EUCTR2017-000937-30-PL   Austria;Belgium;France;Germany;Hungary;Poland;Spain;
      2017   Phase 2   EUCTR2017-000937-30-FR   Austria;Belgium;France;Germany;Hungary;Poland;Spain;
      2017   Phase 2   EUCTR2017-000937-30-ES   Austria;Belgium;France;Germany;Hungary;Poland;Spain;
      2017   Phase 2   EUCTR2017-000937-30-DE   Austria;Belgium;France;Germany;Hungary;Poland;Spain;
      2017   Phase 2   EUCTR2017-000937-30-BE   Austria;Belgium;Germany;Hungary;Poland;Spain;
   Abivax
      2021   Phase 2   EUCTR2021-004398-30-IT   Austria;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;
      2020   Phase 2   EUCTR2019-000733-39-IT   Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Ireland;Italy;Netherlands;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;
      2019   Phase 2   EUCTR2018-003558-26-IT   Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Ireland;Italy;Netherlands;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;
   Abivax S.A.
      2021   Phase 2   NCT05177835   Belgium;Czechia;Hungary;Poland;
      2020   Phase 2   NCT04023396   Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;
      2019   Phase 2   NCT03760003   Austria;Belarus;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Poland;Serbia;Slovakia;Slovenia;Spain;Ukraine;United Kingdom;United States;
      2018   Phase 2   NCT03368118   Belgium;
      2017   Phase 2   NCT03093259   Belgium;
   Owada Yasuko
      2021   Phase 1   JPRN-jRCT2051210087   Japan;
ACETATO DI AMMONIO   
   Protagonist Therapeutics, Inc.
      2020   Phase 2   EUCTR2019-004469-41-IT   Austria;Bulgaria;Canada;Georgia;Germany;Hungary;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Ukraine;United States;
AEB071   
   Novartis Pharma Services AG
      2007   Phase 2   EUCTR2007-002542-38-DK   Denmark;Germany;
   Novartis Pharmaceuticals
      2010   Phase 2   NCT00572585   Denmark;Germany;Poland;United States;
AEB071A   
   Novartis Pharma Services AG
      2007   -   EUCTR2007-002542-38-DE   Denmark;Germany;
AG011   
   ActoGeniX N.V.
      2008   Phase 1/Phase 2   NCT00729872   Belgium;Canada;Netherlands;Sweden;
AG011 - Capsules   
   ActoGeniX N.V
      2008   -   EUCTR2008-000967-40-BE   Belgium;Netherlands;Sweden;
   ActoGeniX NV.
      2008   -   EUCTR2008-000967-40-SE   Belgium;Netherlands;Sweden;
      2008   -   EUCTR2008-000967-40-NL   Belgium;Netherlands;Sweden;
AG011 - Enema   
   ActoGeniX N.V
      2008   -   EUCTR2008-000967-40-BE   Belgium;Netherlands;Sweden;
   ActoGeniX NV.
      2008   -   EUCTR2008-000967-40-SE   Belgium;Netherlands;Sweden;
      2008   -   EUCTR2008-000967-40-NL   Belgium;Netherlands;Sweden;
AJG501   
   Ajinomoto Pharmaceuticals Co., Ltd.
      -   Phase 2-3   JPRN-JapicCTI-101144   -
AJG511   
   Ajinomoto Pharmaceuticals Co., Ltd.
      -   Phase 2   JPRN-JapicCTI-132294   -
   EA Pharma Co.,Ltd.
      2014   Phase 3   JPRN-JapicCTI-142704   -
AJM300   
   EA Pharma Co., Ltd.
      2018   Phase 3   NCT03531892   Japan;
ALTH12-1:4   
   Altheus Therapeutics, Inc.
      2009   Phase 1   NCT01020708   United States;
ALTH12-2:4   
   Altheus Therapeutics, Inc.
      2009   Phase 1   NCT01020708   United States;
AMG 181   
   Amgen
      2011   Phase 1   NCT01290042   Australia;United States;
   Amgen Inc
      2014   Phase 2   EUCTR2011-005251-13-LV   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;New Zealand;Norway;Poland;Russian Federation;Switzerland;United Kingdom;United States;
      2014   Phase 2   EUCTR2011-005251-13-EE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;New Zealand;Norway;Poland;Russian Federation;Switzerland;United Kingdom;United States;
      2013   Phase 2   EUCTR2011-005251-13-PL   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Switzerland;United Kingdom;United States;
      2013   Phase 2   EUCTR2011-005251-13-NL   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Switzerland;United Kingdom;United States;
      2012   Phase 2   EUCTR2011-005251-13-HU   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Switzerland;United Kingdom;United States;
      2012   Phase 2   EUCTR2011-005251-13-GR   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Switzerland;United Kingdom;United States;
      2012   Phase 2   EUCTR2011-005251-13-GB   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Switzerland;United Kingdom;United States;
      2012   Phase 2   EUCTR2011-005251-13-DK   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Switzerland;United Kingdom;United States;
      2012   Phase 2   EUCTR2011-005251-13-DE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Switzerland;United Kingdom;United States;
      2012   Phase 2   EUCTR2011-005251-13-CZ   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Switzerland;United Kingdom;United States;
      2012   Phase 2   EUCTR2011-005251-13-BE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Switzerland;United Kingdom;United States;
      2012   Phase 2   EUCTR2011-005251-13-AT   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Switzerland;United Kingdom;United States;
AMG 592   
   AMGEN INC.
      2021   Phase 2   EUCTR2021-002537-41-IT   Argentina;Austria;Bulgaria;Canada;Czechia;Denmark;Finland;Germany;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United States;
   Amgen Inc.
      2022   Phase 2   EUCTR2021-002537-41-ES   Argentina;Austria;Belgium;Bulgaria;Canada;Czechia;Denmark;Finland;Germany;Greece;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States;
      2022   Phase 2   EUCTR2021-002537-41-BG   Argentina;Austria;Bulgaria;Canada;Czechia;Denmark;Finland;Germany;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United States;
      2021   Phase 2   EUCTR2021-002537-41-NL   Argentina;Austria;Bulgaria;Canada;Czechia;Denmark;Finland;Germany;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United States;
      2021   Phase 2   EUCTR2021-002537-41-HU   Argentina;Austria;Bulgaria;Canada;Czechia;Denmark;Finland;Germany;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United States;
      2021   Phase 2   EUCTR2021-002537-41-DE   Argentina;Austria;Bulgaria;Canada;Czechia;Denmark;Finland;Germany;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Mexico;Netherlands;Poland;Romania;Russian Federation;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United States;
AMG181   
   AMGEN INC.
      2012   Phase 2   EUCTR2011-005251-13-IT   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Poland;Switzerland;United Kingdom;United States;
AMGEVITA   
   CHU Amiens-Picardie
      2020   Phase 4   EUCTR2020-004391-18-FR   France;
AMGEVITA (Adalimumab biosimilar )   
   Fundación Publica Andaluza para la Gestión de Salud en Sevilla (FISEVI)
      2019   Phase 4   EUCTR2019-000717-37-ES   Spain;
AMGEVITA®   
   Fundación Publica Andaluza para la Gestión de Salud en Sevilla (FISEVI)
      2019   Phase 4   EUCTR2019-000717-37-ES   Spain;
AMT-101   
   Applied Molecular Transport
      2019   Phase 1   NCT04224857   Georgia;Germany;Moldova, Republic of;Ukraine;
   Applied Molecular Transport Inc.
      2021   Phase 2   EUCTR2020-002833-13-PL   Georgia;Netherlands;Poland;Ukraine;
      2021   Phase 2   EUCTR2020-002833-13-NL   Georgia;Netherlands;Poland;Ukraine;
      2021   Phase 2   EUCTR2020-000047-31-PL   Belarus;Bulgaria;Canada;France;Georgia;Germany;Hungary;India;Italy;Kazakhstan;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Switzerland;Ukraine;United Kingdom;United States;
      2021   Phase 2   EUCTR2020-000047-31-DE   Belarus;Belgium;Bulgaria;Canada;France;Georgia;Germany;Hungary;India;Italy;Kazakhstan;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Switzerland;Ukraine;United Kingdom;United States;
      2020   Phase 2   EUCTR2020-000047-31-HU   Belarus;Belgium;Bulgaria;Canada;France;Georgia;Germany;Hungary;India;Italy;Kazakhstan;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Switzerland;Ukraine;United Kingdom;United States;
      2020   Phase 2   EUCTR2020-000047-31-GB   Belarus;Bulgaria;Canada;France;Georgia;Germany;Hungary;India;Italy;Kazakhstan;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Switzerland;Ukraine;United Kingdom;United States;
      2020   Phase 2   EUCTR2020-000047-31-FR   Belarus;Belgium;Bulgaria;Canada;Czech Republic;France;Georgia;Germany;Hungary;India;Italy;Kazakhstan;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Switzerland;Ukraine;United Kingdom;United States;
      2020   Phase 2   EUCTR2020-000047-31-BG   Belarus;Belgium;Bulgaria;Canada;France;Georgia;Germany;Hungary;India;Italy;Kazakhstan;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Switzerland;Ukraine;United Kingdom;United States;
AMT-101 (oral)   
   Applied Molecular Transport
      2020   Phase 2   NCT04583358   Bulgaria;Canada;France;Georgia;Germany;Hungary;Moldova, Republic of;Poland;Russian Federation;Switzerland;Ukraine;United Kingdom;United States;
AND (Andrographolide)   
   Nutrition Science Partners Limited
      2014   -   EUCTR2013-003060-31-PL   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2014   -   EUCTR2013-003060-31-LV   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2014   -   EUCTR2013-003060-31-LT   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2014   -   EUCTR2013-003060-31-HU   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2014   -   EUCTR2013-003060-31-CZ   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2014   -   EUCTR2013-003060-31-BG   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2013   Phase 3   EUCTR2013-002116-27-CZ   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
      2013   -   EUCTR2013-002116-27-LV   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
      2013   -   EUCTR2013-002116-27-LT   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
      2013   -   EUCTR2013-002116-27-HU   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
      2013   -   EUCTR2013-002116-27-BG   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
ANDROGRAPHIS PANICULATA   
   Nutrition Science Partners Limited
      2014   -   EUCTR2013-003060-31-PL   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2014   -   EUCTR2013-003060-31-LV   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2014   -   EUCTR2013-003060-31-LT   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2014   -   EUCTR2013-003060-31-HU   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2014   -   EUCTR2013-003060-31-CZ   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2014   -   EUCTR2013-003060-31-BG   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2013   Phase 3   EUCTR2013-002116-27-CZ   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
      2013   -   EUCTR2013-002116-27-LV   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
      2013   -   EUCTR2013-002116-27-LT   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
      2013   -   EUCTR2013-002116-27-HU   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
      2013   -   EUCTR2013-002116-27-BG   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
ANDROGRAPHIS PANICULATA (ethanol extract)   
   Hutchison MediPharma Enterprises Limited
      2008   -   EUCTR2007-005166-12-DE   Germany;
AODG (Apigenin-7-O-glucuronide)   
   Nutrition Science Partners Limited
      2014   -   EUCTR2013-003060-31-PL   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2014   -   EUCTR2013-003060-31-LV   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2014   -   EUCTR2013-003060-31-LT   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2014   -   EUCTR2013-003060-31-HU   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2014   -   EUCTR2013-003060-31-CZ   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2014   -   EUCTR2013-003060-31-BG   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2013   Phase 3   EUCTR2013-002116-27-CZ   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
      2013   -   EUCTR2013-002116-27-LV   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
      2013   -   EUCTR2013-002116-27-LT   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
      2013   -   EUCTR2013-002116-27-HU   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
      2013   -   EUCTR2013-002116-27-BG   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
APD334   
   ARENA PHARMACEUTICALS, INC.
      2021   Phase 2   EUCTR2020-003507-34-IT   Australia;Belgium;Bulgaria;Canada;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Moldova, Republic of;Netherlands;Poland;Portugal;Russian Federation;South Africa;Spain;United States;
      2019   Phase 3   EUCTR2018-003987-29-IT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
   Arena Pharmaceuticals Inc.
      2020   Phase 3   EUCTR2018-003987-29-PT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-003987-29-FR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-003987-29-DE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-003987-29-BG   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-003987-29-AT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-003985-15-FR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-003985-15-AT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003987-29-SK   Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003987-29-NL   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003987-29-LV   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003987-29-LT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003987-29-HU   Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003987-29-HR   Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003987-29-ES   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003987-29-DK   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003987-29-BE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003986-33-SK   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003985-15-SK   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003985-15-PT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003985-15-NL   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003985-15-LV   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003985-15-LT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003985-15-HU   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003985-15-HR   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003985-15-ES   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003985-15-EE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003985-15-DK   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003985-15-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003985-15-BG   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2018-003987-29-PL   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2018-003987-29-EE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2018-003987-29-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2018-003985-15-PL   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2018-003985-15-DE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2018-003985-15-BE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
   Arena Pharmaceuticals, Inc.
      2021   Phase 2   EUCTR2020-003507-34-PT   Australia;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;United States;
      2021   Phase 2   EUCTR2020-003507-34-HU   Australia;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;United States;
      2021   Phase 2   EUCTR2020-003507-34-FR   Australia;Belgium;Bulgaria;Canada;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Moldova, Republic of;Netherlands;Poland;Portugal;Russian Federation;South Africa;Spain;United States;
      2021   Phase 2   EUCTR2020-003507-34-BG   Australia;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;United States;
      2020   Phase 3   EUCTR2018-003986-33-PT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-003986-33-LV   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-003986-33-GB   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-003986-33-FR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-003986-33-ES   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-003986-33-DK   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-003986-33-BG   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-003986-33-AT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003986-33-NL   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003986-33-LT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003986-33-HU   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003986-33-HR   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003986-33-BE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2017   Phase 2   EUCTR2016-003797-40-DE   Belgium;Germany;United States;
      2017   Phase 2   EUCTR2016-003797-40-BE   Belgium;Germany;United States;
      2017   Phase 2   EUCTR2015-001942-28-FR   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
      2017   Phase 2   EUCTR2015-001942-28-DE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Spain;Ukraine;United Kingdom;United States;
      2016   Phase 2   EUCTR2015-002109-12-LV   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
      2016   Phase 2   EUCTR2015-002109-12-LT   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
      2016   Phase 2   EUCTR2015-002109-12-HU   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Spain;Ukraine;United Kingdom;United States;
      2016   Phase 2   EUCTR2015-002109-12-GB   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
      2016   Phase 2   EUCTR2015-002109-12-ES   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
      2016   Phase 2   EUCTR2015-002109-12-CZ   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
      2016   Phase 2   EUCTR2015-002109-12-BG   Austria;Belgium;Bulgaria;Canada;Czech Republic;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
      2016   Phase 2   EUCTR2015-002109-12-BE   Austria;Belgium;Bulgaria;Canada;Czech Republic;Germany;Hungary;Latvia;Lithuania;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
      2016   Phase 2   EUCTR2015-002109-12-AT   Austria;Belgium;Bulgaria;Canada;Czech Republic;Germany;Hungary;Latvia;Lithuania;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
      2016   Phase 2   EUCTR2015-001942-28-PL   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
      2016   Phase 2   EUCTR2015-001942-28-GB   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
      2016   Phase 2   EUCTR2015-001942-28-BE   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Latvia;Lithuania;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
      2016   Phase 2   EUCTR2015-001942-28-AT   Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Latvia;Lithuania;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
      2015   Phase 2   EUCTR2015-001942-28-LT   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Korea, Republic of;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
      2015   Phase 2   EUCTR2015-001942-28-ES   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
      2015   Phase 2   EUCTR2015-001942-28-CZ   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Latvia;Lithuania;New Zealand;Poland;Romania;Spain;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2018-003986-33-PL   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2018-003986-33-EE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2018-003986-33-DE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2018-003986-33-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
APD334 L-arginine   
   ARENA PHARMACEUTICALS, INC.
      2019   Phase 3   EUCTR2018-003986-33-IT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003985-15-IT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
APRISO 375 mg extended-release capsules   
   Bausch Health Americas, Inc.
      2017   Phase 1   NCT03327558   United States;
APVO210   
   Aptevo Therapeutics
      2019   Phase 1   NCT03768219   Australia;
AR401959 L-arginine   
   Arena Pharmaceuticals Inc.
      2020   Phase 3   EUCTR2018-003987-29-PT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-003987-29-FR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-003987-29-DE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-003987-29-BG   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-003987-29-AT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-003985-15-FR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-003985-15-AT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003987-29-SK   Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003987-29-NL   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003987-29-LV   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003987-29-LT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003987-29-HU   Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003987-29-HR   Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003987-29-ES   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003987-29-DK   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003987-29-BE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003986-33-SK   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003985-15-SK   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003985-15-PT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003985-15-NL   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003985-15-LV   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003985-15-LT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003985-15-HU   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003985-15-HR   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003985-15-ES   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003985-15-EE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003985-15-DK   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003985-15-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003985-15-BG   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2018-003987-29-PL   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2018-003987-29-EE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2018-003987-29-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2018-003985-15-PL   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2018-003985-15-DE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2018-003985-15-BE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
   Arena Pharmaceuticals, Inc.
      2021   Phase 2   EUCTR2020-003507-34-PT   Australia;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;United States;
      2021   Phase 2   EUCTR2020-003507-34-HU   Australia;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;United States;
      2021   Phase 2   EUCTR2020-003507-34-FR   Australia;Belgium;Bulgaria;Canada;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Moldova, Republic of;Netherlands;Poland;Portugal;Russian Federation;South Africa;Spain;United States;
      2021   Phase 2   EUCTR2020-003507-34-BG   Australia;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;United States;
      2020   Phase 3   EUCTR2018-003986-33-PT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-003986-33-LV   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-003986-33-GB   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-003986-33-FR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-003986-33-ES   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-003986-33-DK   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-003986-33-BG   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-003986-33-AT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003986-33-NL   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003986-33-LT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003986-33-HU   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003986-33-HR   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003986-33-BE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2018-003986-33-PL   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2018-003986-33-EE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2018-003986-33-DE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2018-003986-33-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
AS INN   
   OSE Immunotherapeutics
      2020   Phase 2   EUCTR2020-001398-59-HR   Belarus;Belgium;Bulgaria;Croatia;France;Georgia;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Ukraine;
ASACOL   
   GIULIANI
      2009   -   EUCTR2008-007292-25-IT   Italy;
   GlaxoSmithKline Research and Development Ltd
      2009   Phase 2   EUCTR2009-011608-51-BE   Belgium;Germany;Sweden;
      2009   -   EUCTR2009-011608-51-SE   Germany;Sweden;
   GlaxoSmithKline Research and Development Ltd.
      2009   -   EUCTR2009-011608-51-DE   Germany;Sweden;
ASC   
   Fundacion para la Investigacion Biomedica Hospital Universitario La Paz
      2012   -   EUCTR2010-023798-20-ES   Spain;
ASP015K   
   Janssen-Cilag International NV
      2014   Phase 2   EUCTR2013-000263-88-RO   Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
      2014   Phase 2   EUCTR2013-000263-88-DE   Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
      2014   Phase 2   EUCTR2013-000263-88-BG   Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
      2014   -   EUCTR2013-000263-88-PL   Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
      2014   -   EUCTR2013-000263-88-NL   Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
      2014   -   EUCTR2013-000263-88-HU   Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
      2014   -   EUCTR2013-000263-88-BE   Australia;Belgium;Bulgaria;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
ASP3291   
   Telsar Pharma Inc.
      2012   Phase 2   NCT01612039   United States;
      2010   Phase 1   NCT01320332   United States;
AST-120   
   Ocera Therapeutics, Inc.
      2007   -   EUCTR2005-005363-28-HU   Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom;
      2007   -   EUCTR2005-005363-28-AT   Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom;
      2006   Phase 3   EUCTR2005-005363-28-GB   Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom;
      2006   -   EUCTR2005-005363-28-DE   Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom;
      2006   -   EUCTR2005-005363-28-CZ   Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom;
      2006   -   EUCTR2005-005363-28-BE   Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom;
ATL-2502   
   ALIZYME
      2006   -   EUCTR2004-005032-35-IT   Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom;
   Alizyme Therapeutics Limited
      2007   -   EUCTR2004-005032-35-BE   Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom;
      2005   Phase 3   EUCTR2004-005032-35-GB   Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom;
      2005   -   EUCTR2004-005032-35-SE   Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom;
      2005   -   EUCTR2004-005032-35-HU   Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom;
      2005   -   EUCTR2004-005032-35-DK   Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom;
      2005   -   EUCTR2004-005032-35-CZ   Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom;
AVX 470   
   Avaxia Biologics, Incorporated
      2013   Phase 1   NCT01759056   Belgium;Canada;Hungary;United States;
AZA   
   Dipartimento di Pediatria Università Federico II di Napoli
      2013   -   EUCTR2012-001653-13-IT   Italy;
AZAFOR   
   Dipartimento di Pediatria Università Federico II di Napoli
      2013   -   EUCTR2012-001653-13-IT   Italy;
AZAFOR - 50 MG COMPRESSE RIVESTITE CON FILM 50 COMPRESSE IN BLISTER PVC/PVDC/AL   
   IRCCS ISTITUTO CLINICO HUMANITAS
      2017   Phase 4   EUCTR2016-002707-25-IT   Italy;
AZATHIOPRINE BP   
   Instituto Clinico Humanitas
      2021   Phase 4   EUCTR2020-003420-16-BE   Austria;Belgium;France;Germany;Italy;Portugal;Spain;Sweden;Switzerland;United Kingdom;
AbGn-168H   
   AbGenomics International, Inc.
      2018   Phase 2   NCT03298022   Puerto Rico;United States;
Abalimumab   
   AbbVie GK
      2014   Phase 3   JPRN-JapicCTI-142649   Japan, North America, Europe;
Abatacept   
   Bristol-Myers Squibb International Corporation
      2008   -   EUCTR2006-003604-19-PL   Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
      2007   Phase 3   EUCTR2006-003604-19-GB   Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
      2007   Phase 3   EUCTR2006-003604-19-FR   Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
      2007   -   EUCTR2006-003604-19-IT   Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
      2007   -   EUCTR2006-003604-19-IE   Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
      2007   -   EUCTR2006-003604-19-DE   Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
      2007   -   EUCTR2006-003604-19-CZ   Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
      2007   -   EUCTR2006-003604-19-BE   Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
Abatacept (ABA)   
   Bristol-Myers Squibb
      2006   Phase 3   NCT00410410   Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;France;Germany;India;Ireland;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Puerto Rico;South Africa;Spain;Switzerland;United Kingdom;United States;
Abrilumab   
   Amgen
      2012   Phase 2   NCT01694485   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Norway;Poland;Russian Federation;Switzerland;United Kingdom;United States;
Accelerated 1 hour-infusion   
   Asan Medical Center
      2011   Phase 4   NCT01346826   Korea, Republic of;
Accelerated 30 minutes-infusion   
   Asan Medical Center
      2011   Phase 4   NCT01346826   Korea, Republic of;
Acetic acid   
   Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
      2015   -   JPRN-UMIN000021460   Japan;
Acidophilus   
   Odense University Hospital
      2003   -   NCT00374725   Denmark;
Adalimumab   
   AbbVie
      2016   -   NCT02750800   Hungary;
      2015   Phase 3   NCT02632175   Japan;Poland;Slovakia;Spain;United Kingdom;United States;
      2014   Phase 3   NCT02065622   Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Romania;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
      2014   Phase 3   NCT02065557   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Hungary;Israel;Italy;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
      2013   -   NCT01768858   Austria;
   AbbVie (prior sponsor, Abbott)
      2012   Phase 3   NCT01550965   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      2009   Phase 3   NCT00853099   Japan;
      2007   Phase 3   NCT00573794   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Poland;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;United States;
   AbbVie Deutschland GmbH & Co. KG
      2009   Phase 3   EUCTR2007-004157-28-SE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
      2008   Phase 3   EUCTR2007-004157-28-NL   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
      2008   Phase 3   EUCTR2007-004157-28-HU   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
      2008   Phase 3   EUCTR2007-004157-28-DE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
      2008   Phase 3   EUCTR2007-004157-28-CZ   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
      2008   Phase 3   EUCTR2007-004157-28-BE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
      2008   Phase 3   EUCTR2007-004157-28-AT   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
   AbbVie GK
      2014   Phase 3   JPRN-JapicCTI-142649   Japan, North America, Europe;
      2014   Phase 3   JPRN-JapicCTI-142648   Japan, North America, Europe;
      2009   Phase 2-3   JPRN-JapicCTI-090718   -
   Abbott
      2006   Phase 3   NCT00408629   Argentina;Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;New Zealand;Norway;Poland;Portugal;Spain;Sweden;Switzerland;United States;
      2006   Phase 3   NCT00385736   Austria;Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Netherlands;Poland;Puerto Rico;Slovakia;Sweden;United States;
   Abbott GmbH & Co. KG
      2009   Phase 3   EUCTR2007-004157-28-PT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;
      2008   Phase 3   EUCTR2007-004157-28-SK   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;
      2008   Phase 3   EUCTR2007-004157-28-IT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;
      2008   Phase 3   EUCTR2007-004157-28-FR   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;
      2008   -   EUCTR2006-002782-40-DE   Austria;Czech Republic;Denmark;France;Germany;Hungary;Portugal;
      2008   -   EUCTR2006-002782-40-AT   Austria;Czech Republic;Denmark;France;Germany;Hungary;Portugal;
      2008   -   EUCTR2006-002781-20-SE   Austria;Czech Republic;Germany;Hungary;Italy;Sweden;
      2008   -   EUCTR2006-002781-20-AT   Austria;Czech Republic;Germany;Hungary;Italy;Sweden;
      2007   Phase 3   EUCTR2006-002782-40-FR   Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Portugal;Spain;
      2007   Phase 3   EUCTR2006-002781-20-SK   Austria;Belgium;Czech Republic;Germany;Hungary;Italy;Slovakia;Sweden;
      2007   -   EUCTR2006-002782-40-PT   Austria;Czech Republic;Denmark;France;Germany;Hungary;Portugal;
      2007   -   EUCTR2006-002782-40-HU   Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Portugal;Spain;
      2007   -   EUCTR2006-002782-40-ES   Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Portugal;Spain;
      2007   -   EUCTR2006-002782-40-DK   Austria;Czech Republic;Denmark;France;Germany;Hungary;Portugal;
      2007   -   EUCTR2006-002782-40-CZ   Austria;Czech Republic;Denmark;France;Germany;Hungary;Portugal;
      2007   -   EUCTR2006-002782-40-BE   Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Portugal;Spain;
      2007   -   EUCTR2006-002781-20-HU   Austria;Czech Republic;Germany;Hungary;Italy;Sweden;
      2007   -   EUCTR2006-002781-20-DE   Austria;Czech Republic;Germany;Hungary;Italy;Sweden;
      2007   -   EUCTR2006-002781-20-CZ   Austria;Czech Republic;Germany;Hungary;Italy;Sweden;
      2007   -   EUCTR2006-002781-20-BE   Austria;Belgium;Czech Republic;Germany;Hungary;Italy;Sweden;
   Clalit Health Services
      2012   Phase 3   NCT01494857   Israel;
   Fukuyama Medical Center
      2016   -   JPRN-UMIN000020840   Japan;
   Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
      2020   Phase 4   NCT04183608   France;
   Hoffmann-La Roche
      2014   Phase 3   NCT02171429   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czechia;France;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States;
      2014   Phase 3   NCT02163759   Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States;
   Instituto Clinico Humanitas
      2021   Phase 4   EUCTR2020-003420-16-BE   Austria;Belgium;France;Germany;Italy;Portugal;Spain;Sweden;Switzerland;United Kingdom;
   Iwate Medical UniversityKochi Medical School HospitalKeio University School of Medicine
      2016   -   JPRN-UMIN000019958   Japan;
   Keio University Gastroenterology and Hepatology
      2016   -   JPRN-UMIN000024936   Japan;
   Mayo Clinic
      2006   Phase 1   NCT00421642   United States;
   McMaster University
      2018   Phase 4   NCT03059849   -
   Odense University Hospital
      2012   Phase 3   NCT01670240   Denmark;
   Osaka Medical College
      2014   -   JPRN-UMIN000015912   Japan;
   Royal Liverpool University Hospital
      2012   -   EUCTR2011-006084-22-GB   United Kingdom;
   Sakura Medical Center, Toho university
      2018   -   JPRN-UMIN000030988   Japan;
   Sakura Medical Center,Toho university
      2015   -   JPRN-UMIN000019066   Japan;
   Shandong Qilu Stem Cells Engineering Co., Ltd.
      2021   -   NCT04882683   China;
   Takeda
      2015   Phase 3   NCT02497469   Argentina;Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
   The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine
      2021   Phase 0   ChiCTR2100046284   China;
   University of Western Ontario, Canada
      2014   Phase 4   NCT01960426   United States;
      2013   Phase 4   NCT01716039   -
Adipose derived, autologous mesenchymal stem cells   
   Mayo Clinic
      2020   Phase 1   NCT04312113   United States;
Adipose tissue-derived mesenchymal stem cells   
   Fundacion para la Investigacion Biomedica Hospital Universitario La Paz
      2012   -   EUCTR2010-023798-20-ES   Spain;
Adipose-cord mesenchymal stromal cells (A-MSCs)   
   Liaocheng People's Hospital
      2018   Phase 1/Phase 2   NCT03609905   China;
Algin   
   Ishikawa Dai
      2020   -   JPRN-jRCTs031200103   Japan;
Alicaforsen   
   Isis Pharmaceuticals
      2003   Phase 2   NCT00063830   United States;
      2003   Phase 2   NCT00063414   United States;
Allogeneic adipose tissue-derived mesenchymal stem cells   
   Instituto de Investigación Hospital Universitario La Paz
      2013   Phase 1/Phase 2   NCT01914887   Spain;
Allopurinol   
   SOIBD (The Swedish Organisation for the study of Inflammatory Bowel Diseases)
      2018   Phase 4   EUCTR2016-004112-35-SE   Sweden;
AloASC   
   Fundacion para la Investigacion Biomedica Hospital Universitario La Paz
      2012   -   EUCTR2010-023798-20-ES   Spain;
Aloe Barbadensis Miller   
   National Institute of Medical Sciences and Nutrition, Salvador Zubiran
      2012   Phase 0   NCT01783119   Mexico;
Aloe vera gel   
   Ospedale Sandro Pertini, Roma
      2010   -   NCT04753775   -
Also referred to as 'MEDI2070'   
   ASTRAZENECA AB
      2021   Phase 2   EUCTR2021-001644-10-IT   Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
   AstraZeneca AB
      2022   Phase 2   EUCTR2021-001644-10-HU   Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2021   Phase 2   EUCTR2021-001644-10-ES   Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Also referred to as MEDI2070   
   AstraZeneca AB
      2021   Phase 2   EUCTR2018-001605-93-HU   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2020   Phase 2   EUCTR2018-001605-93-DE   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2020   Phase 2   EUCTR2018-001605-93-AT   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-001605-93-CZ   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Amg 181   
   Amgen
      2010   Phase 1   NCT01164904   Australia;New Zealand;United States;
Amgevita   
   IRCCS ISTITUTO CLINICO HUMANITAS
      2021   Phase 4   EUCTR2020-003420-16-IT   Austria;Belgium;France;Germany;Italy;Portugal;Spain;Sweden;Switzerland;United Kingdom;
   Instituto Clinico Humanitas
      2021   Phase 4   EUCTR2020-003420-16-ES   Austria;Belgium;France;Germany;Italy;Portugal;Spain;Sweden;Switzerland;United Kingdom;
      2021   Phase 4   EUCTR2020-003420-16-BE   Austria;Belgium;France;Germany;Italy;Portugal;Spain;Sweden;Switzerland;United Kingdom;
   University Medical Center Groningen
      2021   Phase 4   EUCTR2020-001811-26-BE   Belgium;Netherlands;
      2020   Phase 4   EUCTR2020-001811-26-NL   Netherlands;
Amgevita 40 mg Injektionslösung im Fertigpen   
   Universitätsklinikum Erlangen
      2019   Phase 4   EUCTR2019-003662-40-DE   Germany;
Amgevita 40 mg Injektionslösung in einer Fertigspritze   
   Universitätsklinikum Erlangen
      2019   Phase 4   EUCTR2019-003662-40-DE   Germany;
Amgevita 40Mg Solution for Injection   
   Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
      2019   Phase 4   NCT04131322   Spain;
Amiselimod   
   Salix Pharmaceuticals, Inc.
      2021   Phase 2   EUCTR2020-005232-30-SK   Australia;Belarus;Belgium;Bulgaria;Czechia;Estonia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia;Taiwan;Ukraine;United States;
      2021   Phase 2   EUCTR2020-005232-30-HU   Australia;Belarus;Belgium;Bulgaria;Czechia;Estonia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia;Taiwan;Ukraine;United States;
      2021   Phase 2   EUCTR2020-005232-30-EE   Australia;Belarus;Belgium;Bulgaria;Czechia;Estonia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia;Taiwan;Ukraine;United States;
      2021   Phase 2   EUCTR2020-005232-30-DE   Australia;Belarus;Belgium;Bulgaria;Czechia;Estonia;France;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Moldova, Republic of;New Zealand;Poland;Russian Federation;Serbia;Slovakia;Taiwan;Ukraine;United States;
      2021   Phase 2   EUCTR2020-005232-30-BG   Australia;Belarus;Belgium;Bulgaria;Canada;Estonia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia;Taiwan;Ukraine;United States;
Amitriptyline hydrochloride   
   University of Leeds
      2020   Phase 2;Phase 3   EUCTR2019-003220-21-GB   United Kingdom;
Amoxicillin   
   Division of General Medicine, Department of Internal Medicine, Nihon University School of Medicine
      2013   Phase 3   JPRN-UMIN000009811   Japan;
   Hokkaido University Hospital
      2016   -   JPRN-UMIN000024520   Japan;
   Ishikawa Dai
      2017   -   JPRN-jRCTs031180415   Japan;
   Japan UC Antibiotics-therapy Study Group(JUCASG)
      2003   Phase 2   JPRN-C000000078   Japan;
   Juntendo university school of medicine Department of gastroenterology
      2015   -   JPRN-UMIN000018642   Japan;
      2014   -   JPRN-UMIN000014152   Japan;
   Juntendo university school of medicineDepartment of gastroenterology
      2017   -   JPRN-UMIN000025846   Japan;
   National Center for Child Health and Development
      2016   -   JPRN-UMIN000026485   Japan;
   Shiga University of Medical Science
      2015   -   JPRN-UMIN000017844   Japan;
Amoxicillin and doxycyclin   
   Wolfson Medical Center
      2019   Phase 2   NCT03986996   Israel;
Amoxicillin, metronidazole and doxycycline   
   Wolfson Medical Center
      2019   Phase 2   NCT03986996   Israel;
Anakinra   
   Cambridge University Hospitals NHS Foundation Trust & University of Cambridge
      2017   Phase 2   EUCTR2017-001389-10-GB   United Kingdom;
Andecaliximab   
   Gilead Sciences
      2015   Phase 2/Phase 3   NCT02520284   Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Germany;Hong Kong;Hungary;Iceland;Ireland;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
AndoSan   
   Oslo University Hospital
      2011   Phase 2/Phase 3   NCT01496053   Norway;
Anrukinzumab   
   Pfizer
      2011   Phase 2   NCT01284062   Austria;Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Spain;United States;
Anti Beta7   
   Genentech, Inc.
      2012   Phase 2   EUCTR2011-003409-36-CZ   Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
      2011   Phase 2   EUCTR2011-003409-36-GB   Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
Anti CD3 monoclonal antibody   
   PDL BioPharma, Inc
      2006   -   EUCTR2005-004105-28-NL   France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
   PDL BioPharma, Inc.
      2007   -   EUCTR2005-004105-28-GR   France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
      2007   -   EUCTR2005-004105-28-FR   France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
      2006   Phase 2   EUCTR2005-004105-28-IE   France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
      2006   -   EUCTR2005-004105-28-GB   France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
      2006   -   EUCTR2005-004105-28-DE   France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
Anti TNF therapy including infliximab   
   Janssen Biotech, Inc.
      2007   -   NCT00606346   Canada;United States;
Anti-CD3 monoclonal antibody   
   PDL BioPharma, Inc
      2007   -   EUCTR2005-003707-37-BE   Austria;Belgium;
      2007   -   EUCTR2005-003707-37-AT   Austria;Belgium;
      2006   Phase 2;Phase 3   EUCTR2005-002063-87-SK   Austria;Belgium;Czech Republic;Germany;Hungary;Slovakia;
      2006   Phase 2   EUCTR2005-003481-42-IE   Austria;Czech Republic;Germany;Greece;Hungary;Ireland;Slovakia;Spain;
      2006   -   EUCTR2005-003481-42-ES   Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;
      2006   -   EUCTR2005-002063-87-DE   Belgium;Czech Republic;Germany;Hungary;
   PDL BioPharma, Inc.
      2007   -   EUCTR2005-003482-17-GR   Greece;Ireland;Italy;Spain;United Kingdom;
      2007   -   EUCTR2005-003482-17-GB   Greece;Ireland;Italy;Spain;United Kingdom;
      2007   -   EUCTR2005-003481-42-GR   Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;
      2006   Phase 2   EUCTR2005-003482-17-IE   Greece;Ireland;Italy;Spain;United Kingdom;
      2006   -   EUCTR2005-003482-17-ES   Greece;Ireland;Italy;Spain;United Kingdom;
      2006   -   EUCTR2005-003481-42-HU   Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;
      2006   -   EUCTR2005-003481-42-DE   Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;
      2006   -   EUCTR2005-003481-42-CZ   Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;
      2006   -   EUCTR2005-002063-87-CZ   Belgium;Czech Republic;Germany;Hungary;
   Protein Design Labs, Inc
      2006   Phase 2   EUCTR2005-003481-42-SK   Austria;Czech Republic;Germany;Greece;Hungary;Ireland;Slovakia;Spain;
      2006   -   EUCTR2005-003481-42-AT   Austria;Czech Republic;Germany;Greece;Hungary;Ireland;Slovakia;Spain;
   Protein Design Labs, Inc.
      2006   -   EUCTR2005-002063-87-HU   Belgium;Czech Republic;Germany;Hungary;
      2006   -   EUCTR2005-002063-87-BE   Belgium;Czech Republic;Germany;Hungary;
      2005   -   EUCTR2005-002063-87-AT   Austria;Belgium;Czech Republic;Germany;Hungary;
Anti-IP-10 Antibody   
   Bristol-Myers Squibb
      2011   Phase 2   NCT01294410   Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Huma   
   ALLERGAN LIMITED
      2019   Phase 2   EUCTR2018-001605-93-IT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human Monoclonal Antibody   
   ALLERGAN LIMITED
      2019   Phase 2   EUCTR2018-001605-93-IT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
   ASTRAZENECA AB
      2021   Phase 2   EUCTR2021-001644-10-IT   Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
   Allergan Ltd.
      2019   Phase 2   EUCTR2018-001605-93-RO   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-001605-93-FR   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-001605-93-ES   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-001605-93-BG   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
   AstraZeneca AB
      2022   Phase 2   EUCTR2021-001644-10-HU   Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2021   Phase 2   EUCTR2021-001644-10-ES   Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2021   Phase 2   EUCTR2018-001605-93-HU   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2020   Phase 2   EUCTR2018-001605-93-DE   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2020   Phase 2   EUCTR2018-001605-93-AT   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-001605-93-GB   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-001605-93-CZ   Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-001605-93-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
Anti-MAdCAM antibody   
   Baxalta Innovations GmbH
      -   Phase 3   EUCTR2017-000573-37-BE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
   Pfizer Inc, 235 East 42nd Street, New York, NY10017, United States
      2014   -   EUCTR2012-002030-37-HR   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
      2013   Phase 2   EUCTR2012-002031-28-SE   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
      2013   Phase 2   EUCTR2012-002031-28-IT   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
      2013   Phase 2   EUCTR2012-002031-28-HU   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
      2013   Phase 2   EUCTR2012-002031-28-ES   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
      2013   Phase 2   EUCTR2012-002030-37-DE   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
      2013   Phase 2   EUCTR2012-002030-37-CZ   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
      2013   Phase 2   EUCTR2012-002030-37-BG   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
      2013   Phase 2   EUCTR2012-002030-37-AT   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
      2013   -   EUCTR2012-002030-37-SK   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
      2013   -   EUCTR2012-002030-37-SE   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
      2013   -   EUCTR2012-002030-37-PL   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
      2013   -   EUCTR2012-002030-37-NL   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
      2013   -   EUCTR2012-002030-37-IT   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
      2013   -   EUCTR2012-002030-37-HU   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
      2013   -   EUCTR2012-002030-37-ES   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
   Pfizer Inc.
      2013   -   EUCTR2012-002030-37-BE   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Serbia;Slovakia;South Africa;Spain;Sweden;Switzerland;United Kingdom;
   Shire Human Genetic Therapie, Inc.
      2013   Phase 2   EUCTR2012-002031-28-BG   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
   Shire Human Genetic Therapies, Inc.
      2019   Phase 3   EUCTR2017-000574-11-GR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-000574-11-ES   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-000573-37-ES   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-000572-28-FR   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Mexico;Portugal;Slovakia;Spain;Switzerland;Ukraine;United States;
      2018   Phase 3   EUCTR2017-000572-28-ES   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Mexico;Portugal;Slovakia;Spain;Switzerland;Ukraine;United States;
      2017   Phase 3   EUCTR2017-000573-37-GR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2017-000572-28-GR   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Mexico;Portugal;Slovakia;Spain;Switzerland;Ukraine;United States;
      2013   Phase 2   EUCTR2012-002031-28-SK   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
      2013   Phase 2   EUCTR2012-002031-28-PL   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
      2013   Phase 2   EUCTR2012-002031-28-NL   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
      2013   Phase 2   EUCTR2012-002031-28-DE   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
      2013   Phase 2   EUCTR2012-002031-28-CZ   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
      2013   Phase 2   EUCTR2012-002031-28-BE   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
      2013   Phase 2   EUCTR2012-002031-28-AT   Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Norway;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States;
Anti-TL1A   
   Pfizer Inc
      2020   Phase 2   EUCTR2019-002698-74-SK   Australia;Belgium;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 2   EUCTR2019-002698-74-PL   Australia;Austria;Belgium;Bulgaria;Canada;China;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 2   EUCTR2019-002698-74-HU   Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
      2020   Phase 2   EUCTR2019-002698-74-GB   Australia;Austria;Belgium;Bulgaria;Canada;China;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 2   EUCTR2019-002698-74-FR   Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
      2020   Phase 2   EUCTR2019-002698-74-ES   Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
      2020   Phase 2   EUCTR2019-002698-74-DE   Australia;Austria;Belgium;Bulgaria;Canada;China;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 2   EUCTR2019-002698-74-BG   Australia;Austria;Belgium;Bulgaria;Canada;China;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 2   EUCTR2019-002698-74-BE   Australia;Austria;Belgium;Bulgaria;Canada;China;France;Germany;Hungary;India;Italy;Japan;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States;
Anti-TNF Drug   
   HaEmek Medical Center, Israel
      2009   -   NCT03747068   -
Anti-TNF Therapy   
   Takeda
      2017   -   NCT03090139   Argentina;China;Colombia;Korea, Republic of;Mexico;Russian Federation;Saudi Arabia;Singapore;Taiwan;Turkey;
Anti-TNF discontinuation: Physiological saline solution   
   Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
      2017   Phase 4   NCT02994836   Spain;
Anti-TNF: Infliximab (Infusion)   
   Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
      2017   Phase 4   NCT02994836   Spain;
Anti-TNF:Adalimumab (Subcutaneus)   
   Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
      2017   Phase 4   NCT02994836   Spain;
Antibiotic cocktail   
   Prof. Arie Levine
      2015   Phase 4   NCT02345733   Canada;Israel;United States;
      2014   -   NCT02217722   Israel;
Apixaban 2.5 milligram   
   McMaster University
      2021   Early Phase 1   NCT03935451   Canada;
Apremilast   
   Amgen
      2015   Phase 2   NCT02289417   Australia;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Russian Federation;Ukraine;United States;
Apriso 0.375G ER CAP   
   Bausch Health Americas, Inc.
      2017   Phase 1   NCT03327558   United States;
Aquamin   
   James Varani
      2021   Phase 2   NCT04855799   United States;
Aquamin®   
   James Varani
      2019   Phase 2   NCT03869905   United States;
Asacol   
   Annette Langseder
      2006   -   NCT00349388   United States;
   Procter & Gamble Pharmaceuticals
      -   Phase 3   EUCTR2007-005702-49-PL   Poland;
   Shire
      2005   Phase 3   NCT00151892   Argentina;Australia;Belgium;Brazil;Canada;Chile;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Korea, Republic of;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Singapore;South Africa;Spain;Sweden;Taiwan;United Kingdom;United States;
   Tillotts Pharma AG
      2015   Phase 3   EUCTR2013-000366-11-RO   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
      2014   Phase 3   EUCTR2013-000366-11-SK   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;Hungary;Ireland;Latvia;Lithuania;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;
      2014   Phase 3   EUCTR2013-000366-11-LV   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
      2014   Phase 3   EUCTR2013-000366-11-LT   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
      2014   Phase 3   EUCTR2013-000366-11-HU   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
      2014   Phase 3   EUCTR2013-000366-11-BG   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
      2013   Phase 3   NCT01903252   Netherlands;Switzerland;
      2013   Phase 3   EUCTR2013-000366-11-SE   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
      2013   Phase 3   EUCTR2013-000366-11-PL   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;Hungary;Ireland;Latvia;Lithuania;Poland;Romania;Russian Federation;Spain;Sweden;Ukraine;
      2013   Phase 3   EUCTR2013-000366-11-IE   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
      2013   Phase 3   EUCTR2013-000366-11-GB   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
      2013   Phase 3   EUCTR2013-000366-11-FI   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
      2013   Phase 3   EUCTR2013-000366-11-DK   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
      2013   Phase 3   EUCTR2013-000366-11-CZ   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
      2013   Phase 3   EUCTR2013-000366-11-BE   Belarus;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Hungary;Ireland;Latvia;Lithuania;Norway;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United Kingdom;
      2013   -   EUCTR2013-000366-11-ES   Belarus;Belgium;Bulgaria;Canada;Denmark;Finland;Hungary;Ireland;Latvia;Lithuania;Poland;Russian Federation;Spain;Sweden;Ukraine;
   Warner Chilcott
      2009   Phase 3   NCT01004185   Canada;Croatia;Poland;Romania;Russian Federation;United States;
      2008   Phase 3   NCT00713310   Canada;Croatia;Poland;Romania;United States;
Asacol (mesalamine)   
   University of Chicago
      2006   Phase 3   NCT00343850   United States;
   University of Washington
      2003   Phase 4   NCT00194818   United States;
Asacol (mesalamine) Delayed-release Tablets   
   Otsuka Maryland Research Institute, Inc.
      2004   -   EUCTR2004-000611-25-IE   Hungary;Ireland;
      2004   -   EUCTR2004-000611-25-HU   Hungary;Ireland;
Asacol 400 mg (mesalamine)   
   Warner Chilcott
      2000   Phase 3   NCT00073021   Canada;Puerto Rico;United States;
Asacol 400 mg tablet   
   Procter & Gamble Technical Centres Limited
      2006   -   EUCTR2006-001310-32-LT   Czech Republic;Estonia;Hungary;Latvia;Lithuania;
      2006   -   EUCTR2006-001310-32-HU   Czech Republic;Estonia;Hungary;Latvia;Lithuania;
      2006   -   EUCTR2006-001310-32-EE   Czech Republic;Estonia;Hungary;Latvia;Lithuania;
      2006   -   EUCTR2006-001310-32-CZ   Czech Republic;Estonia;Hungary;Latvia;Lithuania;
Asacol 400mg tablet   
   Procter & Gamble Technical Centres Limited
      2006   -   EUCTR2006-001310-32-LV   Czech Republic;Estonia;Hungary;Latvia;Lithuania;
Asacol 800 mg (mesalamine)   
   Warner Chilcott
      2000   Phase 3   NCT00073021   Canada;Puerto Rico;United States;
Asacol 800 mg tablet   
   Procter & Gamble Technical Centres Limited
      2006   -   EUCTR2006-001310-32-LT   Czech Republic;Estonia;Hungary;Latvia;Lithuania;
      2006   -   EUCTR2006-001310-32-HU   Czech Republic;Estonia;Hungary;Latvia;Lithuania;
      2006   -   EUCTR2006-001310-32-EE   Czech Republic;Estonia;Hungary;Latvia;Lithuania;
      2006   -   EUCTR2006-001310-32-CZ   Czech Republic;Estonia;Hungary;Latvia;Lithuania;
Asacol 800mg tablet   
   Procter & Gamble Technical Centres Limited
      2006   -   EUCTR2006-001310-32-LV   Czech Republic;Estonia;Hungary;Latvia;Lithuania;
Asacol Delayed Release Tablets   
   Shire Pharmaceutical Development Ltd
      2009   -   EUCTR2004-004184-29-DK   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2008   Phase 3   EUCTR2004-004184-29-NL   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2007   -   EUCTR2004-004184-29-SE   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2007   -   EUCTR2004-004184-29-PT   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2005   Phase 3   EUCTR2004-004184-29-HU   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2005   Phase 3   EUCTR2004-004184-29-GB   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2005   -   EUCTR2004-004184-29-ES   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2005   -   EUCTR2004-004184-29-DE   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2005   -   EUCTR2004-004184-29-CZ   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
Asacol Delayed-Release Tablets   
   EMET Pharmaceuticals LLC
      2008   -   EUCTR2007-004732-23-LV   Estonia;Latvia;Poland;
      2007   -   EUCTR2007-004732-23-EE   Estonia;Latvia;Poland;
   EMET Pharmaceuticals, LLC
      2008   -   EUCTR2007-004732-23-PL   Estonia;Latvia;Poland;
Asacol tablet   
   MOCHIDA PHARMACEUTICAL CO., LTD.
      2013   Phase 3   JPRN-JapicCTI-142475   -
Asacol®   
   Bausch Health Americas, Inc.
      2008   Phase 3   NCT00679432   Canada;India;Mexico;United States;
   Copenhagen University Hospital Hvidovre
      2019   Phase 4   EUCTR2019-002070-31-DK   Denmark;
   Otsuka Pharmaceutical Development & Commercialization, Inc.
      2004   Phase 3   NCT00092508   United States;
   Tillotts Pharma AG
      2010   Phase 3   NCT01257399   China;
      2010   Phase 3   NCT01257386   China;
Aspergillus oryzae   
   Graduate School of Medical Science, KyotoPrefectural University of Medicine
      2012   Phase 2   JPRN-UMIN000009364   Japan;
Atorvastatin Calcium   
   National Cancer Institute (NCI)
      2021   Phase 2   NCT04767984   United States;
Avonex   
   Biogen Idec Ltd
      2009   Phase 2   EUCTR2007-004867-22-SK   Czech Republic;Hungary;Slovakia;
      2008   -   EUCTR2007-004867-22-HU   Czech Republic;Hungary;
      2008   -   EUCTR2007-004867-22-CZ   Czech Republic;Hungary;
Azathioprine   
   Affiliated Hospital of Nanjing University of Chinese Medicine
      2015   Phase 1 study   ChiCTR-IPR-15005760   China;
   Essex Pharma GmbH
      2009   -   EUCTR2009-010065-23-DE   Germany;
   Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
      2016   Phase 4   NCT02425852   France;
   Indiana University
      2015   -   NCT02413047   United States;
   Istituto Clinico Humanitas
      2017   Phase 4   NCT03151525   Italy;
   Kyungpook National University Hospital
      2016   Phase 4   NCT02579733   Korea, Republic of;
   Merck Sharp & Dohme Corp.
      2009   Phase 3   NCT00984568   Germany;
   Region Örebro län
      2021   Phase 4   EUCTR2019-002942-19-DK   Denmark;
   SCHERING-PLOUGH
      2007   -   EUCTR2006-002670-22-IT   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
   SOIBD (The Swedish Organisation for the study of Inflammatory Bowel Diseases)
      2018   Phase 4   EUCTR2016-004112-35-SE   Sweden;
   Sakura Medical Center, Toho university
      2018   -   JPRN-UMIN000030988   Japan;
   Shandong Qilu Stem Cells Engineering Co., Ltd.
      2021   -   NCT04882683   China;
   The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine
      2021   Phase 0   ChiCTR2100046284   China;
Azathioprine (AZA)   
   Merck Sharp & Dohme Corp.
      2007   Phase 3   NCT00537316   Argentina;Belgium;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Ukraine;United Kingdom;
Azathioprine (AZA) or 6-mercaptopurine (6-MP)   
   ZonMw: The Netherlands Organisation for Health Research and Development
      2007   -   NCT00521950   Netherlands;
Azathioprine (Imuran) 50 mg Overencapsulated Tablet   
   Schering-Plough Research Institute, a division of Schering Corporation
      2007   Phase 3   EUCTR2006-002670-22-FR   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
Azathioprine and Allopurinol   
   Hvidovre University Hospital
      2016   Phase 3   NCT03101800   Denmark;
Azathioprine or 6-mercaptopurine   
   ZonMw: The Netherlands Organisation for Health Research and Development
      2007   -   NCT00521950   Netherlands;
B2-ASmedic   
   Novartis Pharma Services AG
      2007   -   EUCTR2007-002542-38-DE   Denmark;Germany;
B: 2 dosis   
   AB Biotics, SA
      2018   -   NCT03444311   Spain;
BBT-401-1S   
   Bridge Biotherapeutics, Inc.
      2021   Phase 2   NCT04596293   Korea, Republic of;New Zealand;Poland;Ukraine;United States;
      2021   Phase 2   EUCTR2020-003556-33-PL   Korea, Republic of;New Zealand;Poland;Ukraine;United States;
      2021   Phase 1   NCT04478825   New Zealand;
      2019   Phase 2   NCT03800420   United States;
BBT-401-1S, Multiple doses   
   Bridge Biotherapeutics, Inc.
      2018   Phase 1   NCT03482648   United States;
BBT-401-1S, Single dose   
   Bridge Biotherapeutics, Inc.
      2018   Phase 1   NCT03482648   United States;
BG9418 (Interferon beta-1a)   
   Biogen
      2008   Phase 2   NCT00616434   Canada;Czech Republic;Hungary;Poland;Russian Federation;Slovakia;United States;
BG9924   
   Biogen Idec Ltd.
      2011   Phase 2   EUCTR2010-019558-42-SK   Belgium;Czech Republic;Hungary;Slovakia;
      2011   -   EUCTR2010-019558-42-HU   Belgium;Czech Republic;Hungary;
      2011   -   EUCTR2010-019558-42-CZ   Belgium;Czech Republic;Hungary;
      2010   -   EUCTR2010-019558-42-BE   Belgium;Czech Republic;Hungary;
BGP-014   
   BioGaia Pharma AB
      2022   Phase 1/Phase 2   NCT05118919   Sweden;
BGP-014 Capsules   
   BioGaia Pharma AB
      2021   Phase 1;Phase 2   EUCTR2019-004578-25-SE   Sweden;
BI 655130   
   BOEHRINGER-INGELHEIM ITALIA S.P.A.
      2018   Phase 2;Phase 3   EUCTR2017-004230-28-IT   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
      2018   Phase 2   EUCTR2018-000334-35-IT   Australia;Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
   Boehringer Ingelheim BV Netherlands
      2017   Phase 2   EUCTR2016-004572-21-NL   Denmark;Germany;Netherlands;Norway;Spain;United Kingdom;
   Boehringer Ingelheim Denmark A/S
      2019   Phase 2;Phase 3   EUCTR2017-004230-28-DK   Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
   Boehringer Ingelheim España, S.A.
      2018   Phase 2;Phase 3   EUCTR2017-004230-28-ES   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
      2018   Phase 2   EUCTR2018-000334-35-ES   Austria;Belgium;Canada;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;United Kingdom;United States;
      2017   Phase 2   EUCTR2016-004572-21-ES   Denmark;Germany;Netherlands;Norway;Spain;
   Boehringer Ingelheim International GmbH
      2019   Phase 2;Phase 3   EUCTR2017-004230-28-HU   Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
      2019   Phase 2;Phase 3   EUCTR2017-004230-28-GR   Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
      2019   Phase 2;Phase 3   EUCTR2017-004230-28-CZ   Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
   Boehringer Ingelheim LImited
      2018   Phase 2   EUCTR2018-000334-35-GB   Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
   Boehringer Ingelheim Limited
      2018   Phase 2;Phase 3   EUCTR2017-004230-28-GB   Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
      2017   Phase 2   EUCTR2017-000100-20-GB   Belgium;Germany;United Kingdom;
      2017   Phase 2   EUCTR2016-004572-21-GB   Denmark;Germany;Netherlands;Norway;Spain;United Kingdom;
   Boehringer Ingelheim Norway KS
      2019   Phase 2   EUCTR2018-000334-35-NO   Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
      2017   Phase 2   EUCTR2016-004572-21-NO   Denmark;Germany;Netherlands;Norway;Spain;United Kingdom;
   Boehringer Ingelheim Pharma GmbH & Co. KG
      2018   Phase 2;Phase 3   EUCTR2017-004230-28-DE   Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
      2018   Phase 2   EUCTR2018-000334-35-DE   Australia;Austria;Belgium;Canada;Czechia;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
      2017   Phase 2   EUCTR2017-000100-20-DE   Belgium;Germany;United Kingdom;
      2017   Phase 2   EUCTR2016-004572-21-DK   Denmark;Germany;Netherlands;Norway;Spain;United Kingdom;
      2017   Phase 2   EUCTR2016-004572-21-DE   Denmark;Germany;Netherlands;Norway;Spain;United Kingdom;
   Boehringer Ingelheim RCV GmbH & Co KG
      2018   Phase 2;Phase 3   EUCTR2017-004230-28-AT   Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
   Boehringer Ingelheim RCV GmbH&Co. KG
      2019   Phase 2   EUCTR2018-000334-35-PL   Australia;Austria;Belgium;Canada;Czechia;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-000334-35-HU   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
      2018   Phase 2   EUCTR2018-000334-35-AT   Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
   Boehringer Ingelheim bv
      2018   Phase 2;Phase 3   EUCTR2017-004230-28-NL   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
   Boehringer Ingelheim bv Netherlands
      2019   Phase 2   EUCTR2018-000334-35-NL   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
   SCS Boehringer Ingelheim Comm. V
      2018   Phase 2;Phase 3   EUCTR2017-004230-28-BE   Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
      2018   Phase 2   EUCTR2018-000334-35-BE   Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
      2017   Phase 2   EUCTR2017-000100-20-BE   Belgium;Germany;United Kingdom;
BITTER CANDYTUFT FRESH PLANT EXTRACT   
   Steigerwald Arzneimittelwerk GmbH
      2014   -   EUCTR2013-000891-13-DE   Germany;
BL-7040   
   BioLineRx, Ltd.
      2012   Phase 2   NCT01506362   Israel;
BMS-188667   
   Bristol-Myers Squibb International Corporation
      2008   -   EUCTR2006-003604-19-PL   Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
      2007   Phase 3   EUCTR2006-003604-19-GB   Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
      2007   Phase 3   EUCTR2006-003604-19-FR   Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
      2007   -   EUCTR2006-003604-19-IE   Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
      2007   -   EUCTR2006-003604-19-DE   Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
      2007   -   EUCTR2006-003604-19-CZ   Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
      2007   -   EUCTR2006-003604-19-BE   Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
BMS-936557   
   Bristol-Myers Squibb International Corporation
      2011   Phase 2   EUCTR2010-022506-41-BE   Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
      2011   -   EUCTR2010-022506-41-PL   Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
      2011   -   EUCTR2010-022506-41-IT   Australia;Austria;Brazil;Canada;Germany;Hungary;Italy;Mexico;Poland;South Africa;United States;
      2011   -   EUCTR2010-022506-41-HU   Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
      2011   -   EUCTR2010-022506-41-DE   Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
      2011   -   EUCTR2010-022506-41-AT   Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
BMS-986165   
   BRISTOL-MYERS SQUIBB INTERNATIONAL CORPORATION
      2021   Phase 2   EUCTR2020-004461-40-IT   Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-004694-27-IT   Australia;Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States;
   Bristol-Myers Squibb
      2021   Phase 2   NCT04877990   Australia;Brazil;China;Germany;Hungary;Italy;Japan;Poland;Romania;Russian Federation;United Kingdom;United States;
      2019   Phase 2   NCT03934216   Australia;Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States;
   Bristol-Myers Squibb International Corporation
      2021   Phase 2   EUCTR2020-004461-40-DE   Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States;
      2021   Phase 2   EUCTR2019-004878-26-NL   Australia;Canada;Germany;Netherlands;United Kingdom;United States;
      2021   Phase 2   EUCTR2019-004878-26-DE   Australia;Canada;Germany;Netherlands;United Kingdom;United States;
      2020   Phase 2   EUCTR2018-004694-27-FR   Australia;Belgium;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-004694-27-PL   Australia;Belgium;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-004694-27-HU   Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;Spain;Switzerland;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-004694-27-GB   Australia;Belgium;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-004694-27-DE   Australia;Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-004694-27-CZ   Australia;Belgium;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States;
BMS-986165 Dose 1   
   Bristol-Myers Squibb
      2021   Phase 2   NCT04613518   Australia;Canada;Germany;Netherlands;Poland;Puerto Rico;United Kingdom;United States;
BMS-986165 Dose 2   
   Bristol-Myers Squibb
      2021   Phase 2   NCT04613518   Australia;Canada;Germany;Netherlands;Poland;Puerto Rico;United Kingdom;United States;
BMS-986166   
   Bristol-Myers Squibb
      2017   Phase 1   NCT03038711   United States;
BMS-986184   
   Bristol-Myers Squibb
      2016   Phase 1   NCT02864264   Australia;Georgia;Moldova, Republic of;Romania;
BMS986165   
   Bristol-Myers Squibb International Corporation
      2021   Phase 2   EUCTR2020-004461-40-DE   Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States;
      2021   Phase 2   EUCTR2019-004878-26-NL   Australia;Canada;Germany;Netherlands;United Kingdom;United States;
      2021   Phase 2   EUCTR2019-004878-26-DE   Australia;Canada;Germany;Netherlands;United Kingdom;United States;
      2020   Phase 2   EUCTR2018-004694-27-FR   Australia;Belgium;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-004694-27-PL   Australia;Belgium;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-004694-27-HU   Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;Spain;Switzerland;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-004694-27-GB   Australia;Belgium;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-004694-27-DE   Australia;Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-004694-27-CZ   Australia;Belgium;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Poland;Russian Federation;United Kingdom;United States;
BT-11   
   Landos Biopharma Inc.
      2020   Phase 2   EUCTR2018-005086-39-BG   Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
      2019   Phase 2   EUCTR2018-005086-39-PL   Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
      2019   Phase 2   EUCTR2018-005086-39-HU   Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
      2019   Phase 2   EUCTR2018-005086-39-HR   Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
BT-11 (1000 mg)   
   Landos Biopharma Inc.
      2019   Phase 2   NCT03861143   Belarus;Bosnia and Herzegovina;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
BT-11 (500 mg)   
   Landos Biopharma Inc.
      2019   Phase 2   NCT03861143   Belarus;Bosnia and Herzegovina;Croatia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
BT-11 Active   
   Landos Biopharma Inc.
      2018   Phase 1   NCT03860571   United States;
BT051 up to   
   Bacainn Therapeutics, Inc.
      2021   Phase 1   NCT05084261   Georgia;Moldova, Republic of;Poland;Ukraine;United States;
Bacteriotherapy   
   David Suskind
      2012   Phase 1   NCT01757964   United States;
Balsalazide   
   Roxane Laboratories
      2005   -   NCT00618202   United States;
      2004   -   NCT00618228   United States;
Balsalazide Disodium   
   Bausch Health Americas, Inc.
      2006   Phase 3   NCT00486031   United States;
Balsalazide disodium   
   Bausch Health Americas, Inc.
      2006   Phase 3   NCT00408174   United States;
Baminercept   
   Biogen Idec Ltd.
      2011   Phase 2   EUCTR2010-019558-42-SK   Belgium;Czech Republic;Hungary;Slovakia;
      2011   -   EUCTR2010-019558-42-HU   Belgium;Czech Republic;Hungary;
      2011   -   EUCTR2010-019558-42-CZ   Belgium;Czech Republic;Hungary;
      2010   -   EUCTR2010-019558-42-BE   Belgium;Czech Republic;Hungary;
Bascial prescription plus or minus herbs depend on symptoms   
   Shanghai University of Traditional Chinese Medicine
      2009   -   NCT00963287   China;
Basiliximab   
   Cerimon Pharmaceuticals
      2007   Phase 2   NCT01061996   United Kingdom;
      2007   Phase 2   NCT00430898   Belgium;Czech Republic;India;Poland;Russian Federation;Slovakia;Ukraine;United Kingdom;United States;
   Cerimon Pharmaceuticals, Inc.
      2007   Phase 2   EUCTR2006-006319-54-SK   Belgium;Czech Republic;Slovakia;United Kingdom;
      2007   Phase 2   EUCTR2006-006319-54-GB   Belgium;Czech Republic;Slovakia;United Kingdom;
      2007   Phase 2   EUCTR2006-006319-54-CZ   Belgium;Czech Republic;United Kingdom;
      2007   Phase 2   EUCTR2006-004303-19-SK   Belgium;Czech Republic;Slovakia;United Kingdom;
      2007   Phase 2   EUCTR2006-004303-19-GB   Belgium;Czech Republic;Slovakia;United Kingdom;
      2007   -   EUCTR2006-006319-54-BE   Belgium;United Kingdom;
      2007   -   EUCTR2006-004303-19-CZ   Belgium;Czech Republic;United Kingdom;
      2007   -   EUCTR2006-004303-19-BE   Belgium;Czech Republic;United Kingdom;
Beclometasone   
   CHIESI
      2007   -   EUCTR2006-004230-32-IT   Belgium;Italy;Poland;Spain;
Beclomethasone diproprionate   
   Chiesi Farmaceutici SpA
      2007   Phase 3   EUCTR2006-004230-32-PL   Belgium;Italy;Poland;Spain;
Berberine   
   Xijing Hospital of Digestive Diseases
      2016   Phase 4   NCT02962245   -
Berberine Chloride   
   National Cancer Institute (NCI)
      2016   Phase 1   NCT02365480   China;United States;
Bertilimumab   
   Immune Pharmaceuticals
      2015   Phase 2   NCT01671956   Israel;
Beta-1,3/1,6-D-Glucan   
   Fakultas Kedokteran Universitas Indonesia
      2019   Phase 2/Phase 3   NCT04029649   Indonesia;
Bezlotoxumab   
   David Binion, MD
      2021   Phase 4   NCT04626947   United States;
Bifidobacterium breve   
   Public Health Research foundation
      2012   -   JPRN-UMIN000007593   Japan;
Bifidobacterium infantis 35624   
   University College Cork
      2002   Phase 2/Phase 3   NCT00510978   Ireland;
Bimekizumab   
   UCB Biopharma SPRL
      2017   Phase 2   EUCTR2016-000420-26-PL   Bulgaria;Czech Republic;France;Georgia;Italy;Moldova, Republic of;Poland;Romania;South Africa;Spain;United Kingdom;
      2017   Phase 2   EUCTR2016-000420-26-BG   Bulgaria;Czech Republic;Georgia;Italy;Moldova, Republic of;Poland;Romania;South Africa;Spain;United Kingdom;
      2016   Phase 2   EUCTR2016-000420-26-ES   Bulgaria;Czech Republic;France;Georgia;Italy;Moldova, Republic of;Poland;Romania;South Africa;Spain;United Kingdom;
      2016   Phase 2   EUCTR2016-000420-26-CZ   Bulgaria;Czech Republic;France;Georgia;Italy;Moldova, Republic of;Poland;Romania;South Africa;Spain;United Kingdom;
Bio-enhanced Curcumin Soft Gelatin Capsule   
   Asian Institute of Gastroenterology, India
      2016   Phase 3   NCT02683759   India;
      2016   Phase 3   NCT02683733   India;
Biological Drug   
   Assiut University
      2021   -   NCT04818788   -
Biologically active human fecal microbiota   
   Virginia O. Shaffer
      2014   Phase 2   NCT02049502   United States;
Biopsies   
   Centre Hospitalier Universitaire de Saint Etienne
      2019   -   NCT04030676   France;
      2017   -   NCT03172195   France;
Biosimilar   
   McGill University Health Centre/Research Institute of the McGill University Health Centre
      2018   -   NCT03729674   Canada;
Biosimilar infliximab   
   Diakonhjemmet Hospital
      2014   Phase 4   NCT02148640   Norway;
Biospecimen Collection   
   National Cancer Institute (NCI)
      2021   Phase 2   NCT04767984   United States;
Bitterschleifenblume-ganzpflanze 1,5ml/10ml   
   Steigerwald Arzneimittelwerk GmbH
      2014   -   EUCTR2013-000891-13-DE   Germany;
Blood sample   
   Centre Hospitalier Universitaire de Saint Etienne
      2017   -   NCT03172195   France;
Blood samples   
   Centre Hospitalier Universitaire de Saint Etienne
      2019   -   NCT04030676   France;
      2017   Phase 2   NCT03182166   France;
   University Hospital, Bordeaux
      2020   -   NCT04272307   France;
Blood sampling, endoscopy   
   Bausch Health Americas, Inc.
      2008   Phase 3   NCT00679432   Canada;India;Mexico;United States;
      2008   Phase 3   NCT00679380   Australia;Belgium;Estonia;France;Israel;Italy;Latvia;Lithuania;Poland;Romania;Russian Federation;Slovakia;Sweden;Ukraine;United Kingdom;
Boulardii   
   University Clinic Dr Dragisa Misovic-Dedinje
      2019   -   NCT03941418   -
Bovine intestinal alkaline phosphatase (BIAP)   
   AM-Pharma
      2006   Phase 2   NCT00727324   Czech Republic;Italy;
Bovine-Calf Alkaline Phosphatase (BIAP)   
   AM-Pharma B.V.
      2006   -   EUCTR2006-000197-69-CZ   Czech Republic;Italy;
Bovine-Calf Alkaline Phosphatase BIAP   
   AM PHARMA B.V.
      2006   -   EUCTR2006-000197-69-IT   Italy;
Brazikumab   
   ASTRAZENECA AB
      2021   Phase 2   EUCTR2021-001644-10-IT   Austria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
   AstraZeneca
      2018   Phase 2   NCT04718818   Canada;India;Korea, Republic of;Puerto Rico;Romania;Taiwan;United States;
      2018   Phase 2   NCT03616821   Australia;Austria;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Puerto Rico;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
   Hibi Kazushige
      2021   Phase 2   JPRN-jRCT2011210047   Austria;Canada;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Poland;Russia;South Africa;South Korea;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2021   Phase 2   JPRN-jRCT2011210030   Austria;Canada;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Poland;Russia;South Africa;South Korea;Spain;Taiwan;Ukraine;United Kingdom;United States;
Brazikumab Induction Dose   
   AstraZeneca
      2020   Phase 2   NCT04277546   Austria;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Puerto Rico;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Brazikumab Maintenance Dose   
   AstraZeneca
      2020   Phase 2   NCT04277546   Austria;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Poland;Puerto Rico;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Brepocitinib   
   Pfizer Inc.
      2017   Phase 2   EUCTR2016-003708-29-SK   Austria;Bulgaria;Canada;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2018   Phase 2   EUCTR2016-003708-29-BG   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
      2017   Phase 2   EUCTR2016-003708-29-PL   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
      2017   Phase 2   EUCTR2016-003708-29-DK   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
      2017   Phase 2   EUCTR2016-003708-29-DE   Austria;Bulgaria;Canada;Czechia;Denmark;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
Broccoli   
   University of Tsukuba
      2020   -   JPRN-UMIN000041972   Japan;
Budenofalk   
   Dr. Falk Pharma GmbH
      2007   Phase 3   EUCTR2006-005377-22-SK   Czech Republic;Germany;Latvia;Lithuania;Poland;Slovakia;Spain;
      2007   Phase 3   EUCTR2006-005377-22-ES   Czech Republic;Germany;Latvia;Lithuania;Poland;Slovakia;Spain;
      2007   -   EUCTR2006-005377-22-LV   Czech Republic;Germany;Latvia;Lithuania;Poland;Spain;
      2007   -   EUCTR2006-005377-22-LT   Czech Republic;Germany;Latvia;Lithuania;Poland;Spain;
      2007   -   EUCTR2006-005377-22-DE   Czech Republic;Germany;Latvia;Lithuania;Poland;Spain;
      2007   -   EUCTR2006-005377-22-CZ   Czech Republic;Germany;Latvia;Lithuania;Poland;Spain;
      -   Phase 3   EUCTR2006-005377-22-PL   Czech Republic;Germany;Latvia;Lithuania;Poland;Slovakia;Spain;
Budenofalk 2mg rectal foam   
   University Hospital Birmingham NHS Foundation Trust
      2009   Phase 4   EUCTR2009-015077-12-GB   United Kingdom;
Budenofalk rectal foam   
   University Hospital Birmingham NHS Foundation Trust
      2009   Phase 4   EUCTR2009-015077-12-GB   United Kingdom;
Budenofalk® suppositories (BUS)   
   Dr. Falk Pharma GmbH
      2021   Phase 3   EUCTR2019-003334-16-BG   Belarus;Bulgaria;Germany;Latvia;Poland;Russian Federation;Ukraine;
      2020   Phase 3   EUCTR2019-003334-16-DE   Belarus;Bulgaria;Germany;Latvia;Poland;Russian Federation;Ukraine;
Budesonide   
   Ajinomoto Pharmaceuticals Co., Ltd.
      -   Phase 2   JPRN-JapicCTI-132294   -
   Bausch Health Americas, Inc.
      2010   Phase 3   NCT01100112   India;
   Dr. Falk Pharma GmbH
      2015   Phase 2   NCT02550418   Germany;
      2007   Phase 3   NCT00747110   Germany;
   EA Pharma Co.,Ltd.
      2018   -   JPRN-JapicCTI-183858   Japan;
      2014   Phase 3   JPRN-JapicCTI-142704   -
   Hyogo College of Medicine
      2018   -   JPRN-UMIN000034016   Japan;
   Matsuoka Katsuyoshi
      2021   -   JPRN-jRCTs031210326   Japan;
Budesonide (6 mg)   
   Ferring Pharmaceuticals
      2018   Phase 3   NCT03412682   Japan;
Budesonide (9 mg)   
   Ferring Pharmaceuticals
      2018   Phase 3   NCT03412682   Japan;
Budesonide 6 mg prolonged-release capsule, hard (BUX-PVII prototype)   
   Dr. Falk Pharma GmbH
      2019   Phase 3   EUCTR2017-004576-57-LV   Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
      2019   Phase 3   EUCTR2017-004576-57-LT   Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
      2019   Phase 3   EUCTR2017-004576-57-DE   Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
Budesonide 6 mg prolonged-release capsules, hard (BUX-PVII prototype)   
   Dr. Falk Pharma GmbH
      2019   Phase 3   EUCTR2017-004576-57-SK   Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
      2019   Phase 3   EUCTR2017-004576-57-PL   Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
      2019   Phase 3   EUCTR2017-004576-57-HU   Czech Republic;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Slovakia;Ukraine;
      2019   Phase 3   EUCTR2017-004576-57-CZ   Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
Budesonide 9 mg capsules, hard (BUX-PV)   
   Dr. Falk Pharma GmbH
      2015   Phase 2   EUCTR2014-005635-14-LV   Hungary;Latvia;Lithuania;
      2015   Phase 2   EUCTR2014-005635-14-LT   Hungary;Latvia;Lithuania;
      2015   Phase 2   EUCTR2014-005635-14-HU   Hungary;Latvia;Lithuania;
      2015   Phase 2   EUCTR2014-005635-14-DE   Germany;Hungary;Latvia;Lithuania;
Budesonide 9 mg prolonged-release capsule, hard (BUX-PVII prototype)   
   Dr. Falk Pharma GmbH
      2019   Phase 3   EUCTR2017-004576-57-LV   Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
      2019   Phase 3   EUCTR2017-004576-57-LT   Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
      2019   Phase 3   EUCTR2017-004576-57-DE   Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
Budesonide 9 mg prolonged-release capsules, hard (BUX-PVII prototype)   
   Dr. Falk Pharma GmbH
      2019   Phase 3   EUCTR2017-004576-57-SK   Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
      2019   Phase 3   EUCTR2017-004576-57-PL   Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
      2019   Phase 3   EUCTR2017-004576-57-HU   Czech Republic;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Slovakia;Ukraine;
      2019   Phase 3   EUCTR2017-004576-57-CZ   Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
Budesonide MMX   
   COSMO TECHNOLOGIES LTD
      2008   -   EUCTR2006-004776-12-IT   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
Budesonide MMX 6 mg Tablet   
   Bausch Health Americas, Inc.
      2008   Phase 3   NCT00801723   Canada;United States;
Budesonide MMX®   
   Bausch Health Americas, Inc.
      2012   Phase 3   NCT01532648   Bulgaria;Canada;Czech Republic;Czechia;Estonia;Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;United States;
      2008   Phase 3   NCT00679380   Australia;Belgium;Estonia;France;Israel;Italy;Latvia;Lithuania;Poland;Romania;Russian Federation;Slovakia;Sweden;Ukraine;United Kingdom;
   Ferring Pharmaceuticals
      2015   -   NCT02586259   Canada;Germany;Ireland;Israel;Italy;Netherlands;Poland;Sweden;Switzerland;United Kingdom;
Budesonide-MMX   
   COSMO TECHNOLOGIES LTD
      2009   -   EUCTR2008-003913-28-IT   Italy;
      2008   -   EUCTR2006-004776-12-IT   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
Budesonide-MMX®   
   Bausch Health Americas, Inc.
      2008   Phase 3   NCT00679432   Canada;India;Mexico;United States;
   Santarus, Inc.
      2012   -   EUCTR2011-005115-82-PL   Bulgaria;Canada;Czech Republic;Estonia;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2012   -   EUCTR2011-005115-82-LV   Bulgaria;Canada;Czech Republic;Estonia;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2012   -   EUCTR2011-005115-82-LT   Bulgaria;Canada;Czech Republic;Estonia;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2012   -   EUCTR2011-005115-82-HU   Bulgaria;Canada;Czech Republic;Estonia;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2012   -   EUCTR2011-005115-82-EE   Bulgaria;Canada;Czech Republic;Estonia;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2012   -   EUCTR2011-005115-82-CZ   Bulgaria;Canada;Czech Republic;Estonia;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2012   -   EUCTR2011-005115-82-BG   Bulgaria;Canada;Czech Republic;Estonia;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
Budesonide-MMX™   
   COSMO Technologies Ltd
      2008   Phase 3   EUCTR2006-004776-12-SK   Belgium;Estonia;France;Italy;Latvia;Lithuania;Slovakia;Sweden;United Kingdom;
      2008   Phase 3   EUCTR2006-004776-12-GB   Belgium;Estonia;France;Italy;Latvia;Lithuania;Slovakia;Sweden;United Kingdom;
      2008   -   EUCTR2006-004776-12-SE   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
      2008   -   EUCTR2006-004776-12-LV   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
      2008   -   EUCTR2006-004776-12-LT   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
      2008   -   EUCTR2006-004776-12-FR   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
      2008   -   EUCTR2006-004776-12-EE   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
      2008   -   EUCTR2006-004776-12-BE   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
Butyrate   
   Children's Hospital Los Angeles
      2022   Phase 1   NCT05218850   United States;
By demand   
   Hospital Galdakao-Usansolo
      2020   -   NCT04188990   Spain;
CARVI EXTRACTUM FLUIDUM   
   Steigerwald Arzneimittelwerk GmbH
      2014   -   EUCTR2013-000891-13-DE   Germany;
CAT-354   
   ASTRAZENECA
      2011   -   EUCTR2011-004812-40-IT   Czech Republic;Germany;Italy;Netherlands;United Kingdom;
   AstraZeneca AB
      2012   Phase 2   EUCTR2011-004812-40-GB   Czech Republic;Germany;Italy;Netherlands;United Kingdom;
      2012   -   EUCTR2011-004812-40-NL   Czech Republic;Italy;Netherlands;United Kingdom;
      2012   -   EUCTR2011-004812-40-DE   Czech Republic;Germany;Italy;Netherlands;United Kingdom;
      2012   -   EUCTR2011-004812-40-CZ   Czech Republic;Italy;Netherlands;United Kingdom;
CB-01-02   
   COSMO TECHNOLOGIES LTD
      2009   -   EUCTR2008-003913-28-IT   Italy;
      2008   -   EUCTR2006-004776-12-IT   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
   COSMO Technologies Ltd
      2008   Phase 3   EUCTR2006-004776-12-SK   Belgium;Estonia;France;Italy;Latvia;Lithuania;Slovakia;Sweden;United Kingdom;
      2008   Phase 3   EUCTR2006-004776-12-GB   Belgium;Estonia;France;Italy;Latvia;Lithuania;Slovakia;Sweden;United Kingdom;
      2008   -   EUCTR2006-004776-12-SE   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
      2008   -   EUCTR2006-004776-12-LV   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
      2008   -   EUCTR2006-004776-12-LT   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
      2008   -   EUCTR2006-004776-12-FR   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
      2008   -   EUCTR2006-004776-12-EE   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
      2008   -   EUCTR2006-004776-12-BE   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
CB-01-05-MMX   
   COSMO TECHNOLOGIES LTD
      2006   -   EUCTR2006-001782-42-IT   Hungary;Italy;United Kingdom;
   Cosmo Technologies Ltd
      2006   Phase 2   EUCTR2006-001782-42-GB   Hungary;Italy;United Kingdom;
      2006   -   EUCTR2006-001782-42-HU   Hungary;Italy;United Kingdom;
CBP-307   
   Suzhou Connect Biopharmaceuticals, Ltd.
      2019   Phase 2   NCT04700449   China;Pakistan;Ukraine;United States;
CC-10004   
   CELGENE CORPORATION
      2015   Phase 2   EUCTR2014-002981-64-IT   Australia;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
   Celgene Corporation
      2016   Phase 2   EUCTR2014-002981-64-BG   Australia;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;Ukraine;United States;
      2015   Phase 2   EUCTR2014-002981-64-NL   Australia;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;United Kingdom;United States;
      2015   Phase 2   EUCTR2014-002981-64-DE   Australia;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;Ukraine;United States;
      2015   Phase 2   EUCTR2014-002981-64-CZ   Australia;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;Ukraine;United States;
      2015   -   EUCTR2014-002981-64-HU   Australia;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Slovakia;Turkey;Ukraine;United Kingdom;United States;
CD7 CAR T-cells   
   Zhejiang University
      2022   Early Phase 1   NCT05239702   China;
CGMP protein   
   University of Aarhus
      2012   -   NCT01534312   Denmark;
CLA (Chlorogenic acid)   
   Nutrition Science Partners Limited
      2014   -   EUCTR2013-003060-31-PL   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2014   -   EUCTR2013-003060-31-LV   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2014   -   EUCTR2013-003060-31-LT   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2014   -   EUCTR2013-003060-31-HU   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2014   -   EUCTR2013-003060-31-CZ   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2014   -   EUCTR2013-003060-31-BG   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2013   Phase 3   EUCTR2013-002116-27-CZ   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
      2013   -   EUCTR2013-002116-27-LV   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
      2013   -   EUCTR2013-002116-27-LT   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
      2013   -   EUCTR2013-002116-27-HU   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
      2013   -   EUCTR2013-002116-27-BG   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
CLIPPER*30CPR 5MG R.M.   
   CHIESI
      2007   -   EUCTR2006-004230-32-IT   Belgium;Italy;Poland;Spain;
CNTO 148   
   Centocor BV
      2010   -   EUCTR2006-003398-28-CZ   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2008   -   EUCTR2006-003399-37-LT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2008   -   EUCTR2006-003398-28-SE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2008   -   EUCTR2006-003398-28-NL   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2008   -   EUCTR2006-003398-28-LT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2008   -   EUCTR2006-003398-28-DK   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2008   -   EUCTR2006-003398-28-BG   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2008   -   EUCTR2006-003397-94-SE   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2008   -   EUCTR2006-003397-94-NL   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2008   -   EUCTR2006-003397-94-LT   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2008   -   EUCTR2006-003397-94-BG   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2007   Phase 3   EUCTR2006-003399-37-FR   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
      2007   Phase 2;Phase 3   EUCTR2006-003398-28-SK   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
      2007   Phase 2;Phase 3   EUCTR2006-003398-28-FR   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
      2007   Phase 2;Phase 3   EUCTR2006-003397-94-SK   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
      2007   Phase 2;Phase 3   EUCTR2006-003397-94-HU   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
      2007   Phase 2;Phase 3   EUCTR2006-003397-94-FR   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
      2007   -   EUCTR2006-003398-28-LV   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2007   -   EUCTR2006-003398-28-HU   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2007   -   EUCTR2006-003398-28-DE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2007   -   EUCTR2006-003398-28-BE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2007   -   EUCTR2006-003398-28-AT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2007   -   EUCTR2006-003397-94-LV   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2007   -   EUCTR2006-003397-94-DE   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2007   -   EUCTR2006-003397-94-BE   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2007   -   EUCTR2006-003397-94-AT   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
   Janssen Biologics B.V.
      2010   -   EUCTR2006-003399-37-CZ   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
      2008   -   EUCTR2006-003399-37-SE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
      2008   -   EUCTR2006-003399-37-DK   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
      2008   -   EUCTR2006-003399-37-BG   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
      2007   -   EUCTR2006-003399-37-LV   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
      2007   -   EUCTR2006-003399-37-HU   Australia;Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;India;Israel;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Sweden;Ukraine;
      2007   -   EUCTR2006-003399-37-DE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
      2007   -   EUCTR2006-003399-37-BE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
      2007   -   EUCTR2006-003399-37-AT   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
   Janssen Biologics BV
      2008   -   EUCTR2006-003399-37-NL   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
      2007   Phase 3   EUCTR2006-003399-37-SK   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
CNTO-148   
   University Medical Centre Ljubljana, Department of gastroenterology
      2020   Phase 4   EUCTR2019-003987-37-SI   Slovenia;
CNTO1275   
   JANSSEN CILAG INTERNATIONAL NV
      2015   Phase 3   EUCTR2014-005606-38-IT   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
   Janssen-Cilag International NV
      2021   Phase 3   EUCTR2020-004457-76-PL   Argentina;France;Japan;Poland;Russian Federation;Turkey;United States;
      2021   Phase 3   EUCTR2019-004224-38-DE   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States;
      2020   Phase 3   EUCTR2019-004224-38-HU   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States;
      2016   Phase 3   EUCTR2014-005606-38-PL   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
      2015   Phase 3   EUCTR2014-005606-38-SK   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
      2015   Phase 3   EUCTR2014-005606-38-NL   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
      2015   Phase 3   EUCTR2014-005606-38-HU   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
      2015   Phase 3   EUCTR2014-005606-38-DK   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
      2015   Phase 3   EUCTR2014-005606-38-DE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
      2015   Phase 3   EUCTR2014-005606-38-CZ   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
      2015   Phase 3   EUCTR2014-005606-38-BG   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
      2015   Phase 3   EUCTR2014-005606-38-BE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
      2015   Phase 3   EUCTR2014-005606-38-AT   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
      -   Phase 3   EUCTR2020-004457-76-FR   Argentina;Belgium;France;Germany;Hungary;Italy;Japan;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States;
      -   Phase 3   EUCTR2019-004224-38-PL   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States;
      -   Phase 3   EUCTR2019-004224-38-Outside-EU/EEA   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States;
      -   Phase 3   EUCTR2019-004224-38-GB   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States;
      -   Phase 3   EUCTR2019-004224-38-BE   Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom;United States;
CNTO148   
   Janssen Biologics B.V.
      2019   Phase 3   EUCTR2017-004496-31-IT   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
      2015   Phase 2   EUCTR2013-002042-36-FR   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States;
      2014   Phase 2   EUCTR2013-002042-36-PL   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States;
      2014   Phase 2   EUCTR2013-002042-36-BG   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States;
      2014   -   EUCTR2013-002042-36-NL   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States;
      2014   -   EUCTR2013-002042-36-HU   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States;
      2014   -   EUCTR2013-002042-36-DE   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States;
      2014   -   EUCTR2013-002042-36-CZ   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States;
      2014   -   EUCTR2013-002042-36-BE   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Israel;Netherlands;Poland;Russian Federation;Ukraine;United States;
      2014   -   EUCTR2012-004366-18-BE   Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
      2013   Phase 1   EUCTR2012-004366-18-DK   Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
      2013   Phase 1   EUCTR2012-004366-18-DE   Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
      2013   Phase 1   EUCTR2012-004366-18-AT   Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
      2013   -   EUCTR2012-004366-18-NL   Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
      -   Phase 1   EUCTR2012-004366-18-FR   Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
   Janssen Biologics BV
      2019   Phase 3   EUCTR2017-004496-31-PL   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
      2019   Phase 3   EUCTR2017-004496-31-NL   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
      2018   Phase 3   EUCTR2017-004496-31-FR   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
      2018   Phase 3   EUCTR2017-004496-31-ES   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
      2018   Phase 3   EUCTR2017-004496-31-BE   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
   Janssen-Cilag International NV
      2019   Phase 2   EUCTR2018-001510-15-PL   Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States;
      2019   Phase 2   EUCTR2018-001510-15-DE   Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States;
CNTO1959   
   JANSSEN CILAG INTERNATIONAL NV
      2019   Phase 3   EUCTR2018-004002-25-IT   Argentina;Australia;Belgium;Bulgaria;Canada;China;Czechia;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Malaysia;Netherlands;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
   Janssen-Cilag International NV
      2021   Phase 2;Phase 3   EUCTR2018-004002-25-SK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Malaysia;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 2;Phase 3   EUCTR2018-004002-25-LV   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Netherlands;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 2;Phase 3   EUCTR2018-004002-25-PT   Argentina;Australia;Belgium;Bulgaria;Canada;China;Czechia;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Russian Federation;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 2;Phase 3   EUCTR2018-004002-25-NL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Malaysia;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 2;Phase 3   EUCTR2018-004002-25-ES   Argentina;Australia;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Russian Federation;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 2;Phase 3   EUCTR2018-004002-25-DE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Malaysia;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 2;Phase 3   EUCTR2018-004002-25-BG   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Malaysia;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 2;Phase 3   EUCTR2018-004002-25-SE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Malaysia;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 2;Phase 3   EUCTR2018-004002-25-HU   Argentina;Australia;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Russian Federation;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 2;Phase 3   EUCTR2018-004002-25-GB   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 2;Phase 3   EUCTR2018-004002-25-FR   Argentina;Australia;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Malaysia;Poland;Portugal;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 2;Phase 3   EUCTR2018-004002-25-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Malaysia;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-001510-15-PL   Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States;
      2019   Phase 2   EUCTR2018-001510-15-DE   Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States;
CNTO312   
   Janssen Biologics B.V.
      2019   Phase 3   EUCTR2017-004496-31-IT   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
   Janssen Biologics BV
      2019   Phase 3   EUCTR2017-004496-31-PL   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
      2019   Phase 3   EUCTR2017-004496-31-NL   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
      2018   Phase 3   EUCTR2017-004496-31-BE   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
COFFEE COAL   
   REPHA GmbH
      2008   -   EUCTR2007-007928-18-DE   Germany;
COLAL PRED   
   ALIZYME
      2006   -   EUCTR2004-005032-35-IT   Belgium;Czech Republic;Denmark;Hungary;Italy;Spain;Sweden;United Kingdom;
COLAL-PRED®   
   Alizyme
      2006   Phase 3   NCT00299013   Australia;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Russian Federation;South Africa;Spain;Sweden;United Kingdom;
CP- 690 550   
   Pfizer
      2008   Phase 2   NCT00787202   Belgium;Brazil;Chile;Czech Republic;Denmark;France;Hungary;Israel;Italy;Mexico;Netherlands;Poland;Slovakia;South Africa;Spain;Sweden;Turkey;United Kingdom;
CP-690, 550-10   
   PFIZER INC
      -   Phase 3   EUCTR2018-002378-30-IT   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
CP-690,500   
   Pfizer
      2017   Phase 4   NCT03281304   Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
CP-690,550   
   PFIZER
      2009   -   EUCTR2008-004564-40-IT   Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
   Pfizer
      2017   Phase 4   NCT03281304   Belgium;Canada;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2012   Phase 3   NCT01470612   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   Phase 3   NCT01458574   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
   Pfizer S.A
      2008   Phase 2   EUCTR2008-004564-40-ES   Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
   Pfizer limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK
      2009   Phase 2   EUCTR2008-004564-40-FR   Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
      2009   -   EUCTR2008-004564-40-SE   Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
      2009   -   EUCTR2008-004564-40-NL   Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
      2009   -   EUCTR2008-004564-40-GB   Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
      2009   -   EUCTR2008-004564-40-CZ   Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
      2009   -   EUCTR2008-004564-40-BE   Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
      2008   Phase 2   EUCTR2008-004564-40-SK   Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
      2008   -   EUCTR2008-004564-40-HU   Belgium;Czech Republic;France;Hungary;Italy;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
CP-690,550-10   
   PFIZER INC
      2018   Phase 3;Phase 4   EUCTR2017-002274-39-IT   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
   PFIZER INC.
      2013   -   EUCTR2011-004578-27-IT   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
   PFIZER LIMITED
      2013   Phase 3   EUCTR2011-004580-79-IT   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2013   -   EUCTR2011-004581-14-IT   Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Denmark;Estonia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
   Pfizer Inc
      2012   Phase 3   EUCTR2011-004580-79-CZ   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   Phase 3   EUCTR2011-004579-35-CZ   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   Phase 3   EUCTR2011-004578-27-CZ   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
   Pfizer Inc, 235 East 42nd Street, New York, New York 10017
      2018   Phase 3;Phase 4   EUCTR2017-002274-39-NL   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2018   Phase 3;Phase 4   EUCTR2017-002274-39-GB   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2018   Phase 3;Phase 4   EUCTR2017-002274-39-CZ   Austria;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2018   Phase 3;Phase 4   EUCTR2017-002274-39-BE   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-002274-39-AT   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2017   Phase 3;Phase 4   EUCTR2017-002274-39-HU   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2017-002274-39-ES   Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2013   Phase 3   EUCTR2011-004580-79-HR   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2013   -   EUCTR2011-004581-14-HR   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2013   -   EUCTR2011-004579-35-HR   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2013   -   EUCTR2011-004578-27-NL   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2013   -   EUCTR2011-004578-27-HR   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   Phase 3   EUCTR2011-004581-14-NL   Australia;Austria;Belgium;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2012   Phase 3   EUCTR2011-004581-14-LV   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   Phase 3   EUCTR2011-004581-14-HU   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   Phase 3   EUCTR2011-004581-14-GB   Australia;Austria;Belgium;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2012   Phase 3   EUCTR2011-004581-14-EE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   Phase 3   EUCTR2011-004581-14-DK   Australia;Austria;Belgium;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2012   Phase 3   EUCTR2011-004581-14-BE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   Phase 3   EUCTR2011-004581-14-AT   Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   Phase 3   EUCTR2011-004580-79-SK   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   Phase 3   EUCTR2011-004580-79-PL   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   Phase 3   EUCTR2011-004580-79-LV   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   Phase 3   EUCTR2011-004580-79-HU   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   Phase 3   EUCTR2011-004580-79-GB   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   Phase 3   EUCTR2011-004580-79-ES   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   Phase 3   EUCTR2011-004580-79-EE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   Phase 3   EUCTR2011-004580-79-DK   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   Phase 3   EUCTR2011-004580-79-BE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   Phase 3   EUCTR2011-004580-79-AT   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   Phase 3   EUCTR2011-004579-35-DK   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   Phase 3   EUCTR2011-004578-27-DK   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   -   EUCTR2011-004581-14-ES   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   -   EUCTR2011-004579-35-SK   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   -   EUCTR2011-004579-35-PL   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   -   EUCTR2011-004579-35-NL   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   -   EUCTR2011-004579-35-LV   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   -   EUCTR2011-004579-35-HU   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   -   EUCTR2011-004579-35-GB   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   -   EUCTR2011-004579-35-ES   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   -   EUCTR2011-004579-35-EE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   -   EUCTR2011-004579-35-BE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   -   EUCTR2011-004579-35-AT   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   -   EUCTR2011-004578-27-SK   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   -   EUCTR2011-004578-27-PL   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   -   EUCTR2011-004578-27-LV   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   -   EUCTR2011-004578-27-HU   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   -   EUCTR2011-004578-27-GB   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   -   EUCTR2011-004578-27-ES   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   -   EUCTR2011-004578-27-EE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   -   EUCTR2011-004578-27-BE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   -   EUCTR2011-004578-27-AT   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
   Pfizer Inc, 235 East 42nd Street, New York, New York 10017, USA
      2012   Phase 3   EUCTR2011-004581-14-DE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   Phase 3   EUCTR2011-004580-79-DE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   Phase 3   EUCTR2011-004579-35-DE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   Phase 3   EUCTR2011-004578-27-DE   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
   Pfizer Inc.
      2022   Phase 3   EUCTR2018-002378-30-HU   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
      2017   Phase 3;Phase 4   EUCTR2017-002274-39-SK   Austria;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2012   Phase 3   EUCTR2011-004581-14-SK   Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      2012   Phase 3   EUCTR2011-004581-14-CZ   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2018-002378-30-SK   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
      -   Phase 3   EUCTR2018-002378-30-PL   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
      -   Phase 3   EUCTR2018-002378-30-DE   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
      -   Phase 3   EUCTR2018-002378-30-BE   Australia;Belgium;Canada;Finland;France;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
   Pfizer Inc., 235 East 42nd Street, New York, New York 10017, United States
      2012   Phase 3   EUCTR2011-004581-14-PL   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
CP690,550   
   Pfizer
      2012   Phase 3   NCT01458574   Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
CS (corticosteroids) Only   
   Shaare Zedek Medical Center
      2014   -   NCT02033408   Canada;Finland;Israel;Italy;Poland;Spain;
CT-P13   
   Celltrion
      2016   Phase 1   NCT02883452   Korea, Republic of;
   Pfizer
      2015   -   NCT02539368   Belgium;Czech Republic;Czechia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;United Kingdom;
CT-P13 SC (Infliximab)   
   Celltrion
      2020   Phase 3   NCT04205643   Poland;
CYCLOSPORINE VS INFLIXIMAB   
   Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
      2007   Phase 4   NCT00542152   Belgium;Finland;France;Italy;Spain;
Caffeine   
   Janssen Research & Development, LLC
      2018   Phase 1   NCT03358706   Austria;Belgium;Denmark;Germany;Sweden;United Kingdom;United States;
   Takeda
      2016   Phase 4   NCT02760615   United States;
Calcitonin nasal spray (salmon)   
   Children's Hospital Boston
      2004   -   NCT00114803   United States;
Caltrate   
   Second Affiliated Hospital of Wenzhou Medical University
      2015   -   NCT04276649   China;
Cannabidiol   
   Meir Medical Center
      2010   Phase 1/Phase 2   NCT01037322   Israel;
Cannabis, Medical   
   OMNI Medical Services, LLC
      2018   Phase 2   NCT03944447   United States;
Carbon   
   Hyogo College of Medicine, Department of Internal medicine, Division of Lower GI disease
      2007   Phase 2,3   JPRN-UMIN000004401   Japan;
Carbon dioxide   
   Osaka University, Graduate School of Medicine,Department of Gastroenterology and Hepatology
      2015   -   JPRN-UMIN000018801   Japan;
Carrageenan   
   University of Illinois at Chicago
      2010   -   NCT01065571   United States;
Casein glycomacropeptide (CGMP)   
   University of Aarhus
      2016   -   NCT02825914   Denmark;
Catridecacog   
   Novo Nordisk A/S
      2013   -   EUCTR2011-001568-22-HU   Bulgaria;Croatia;Denmark;European Union;Hungary;Russian Federation;Ukraine;
      2012   Phase 2   NCT01706159   Bulgaria;Croatia;Denmark;Hungary;Poland;Russian Federation;Ukraine;
      2012   -   EUCTR2011-001568-22-DK   Bulgaria;Croatia;Denmark;European Union;Hungary;Russian Federation;Ukraine;
      2012   -   EUCTR2011-001568-22-BG   Bulgaria;Croatia;Denmark;European Union;Hungary;Russian Federation;Ukraine;
Ceftriaxone   
   Postgraduate Institute of Medical Education and Research
      2019   Phase 2   NCT03794765   India;
Cefuroxime   
   University of Dundee
      2006   -   NCT00355602   United Kingdom;
Cholecalciferol   
   Boston Children’s Hospital
      2008   -   NCT00621257   United States;
   Medical clinic, University Hospital of North Norway
      2009   -   EUCTR2009-015649-21-NO   Norway;
Ciclosporin   
   Sigmoid Pharma Ltd
      2010   Phase 2   EUCTR2008-003169-19-GB   Ireland;United Kingdom;
      2009   -   EUCTR2008-003169-19-IE   Ireland;United Kingdom;
Ciclosporina   
   GETECCU (Grupo Español para el estudio de la enfermedad de Crohn y la colitis ulcerosa)
      2008   -   EUCTR2006-005299-42-ES   Belgium;Finland;France;Spain;
Cimzia   
   University of Washington
      2010   Phase 2   NCT01090154   United States;
Ciprofloxacin   
   Hvidovre University Hospital
      2011   Phase 4   NCT01772615   Denmark;
   University of Dundee
      2006   -   NCT00355602   United Kingdom;
Clarithromycin   
   University of Dundee
      2006   -   NCT00355602   United Kingdom;
Clipper   
   CHIESI ESPAÑA S.A.U.
      2017   Phase 3   EUCTR2017-000330-61-ES   Spain;
   Chiesi Farmaceutici SpA
      2007   Phase 3   EUCTR2006-004230-32-PL   Belgium;Italy;Poland;Spain;
      2007   -   EUCTR2006-004230-32-ES   Belgium;Italy;Poland;Spain;
Clipper 30 cpr 5mg R.M.   
   CHIESI Farmaceutici S.p.A.
      2007   -   EUCTR2006-004230-32-BE   Belgium;Italy;Poland;Spain;
Clotrimazole   
   Paul Rufo
      2002   Phase 1/Phase 2   NCT00061282   United States;
Coamoxiclav   
   University of Dundee
      2006   -   NCT00355602   United Kingdom;
Cobitolimod   
   INDEX PHARMACEUTICALS AB
      2021   Phase 3   EUCTR2021-002549-13-IT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 2   EUCTR2016-004217-26-IT   Czech Republic;France;Germany;Hungary;Italy;Montenegro;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;
   InDex Pharmaceuticals
      2021   Phase 3   NCT04985968   Hungary;
      2017   Phase 2   NCT03178669   Czechia;France;Germany;Hungary;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;
   InDex Pharmaceuticals AB
      2021   Phase 1;Phase 2   EUCTR2021-003023-14-SE   Sweden;
      2017   Phase 2   EUCTR2016-004217-26-SE   Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;
      2017   Phase 2   EUCTR2016-004217-26-HU   Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;
      2017   Phase 2   EUCTR2016-004217-26-FR   Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;
      2017   Phase 2   EUCTR2016-004217-26-ES   Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;
      2017   Phase 2   EUCTR2016-004217-26-DE   Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;
      2017   Phase 2   EUCTR2016-004217-26-CZ   Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;
Colectomy   
   Connecticut Children's Medical Center
      2012   Phase 4   NCT01536535   Canada;United States;
Colonoscopy   
   London North West Healthcare NHS Trust
      2006   -   NCT00292175   United Kingdom;
   Tel-Aviv Sourasky Medical Center
      2015   Phase 2   NCT04434872   Israel;
Colorectal biopsies   
   University Hospital, Bordeaux
      2020   -   NCT04272307   France;
Coltect   
   Tel-Aviv Sourasky Medical Center
      2008   -   NCT00793130   Israel;
Combination Oral Budesonide and Rectal Hydrocortisone   
   University of Maryland, Baltimore
      2008   Phase 2   NCT00805285   United States;
Combination Product: Beclomethasone dipropionate in addition to MC-EVOO   
   Casa Sollievo della Sofferenza IRCCS
      2017   -   NCT03408847   Italy;
Combination Product: Beclomethasone dipropionate in addition to refined oil   
   Casa Sollievo della Sofferenza IRCCS
      2017   -   NCT03408847   Italy;
Combination Product: Twice daily 90 mg hydrocortisone acetate suppository administered with Sephure applicator   
   Cristcot LLC
      2020   Phase 3   NCT04469686   Germany;Hong Kong;India;Italy;Philippines;Poland;Romania;Russian Federation;Spain;Ukraine;United States;
Companion Diagnostic (CDx) Testing   
   Prometheus Biosciences, Inc.
      2021   Phase 2   NCT04996797   United States;
Corticosteroid   
   Sixth Affiliated Hospital, Sun Yat-sen University
      2021   -   NCT04879966   China;
   Tampere University Hospital
      2015   -   NCT04564638   -
Corticosteroids   
   Centre Hospitalier Universitaire de Saint Etienne
      2016   Phase 3   NCT02665845   France;Greece;Israel;Italy;Korea, Republic of;Serbia;
   Children's Hospital of Fudan University
      2021   Phase 4   NCT04999228   -
   Jinling Hospital, China
      2013   Phase 1/Phase 2   NCT02922374   China;
Corticosteroids only   
   Sheba Medical Center
      2013   Phase 4   NCT01941589   China;France;Greece;Israel;Italy;Korea, Republic of;Serbia;
CortimentMMX   
   Dr. Falk Pharma GmbH
      2019   Phase 3   EUCTR2017-004576-57-SK   Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
      2019   Phase 3   EUCTR2017-004576-57-PL   Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
      2019   Phase 3   EUCTR2017-004576-57-LV   Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
      2019   Phase 3   EUCTR2017-004576-57-LT   Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
      2019   Phase 3   EUCTR2017-004576-57-HU   Czech Republic;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Slovakia;Ukraine;
      2019   Phase 3   EUCTR2017-004576-57-DE   Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
      2019   Phase 3   EUCTR2017-004576-57-CZ   Czech Republic;Czechia;Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
CosmoFer 50mg/ml solution for infusion or injection   
   Barts Health NHS Trust
      2011   Phase 4   EUCTR2010-023797-39-GB   United Kingdom;
Cotrimoxazole   
   University of Dundee
      2006   -   NCT00355602   United Kingdom;
Curcumin   
   Chinese University of Hong Kong
      2017   -   NCT03122613   Hong Kong;
   Schneider Children's Medical Center, Israel
      2020   Phase 3   NCT02277223   Israel;
   Seattle Children's Hospital
      2009   Phase 1   NCT00889161   United States;
   Sheba Medical Center
      2011   Phase 3   NCT01320436   Israel;
   Tianjin Medical University General Hospital
      2019   Phase 0   ChiCTR1900022243   China;
CyCol   
   Sigmoid Pharma Ltd
      2010   Phase 2   EUCTR2008-003169-19-GB   Ireland;United Kingdom;
      2009   -   EUCTR2008-003169-19-IE   Ireland;United Kingdom;
CyCol™   
   Sigmoid Pharma
      2010   Phase 2   NCT01033305   Ireland;United Kingdom;
Cyclosporine   
   Chiba University Hospital
      2013   -   JPRN-UMIN000010776   Japan;
   Postgraduate Institute of Medical Education and Research
      2021   -   NCT05112263   -
   Sublimity Therapeutics (Hold Co) Ltd.
      2019   Phase 2   EUCTR2018-003349-41-PL   Belarus;Bulgaria;Canada;France;Germany;Hungary;Israel;Italy;Poland;Russian Federation;Serbia;Ukraine;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-003349-41-HU   Belarus;Belgium;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-003349-41-GB   Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-003349-41-FR   Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-003349-41-DE   Belarus;Bulgaria;Canada;France;Germany;Hungary;Israel;Poland;Russian Federation;Serbia;Ukraine;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-003349-41-BG   Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Cyclosporine (USAN)   
   Sigmoid Pharma Ltd
      2010   Phase 2   EUCTR2008-003169-19-GB   Ireland;United Kingdom;
      2009   -   EUCTR2008-003169-19-IE   Ireland;United Kingdom;
Cytochrome P450 (CYP) Substrates   
   AbbVie
      2020   Phase 1   NCT04254783   Germany;Israel;United States;
D.3.6.2.1 - valore: 45 / 0.45 mg/ml   
   Janssen Biologics B.V.
      2019   Phase 3   EUCTR2017-004496-31-IT   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
D.3.6.2.1 - valore: 5 o   
   Janssen Biologics B.V.
      2019   Phase 3   EUCTR2017-004496-31-IT   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
DACORTIN   
   GETECCU (Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa)
      2007   -   EUCTR2007-003815-30-ES   Portugal;Spain;
DAND (14-Deoxyandrographolide)   
   Nutrition Science Partners Limited
      2014   -   EUCTR2013-003060-31-PL   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2014   -   EUCTR2013-003060-31-LV   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2014   -   EUCTR2013-003060-31-LT   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2014   -   EUCTR2013-003060-31-HU   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2014   -   EUCTR2013-003060-31-CZ   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2014   -   EUCTR2013-003060-31-BG   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2013   Phase 3   EUCTR2013-002116-27-CZ   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
      2013   -   EUCTR2013-002116-27-LV   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
      2013   -   EUCTR2013-002116-27-LT   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
      2013   -   EUCTR2013-002116-27-HU   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
      2013   -   EUCTR2013-002116-27-BG   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
DDAND (14-deoxy-11,12-didehydroandrographolide)   
   Nutrition Science Partners Limited
      2014   -   EUCTR2013-003060-31-PL   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2014   -   EUCTR2013-003060-31-LV   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2014   -   EUCTR2013-003060-31-LT   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2014   -   EUCTR2013-003060-31-HU   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2014   -   EUCTR2013-003060-31-CZ   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2014   -   EUCTR2013-003060-31-BG   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2013   Phase 3   EUCTR2013-002116-27-CZ   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
      2013   -   EUCTR2013-002116-27-LV   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
      2013   -   EUCTR2013-002116-27-LT   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
      2013   -   EUCTR2013-002116-27-HU   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
      2013   -   EUCTR2013-002116-27-BG   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
DELTACORTENE FORTE*10CPR   
   CHIESI
      2007   -   EUCTR2006-004230-32-IT   Belgium;Italy;Poland;Spain;
DELTACORTENE*20CPR   
   CHIESI
      2007   -   EUCTR2006-004230-32-IT   Belgium;Italy;Poland;Spain;
DEXTRAN 1 FOR INJECTION   
   PFIZER LIMITED
      2012   -   EUCTR2010-022766-27-IT   Belgium;Canada;Hungary;Italy;Sweden;United States;
   Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK
      2012   -   EUCTR2010-022766-27-SK   Belgium;Canada;Hungary;Italy;Poland;Slovakia;Sweden;United States;
      2012   -   EUCTR2010-022766-27-SE   Belgium;Canada;Germany;Hungary;Italy;Poland;Slovakia;Sweden;United States;
      2012   -   EUCTR2010-022766-27-HU   Belgium;Canada;Germany;Hungary;Italy;Poland;Slovakia;Sweden;United States;
      2012   -   EUCTR2010-022766-27-BE   Belgium;Canada;Germany;Hungary;Italy;Poland;Slovakia;Sweden;United States;
DIMS0150   
   INDEX PHARMACEUTICALS
      2012   -   EUCTR2011-003130-14-IT   Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom;
   InDex Pharmaceuticals AB
      2021   Phase 1;Phase 2   EUCTR2021-003023-14-SE   Sweden;
      2017   Phase 2   EUCTR2016-004217-26-SE   Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;
      2017   Phase 2   EUCTR2016-004217-26-HU   Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;
      2017   Phase 2   EUCTR2016-004217-26-FR   Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;
      2017   Phase 2   EUCTR2016-004217-26-ES   Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;
      2017   Phase 2   EUCTR2016-004217-26-DE   Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;
      2017   Phase 2   EUCTR2016-004217-26-CZ   Czech Republic;France;Germany;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;
      2012   -   EUCTR2011-003130-14-CZ   Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom;
      2011   Phase 3   EUCTR2011-003130-14-GB   Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom;
      2011   -   EUCTR2011-003130-14-PL   Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom;
      2011   -   EUCTR2011-003130-14-HU   Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom;
      2011   -   EUCTR2011-003130-14-DE   Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom;
      2006   -   EUCTR2006-001846-15-SE   Sweden;
Daclizumab   
   Facet Biotech
      2003   Phase 2   NCT00073047   Belgium;Canada;United States;
Dacortin   
   GETECCU (Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa)
      2009   -   EUCTR2007-003815-30-PT   Portugal;Spain;
Decortin H   
   Essex Pharma GmbH
      2009   -   EUCTR2009-010065-23-DE   Germany;
Dekavil   
   PFIZER INC
      2018   Phase 2   EUCTR2017-002108-28-IT   Australia;Belgium;Germany;Israel;Italy;Korea, Democratic People's Republic of;Saudi Arabia;Serbia;Spain;United States;
   Pfizer Inc, 235 East 42nd Street, New York, New York 10017
      2018   Phase 2   EUCTR2017-002108-28-ES   Australia;Belgium;Germany;Israel;Italy;Korea, Republic of;Saudi Arabia;Serbia;Spain;United States;
      2018   Phase 2   EUCTR2017-002108-28-DE   Australia;Belgium;Germany;Israel;Italy;Korea, Republic of;Saudi Arabia;Serbia;Spain;United States;
      2018   Phase 2   EUCTR2017-002108-28-BE   Australia;Belgium;Germany;Israel;Italy;Korea, Republic of;Saudi Arabia;Serbia;Spain;United States;
Dekristol   
   Medical clinic, University Hospital of North Norway
      2009   -   EUCTR2009-015649-21-NO   Norway;
Delayed and extended release mesalazine   
   Shire
      2003   Phase 3   NCT00503243   United States;
Deligoparin   
   Incara Pharmaceuticals
      2001   Phase 2/Phase 3   NCT00033943   United States;
Delmitide acetate   
   Procter & Gamble Pharmaceuticals
      2005   Phase 2   EUCTR2004-004077-29-SK   Czech Republic;Germany;Lithuania;Slovakia;United Kingdom;
      2005   -   EUCTR2004-004077-29-LT   Czech Republic;Germany;Lithuania;United Kingdom;
      2005   -   EUCTR2004-004077-29-DE   Czech Republic;Germany;Lithuania;United Kingdom;
      2005   -   EUCTR2004-004077-29-CZ   Czech Republic;Germany;Lithuania;United Kingdom;
   Procter & Gamble Technical Centres Ltd
      2005   -   EUCTR2004-004077-29-GB   Czech Republic;Germany;Lithuania;United Kingdom;
Deltacortene   
   Chiesi Farmaceutici SpA
      2007   Phase 3   EUCTR2006-004230-32-PL   Belgium;Italy;Poland;Spain;
      2007   -   EUCTR2006-004230-32-ES   Belgium;Italy;Poland;Spain;
Deltacortene 10 cpr   
   CHIESI Farmaceutici S.p.A.
      2007   -   EUCTR2006-004230-32-BE   Belgium;Italy;Poland;Spain;
Deltacortene 20 cpr   
   CHIESI Farmaceutici S.p.A.
      2007   -   EUCTR2006-004230-32-BE   Belgium;Italy;Poland;Spain;
Dersalazina sodica   
   Palau Pharma S.A.
      2008   -   EUCTR2008-004610-27-ES   Belgium;Hungary;Spain;
Dersalazine sodium   
   Palau Pharma S.A.
      2009   Phase 2   EUCTR2008-004610-27-SK   Belgium;Hungary;Slovakia;Spain;
      2009   -   EUCTR2008-004610-27-HU   Belgium;Hungary;Spain;
      2008   Phase 2   NCT00808977   Belgium;Hungary;Slovakia;Spain;
      2008   -   EUCTR2008-004610-27-ES   Belgium;Hungary;Spain;
      2008   -   EUCTR2008-004610-27-BE   Belgium;Hungary;Spain;
Deucravacitinib   
   BRISTOL-MYERS SQUIBB INTERNATIONAL CORPORATION
      2021   Phase 2   EUCTR2020-004461-40-IT   Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States;
   Bristol-Myers Squibb International Corporation
      2021   Phase 2   EUCTR2020-004461-40-DE   Australia;Belgium;Brazil;Canada;China;Czechia;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Taiwan;United Kingdom;United States;
Dexamethasone 21-phosphate   
   Casa Sollievo della Sofferenza IRCCS
      2003   Phase 2   NCT01171807   Italy;
Dextromethorphan   
   Janssen Research & Development, LLC
      2018   Phase 1   NCT03358706   Austria;Belgium;Denmark;Germany;Sweden;United Kingdom;United States;
   Takeda
      2016   Phase 4   NCT02760615   United States;
Diet   
   Assiut University
      2020   -   NCT04332328   -
Doxycycline   
   Hamilton Health Sciences Corporation
      2016   Phase 2   NCT02606032   Canada;
   University of Dundee
      2006   -   NCT00355602   United Kingdom;
E. coli Nissle   
   Hvidovre University Hospital
      2011   Phase 4   NCT01772615   Denmark;
E. coli Nissle 1917 (Mutaflor®)   
   Kangbuk Samsung Hospital
      2018   Phase 4   NCT04969679   Korea, Republic of;
E6007   
   EA Pharma Co., Ltd.
      2016   Phase 2   NCT03018054   Japan;
EGF enema   
   University Hospitals of Leicester NHS Trust
      2006   Phase 3   EUCTR2006-002036-25-GB   United Kingdom;
EMEA/H/C/000240   
   Santeon
      2015   Phase 4   EUCTR2015-001954-14-NL   Netherlands;
EMEA/H/C/000481   
   Odense University Hospital
      2011   Phase 3   EUCTR2011-004268-31-DK   Denmark;
EN   
   Friendship Hospital of Capital Medical University
      2008   Phase 1 study   ChiCTR-TRC-08000145   China;
ENTOCORT CR   
   COSMO TECHNOLOGIES LTD
      2008   -   EUCTR2006-004776-12-IT   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
ENTYVIO - 300 MG - POLVERE PE RCONCENTRATO PER SOLUZIONE PER INFU   
   ALLERGAN LIMITED
      2019   Phase 2   EUCTR2018-001605-93-IT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
ENTYVIO - 300 MG - POLVERE PE RCONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) (20ML) - 1 FLACONCINO   
   FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO
      2016   Phase 4   EUCTR2015-003270-32-IT   Italy;
   TAKEDA DEVELOPMENT CENTER AMERICAS INC.
      2021   Phase 3   EUCTR2020-004300-34-IT   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
   TAKEDA DEVELOPMENT CENTRE EUROPE LTD
      2015   Phase 3   EUCTR2015-000939-33-IT   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
ENTYVIO - 300 MG - POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) (20ML) - 1 FLACONCINO   
   TAKEDA DEVELOPMENT CENTRE EUROPE LTD
      2016   Phase 3   EUCTR2015-000480-14-IT   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Ecologic 825   
   Wageningen University
      2014   -   NCT02361957   Netherlands;
Efavaleukin alfa   
   Amgen
      2022   Phase 2   NCT04987307   Austria;Bulgaria;Japan;Korea, Republic of;Poland;United States;
Efmarodocokin alfa   
   Chugai Pharmaceutical Co., Ltd.
      2019   Phase 1   JPRN-JapicCTI-194721   Japan;
   Genentech, Inc.
      2018   Phase 2   EUCTR2017-004997-32-IE   Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Eicosapentaenoic acid   
   Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi
      2014   -   NCT02179372   Italy;
Empagliflozin   
   Sadat City University
      2021   Phase 2   NCT05058417   Egypt;
Encapsulated Mesalamine Granules (eMG)   
   Bausch Health Americas, Inc.
      2005   Phase 3   NCT00326209   United States;
Encapsulated faecal microbiota filtrate   
   Jena University Hospital
      2021   Phase 2/Phase 3   NCT03843385   -
Enema   
   Tel-Aviv Sourasky Medical Center
      2015   Phase 2   NCT04434872   Israel;
Entecavir   
   Saitama Medical University
      2016   -   JPRN-UMIN000020029   Japan;
Entocort EC®   
   Bausch Health Americas, Inc.
      2008   Phase 3   NCT00679380   Australia;Belgium;Estonia;France;Israel;Italy;Latvia;Lithuania;Poland;Romania;Russian Federation;Slovakia;Sweden;Ukraine;United Kingdom;
Entocort® CR   
   COSMO Technologies Ltd
      2008   Phase 3   EUCTR2006-004776-12-SK   Belgium;Estonia;France;Italy;Latvia;Lithuania;Slovakia;Sweden;United Kingdom;
      2008   Phase 3   EUCTR2006-004776-12-GB   Belgium;Estonia;France;Italy;Latvia;Lithuania;Slovakia;Sweden;United Kingdom;
      2008   -   EUCTR2006-004776-12-SE   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
      2008   -   EUCTR2006-004776-12-LV   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
      2008   -   EUCTR2006-004776-12-LT   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
      2008   -   EUCTR2006-004776-12-FR   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
      2008   -   EUCTR2006-004776-12-EE   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
      2008   -   EUCTR2006-004776-12-BE   Belgium;Estonia;France;Italy;Latvia;Lithuania;Sweden;United Kingdom;
Entyvio   
   ALIMENTIV INC.
      2021   Phase 4   EUCTR2019-002485-12-IT   Belarus;Belgium;Canada;France;Italy;Netherlands;Poland;Russian Federation;Ukraine;United Kingdom;United States;
   Academic Medical Center, Gastroenterology
      2017   Phase 4   EUCTR2014-005443-40-HU   Belgium;Hungary;Netherlands;
   Academic Medical Center/ Gastroenterology
      2015   Phase 4   EUCTR2014-005443-40-NL   Belgium;Hungary;Netherlands;
      2015   Phase 4   EUCTR2014-005443-40-BE   Belgium;Hungary;Netherlands;
   Alimentiv Inc.
      2021   Phase 4   EUCTR2019-002485-12-PL   Belarus;Belgium;Canada;France;Italy;Netherlands;Poland;Russian Federation;Ukraine;United Kingdom;United States;
      2021   Phase 4   EUCTR2019-002485-12-NL   Belarus;Belgium;Canada;France;Italy;Netherlands;Poland;Russian Federation;Ukraine;United Kingdom;United States;
   Alimentiv Inc. (formerly Robarts Clinical Trials)
      2020   Phase 4   EUCTR2019-002485-12-GB   Belarus;Belgium;Canada;France;Italy;Netherlands;Poland;Russian Federation;Ukraine;United Kingdom;United States;
   Allergan Ltd.
      2019   Phase 2   EUCTR2018-001605-93-RO   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-001605-93-FR   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-001605-93-ES   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-001605-93-BG   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
   AstraZeneca AB
      2019   Phase 2   EUCTR2018-001605-93-GB   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-001605-93-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czechia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
   CHU Amiens-Picardie
      2020   Phase 4   EUCTR2020-004391-18-FR   France;
   Centre Hospitalier Universitaire de Rennes
      2018   Phase 4   EUCTR2018-002673-21-FR   France;
   Eli Lilly and Company
      2021   Phase 3   EUCTR2019-001653-99-LV   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2019-001653-99-LT   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2019-001653-99-DE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2019-001653-99-BE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2019-001653-99-FR   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
   GENENTECH, INC.
      2018   Phase 2   EUCTR2017-002350-36-IT   Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
   Genentech, Inc.
      2018   Phase 2   EUCTR2017-002350-36-NL   Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
      2018   Phase 2   EUCTR2017-002350-36-IE   Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
      2018   Phase 2   EUCTR2017-002350-36-HU   Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
      2018   Phase 2   EUCTR2017-002350-36-GR   Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
      2018   Phase 2   EUCTR2017-002350-36-GB   Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
      2018   Phase 2   EUCTR2017-002350-36-DE   Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
      2018   Phase 2   EUCTR2017-002350-36-BG   Bulgaria;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
   Roche Farma, S.A por delegación de Genentech, Inc.
      2018   Phase 2   EUCTR2017-002350-36-ES   Bulgaria;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
   Takeda Development Centre Europe Limited
      2017   Phase 4   EUCTR2016-000678-40-BG   Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine;
      2016   Phase 4   EUCTR2016-000678-40-LV   Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine;
      2016   Phase 4   EUCTR2016-000678-40-HU   Australia;Bulgaria;Czech Republic;Czechia;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine;
      2016   Phase 4   EUCTR2016-000678-40-EE   Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine;
      2016   Phase 4   EUCTR2016-000678-40-CZ   Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine;
   Takeda Development Centre Europe, Ltd.
      2018   Phase 2   EUCTR2017-002231-41-PL   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
      2018   Phase 2   EUCTR2017-002231-41-NL   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
      2018   Phase 2   EUCTR2017-002231-41-BE   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
      2018   Phase 2   EUCTR2017-002182-21-PL   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
      2018   Phase 2   EUCTR2017-002182-21-NL   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
      2018   Phase 2   EUCTR2017-002182-21-BE   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
      2017   Phase 2   EUCTR2017-002231-41-HU   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
      2017   Phase 2   EUCTR2017-002231-41-GB   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
      2017   Phase 2   EUCTR2017-002231-41-DE   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
      2017   Phase 2   EUCTR2017-002182-21-HU   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
      2017   Phase 2   EUCTR2017-002182-21-GB   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
      2017   Phase 2   EUCTR2017-002182-21-FR   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
      2017   Phase 2   EUCTR2017-002182-21-DE   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000939-33-PT   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000939-33-PL   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000939-33-NL   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000939-33-HU   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000939-33-HR   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000939-33-ES   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000482-31-NL   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000482-31-HR   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000480-14-SK   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000480-14-SE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000480-14-NL   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000480-14-LT   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000480-14-HU   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000480-14-HR   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000480-14-GB   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000480-14-ES   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000480-14-DK   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000480-14-DE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000480-14-CZ   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000480-14-BG   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000480-14-BE   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-000939-33-SK   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-000939-33-LV   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-000939-33-LT   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-000939-33-GB   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-000939-33-EE   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-000939-33-DK   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-000939-33-DE   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-000939-33-CZ   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-000939-33-BG   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-000939-33-BE   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 2   EUCTR2017-002231-41-FR   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
Epaxal Berna (virosomal hepatitis A vaccine)   
   Asan Medical Center
      2011   Phase 4   NCT01341808   Korea, Republic of;
Epidermal growth factor enema   
   University Hospitals of Leicester NHS Trust
      2006   Phase 3   EUCTR2006-002036-25-GB   United Kingdom;
Ergocalciferol   
   Boston Children’s Hospital
      2008   -   NCT00621257   United States;
Etrasimod   
   Arena Pharmaceuticals
      2022   Phase 2   NCT05287126   -
      2021   Phase 2   NCT05061446   Japan;
      2021   Phase 2   NCT04607837   Australia;Belarus;Belgium;Bulgaria;Canada;Czechia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;Ukraine;United States;
      2020   Phase 3   NCT04706793   Japan;
      2020   Phase 3   NCT03996369   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   NCT03950232   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Croatia;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   NCT03945188   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 2   NCT02536404   Australia;Austria;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;Israel;Korea, Republic of;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
      2015   Phase 2   NCT02447302   Australia;Austria;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;Israel;Korea, Republic of;Latvia;Lithuania;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
   Everstar Therapeutics Limited
      2019   Phase 3   NCT04176588   China;
   IQVIA Services Japan K.K. ICCC:
      2021   Phase 3   JPRN-jRCT2071200081   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Germany;Hungary;India;Israel;Italy;Japan;Korea;Lebanon;Mexico;Moldova;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;
      2020   Phase 3   JPRN-jRCT2071200080   Japan;
   Tanabe Masakazu
      2021   Phase 2   JPRN-jRCT2071210052   Japan;
Etrasimod L-arginine   
   ARENA PHARMACEUTICALS, INC.
      2021   Phase 2   EUCTR2020-003507-34-IT   Australia;Belgium;Bulgaria;Canada;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Moldova, Republic of;Netherlands;Poland;Portugal;Russian Federation;South Africa;Spain;United States;
      2019   Phase 3   EUCTR2018-003987-29-IT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003986-33-IT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003985-15-IT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
   Arena Pharmaceuticals Inc.
      2020   Phase 3   EUCTR2018-003987-29-PT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-003987-29-FR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-003987-29-DE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-003987-29-BG   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-003987-29-AT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-003985-15-FR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-003985-15-AT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003987-29-SK   Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003987-29-NL   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003987-29-LV   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003987-29-LT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003987-29-HU   Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003987-29-HR   Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Croatia;Czech Republic;Denmark;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003987-29-ES   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003987-29-DK   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003987-29-BE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003986-33-SK   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003985-15-SK   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003985-15-PT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003985-15-NL   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003985-15-LV   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003985-15-LT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003985-15-HU   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003985-15-HR   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003985-15-ES   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003985-15-EE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003985-15-DK   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003985-15-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003985-15-BG   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2018-003987-29-PL   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2018-003987-29-EE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2018-003987-29-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2018-003985-15-PL   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2018-003985-15-DE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2018-003985-15-BE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
   Arena Pharmaceuticals, Inc.
      2021   Phase 2   EUCTR2020-003507-34-PT   Australia;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;United States;
      2021   Phase 2   EUCTR2020-003507-34-HU   Australia;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;United States;
      2021   Phase 2   EUCTR2020-003507-34-FR   Australia;Belgium;Bulgaria;Canada;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Moldova, Republic of;Netherlands;Poland;Portugal;Russian Federation;South Africa;Spain;United States;
      2021   Phase 2   EUCTR2020-003507-34-BG   Australia;Belgium;Bulgaria;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Poland;Portugal;Russian Federation;Spain;United States;
      2020   Phase 3   EUCTR2018-003986-33-PT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-003986-33-LV   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-003986-33-GB   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-003986-33-FR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-003986-33-ES   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-003986-33-DK   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-003986-33-BG   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2018-003986-33-AT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003986-33-NL   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003986-33-LT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003986-33-HU   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003986-33-HR   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2018-003986-33-BE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2018-003986-33-PL   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2018-003986-33-EE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;China;Croatia;Czech Republic;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2018-003986-33-DE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Egypt;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2018-003986-33-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Georgia;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lebanon;Lithuania;Mexico;Moldova, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Thailand;Turkey;Ukraine;United Kingdom;United States;
Etrolizumab   
   F. Hoffmann-La Roche Ltd
      2020   Phase 3   EUCTR2019-004652-11-SI   Argentina;Austria;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2014   Phase 3   EUCTR2013-004278-88-AT   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
   Genentech, Inc.
      2011   Phase 2   NCT01461317   Australia;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
      2011   Phase 2   EUCTR2011-003409-36-GB   Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
   Hoffmann-La Roche
      2018   Phase 1   NCT03478956   Belgium;Germany;Poland;Spain;United Kingdom;United States;
      2014   Phase 3   NCT02171429   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czechia;France;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States;
      2014   Phase 3   NCT02165215   Brazil;Canada;Czech Republic;Czechia;Denmark;Germany;Hungary;India;Israel;Italy;Mexico;Poland;Slovakia;South Africa;Ukraine;United States;
      2014   Phase 3   NCT02163759   Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States;
      2014   Phase 3   NCT02136069   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam;
      2014   Phase 3   NCT02118584   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Vietnam;
Etrozulimab   
   Hoffmann-La Roche
      2014   Phase 3   NCT02100696   Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Romania;Spain;Switzerland;United Kingdom;United States;
ExoFlo   
   Direct Biologics, LLC
      2022   Phase 1   NCT05176366   -
Exposure to golimumab   
   University of Zurich
      2018   -   NCT03394586   Switzerland;
F8IL10   
   Pfizer Inc, 235 East 42nd Street, New York, New York 10017
      2018   Phase 2   EUCTR2017-002108-28-ES   Australia;Belgium;Germany;Israel;Italy;Korea, Republic of;Saudi Arabia;Serbia;Spain;United States;
      2018   Phase 2   EUCTR2017-002108-28-DE   Australia;Belgium;Germany;Israel;Italy;Korea, Republic of;Saudi Arabia;Serbia;Spain;United States;
      2018   Phase 2   EUCTR2017-002108-28-BE   Australia;Belgium;Germany;Israel;Italy;Korea, Republic of;Saudi Arabia;Serbia;Spain;United States;
FE 999301   
   University Hospital Schleswig-Holstein (UKSH)
      2016   Phase 2   EUCTR2016-000205-36-DE   Germany;
FMT   
   University of Birmingham
      2017   Phase 3   EUCTR2015-005753-12-GB   United Kingdom;
   Yanling Wei
      2015   Phase 2   NCT02335281   China;
FMT enema   
   University of British Columbia
      2020   Phase 2   NCT04202211   Canada;
FMT infusions   
   The University of New South Wales
      2013   Phase 2   NCT01896635   Australia;
FMT oral   
   University of British Columbia
      2020   Phase 2   NCT04202211   Canada;
FP-110   
   FORMAC Pharmaceuticals NV
      2009   -   EUCTR2009-015136-14-BE   Belgium;
FP-CYA-050   
   Sublimity Therapeutics (Hold Co) Ltd.
      2019   Phase 2   EUCTR2018-003349-41-PL   Belarus;Bulgaria;Canada;France;Germany;Hungary;Israel;Italy;Poland;Russian Federation;Serbia;Ukraine;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-003349-41-HU   Belarus;Belgium;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-003349-41-GB   Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-003349-41-FR   Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-003349-41-DE   Belarus;Bulgaria;Canada;France;Germany;Hungary;Israel;Poland;Russian Federation;Serbia;Ukraine;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-003349-41-BG   Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
   Sublimity Therapeutics HoldCo Limited
      2019   Phase 2   EUCTR2018-003349-41-IT   Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
FP-CYA-053   
   Sublimity Therapeutics (Hold Co) Ltd.
      2019   Phase 2   EUCTR2018-003349-41-PL   Belarus;Bulgaria;Canada;France;Germany;Hungary;Israel;Italy;Poland;Russian Federation;Serbia;Ukraine;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-003349-41-FR   Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
   Sublimity Therapeutics HoldCo Limited
      2019   Phase 2   EUCTR2018-003349-41-IT   Belarus;Bulgaria;Canada;France;Germany;Hungary;Ireland;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Faecal Microbiota Transplant   
   University of Birmingham
      2017   Phase 3   EUCTR2015-005753-12-GB   United Kingdom;
Faecal Microbiota Transplantation   
   St Vincent's Hospital Melbourne
      2018   -   NCT03477032   Australia;
Faecal matter   
   University of Birmingham
      2017   Phase 3   EUCTR2015-005753-12-GB   United Kingdom;
Faecal microbiota transplantation   
   Torkell Ellingsen
      2022   Phase 2   NCT04924270   -
Fecal Microbial Transplant   
   Children's Hospital Los Angeles
      2016   Phase 1   NCT02291523   United States;
Fecal Microbial Transplantation   
   Stony Brook University
      2013   Early Phase 1   NCT03268213   United States;
Fecal Microbiota   
   Tel-Aviv Sourasky Medical Center
      2015   Phase 2   NCT04434872   Israel;
Fecal Microbiota Enema   
   McMaster Children's Hospital
      2015   Phase 1   NCT02487238   Canada;
Fecal Microbiota Transplant   
   Baylor College of Medicine
      2014   Phase 1   NCT01947101   United States;
   Children's Hospital of Philadelphia
      2015   -   NCT02636517   United States;
   University of Alberta
      2014   Phase 1/Phase 2   NCT02227342   Canada;
   University of Vermont
      2015   Early Phase 1   NCT02390726   United States;
Fecal Microbiota Transplant (FMT)   
   Stacy A. Kahn
      2015   Phase 1/Phase 2   NCT02330653   United States;
Fecal Microbiota Transplantation   
   Ari M Grinspan
      2021   Early Phase 1   NCT04968951   United States;
   Dayanand Medical College and Hospital
      2018   Phase 3   NCT03716388   India;
   Jun Liu
      2015   Phase 2/Phase 3   NCT02435160   -
   Weill Medical College of Cornell University
      2020   Phase 2   NCT03998488   United States;
      2016   Phase 1   NCT02516384   United States;
Fecal Microbiota Transplantation (FMT)   
   Assistance Publique - Hôpitaux de Paris
      2018   Phase 3   NCT03483246   France;
   Children's Mercy Hospital Kansas City
      2014   Phase 1   NCT02108821   United States;
Fecal Microbiota Transplantation (FMT), OpenBiome   
   Najwa Elnachef
      2017   Phase 1   NCT03006809   United States;
Fecal microbiota   
   University of Minnesota
      2019   Phase 1   NCT03948919   United States;
Fecal microbiota capsule   
   Zhongshan Hospital Xiamen University
      2020   Phase 1   NCT04521205   China;
Fecal microbiota transplantation   
   Guangzhou First People's Hospital
      2019   Phase 2/Phase 3   NCT03804931   China;
   Gulhane Military Medical Academy
      2015   Phase 3   NCT02575040   Turkey;
   Helsinki University Central Hospital
      2018   Phase 2   NCT03378921   Finland;
   McMaster University
      2021   Phase 4   NCT04231110   Canada;
   The Second Hospital of Nanjing Medical University
      2016   Phase 4   NCT02998112   China;
   University of Chicago
      2013   Phase 1   NCT02058524   United States;
Ferric carboxymaltose   
   Vifor Inc.
      2008   Phase 3   NCT00810030   Austria;Russian Federation;
Ferrous sulphate   
   Barts Health NHS Trust
      2011   Phase 4   EUCTR2010-023797-39-GB   United Kingdom;
   Queen Mary University of London
      2011   Phase 4   NCT01991314   United Kingdom;
Filgotinib   
   GILEAD SCIENCES INCORPORATED
      2018   Phase 3   EUCTR2016-002765-58-IT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2016-001392-78-IT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
   Gilead Sciences
      2018   Phase 1   NCT03417778   Germany;New Zealand;United States;
      2017   Phase 3   NCT02914535   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2016   Phase 3   NCT02914522   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
Film-coated tablet   
   LG Chem
      2020   Phase 1   NCT04360343   Korea, Republic of;
Flagyl   
   FORMAC Pharmaceuticals NV
      2009   -   EUCTR2009-015136-14-BE   Belgium;
Flaxseed lignan-enriched complex (FLC)   
   University of Saskatchewan
      2018   Phase 2   NCT02201758   Canada;
Flixabi   
   Centre Hospitalier Universitaire de Rennes
      2018   Phase 4   EUCTR2018-002673-21-FR   France;
   UMC Amsterdam location AMC
      2020   Phase 4   EUCTR2018-003524-36-IE   Ireland;Netherlands;
   University Medical Center Groningen
      2021   Phase 4   EUCTR2020-001811-26-BE   Belgium;Netherlands;
      2020   Phase 4   EUCTR2020-001811-26-NL   Netherlands;
   University Southampton Hospital NHS Foundation Trust
      2018   Phase 4   EUCTR2018-001546-33-GB   United Kingdom;
Fluorescein   
   Fujita Health University School of Medicine, Department of Gastroenterology
      2017   -   JPRN-UMIN000032250   Japan;
   Ohmiya Naoki
      2017   -   JPRN-jRCTs041180035   Japan;
Flupentixol   
   Guiyang 1st People's Hospital
      2018   -   ChiCTR1800016438   China;
Fosfomycin   
   Division of General Medicine, Department of Internal Medicine, Nihon University School of Medicine
      2013   Phase 3   JPRN-UMIN000009811   Japan;
   Ishikawa Dai
      2017   -   JPRN-jRCTs031180415   Japan;
   National Center for Child Health and Development
      2016   -   JPRN-UMIN000026485   Japan;
Freeze-dried black raspberry powder   
   UConn Health
      2013   Phase 1   NCT02267694   United States;
G1567970   
   Galapagos NV
      2020   Phase 2   EUCTR2020-000659-11-PL   Georgia;Moldova, Republic of;Poland;Ukraine;
G321605   
   Galapagos NV
      2015   Phase 2   EUCTR2014-001893-32-CZ   Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation;
      2015   -   EUCTR2014-001893-32-PL   Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation;
      2014   -   EUCTR2014-001893-32-HU   Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation;
      2014   -   EUCTR2014-001893-32-DE   Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation;
      2014   -   EUCTR2014-001893-32-BE   Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation;
GB004   
   GB004, Inc.
      2020   Phase 2   NCT04556383   Australia;Georgia;Korea, Republic of;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
   GB004, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.
      2019   Phase 1   NCT03860896   Georgia;Moldova, Republic of;United States;
GB004-HCl   
   GB004, Inc.
      2021   Phase 2   EUCTR2020-002306-12-PL   Australia;Belarus;Georgia;Italy;Korea, Republic of;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
GED-0301   
   Celgene
      2015   Phase 2   NCT02601300   Bulgaria;Canada;Hungary;Poland;Slovakia;United States;
   Celgene Corporation
      2016   Phase 2   EUCTR2015-003364-36-SK   Bulgaria;Canada;Hungary;Poland;Slovakia;United States;
      2016   Phase 2   EUCTR2015-003364-36-HU   Bulgaria;Canada;Hungary;Poland;Slovakia;United States;
      2016   Phase 2   EUCTR2015-003364-36-BG   Bulgaria;Canada;Hungary;Poland;Slovakia;United States;
GED-0507-34-Levo   
   GIULIANI
      2012   -   EUCTR2011-003283-78-IT   Italy;
   PPM Services S.A.
      2016   Phase 2   NCT02808390   Bulgaria;Canada;France;Hungary;Italy;Latvia;Poland;Slovakia;Ukraine;United States;
GED0507   
   PPM SERVICES SA
      2017   Phase 2   EUCTR2016-001684-36-LV   Bulgaria;Canada;France;Hungary;Italy;Latvia;Poland;Slovakia;Spain;Ukraine;United States;
      2017   Phase 2   EUCTR2016-001684-36-ES   Bulgaria;Canada;France;Hungary;Italy;Latvia;Poland;Slovakia;Spain;Ukraine;United States;
      2016   Phase 2   EUCTR2016-001684-36-SK   Bulgaria;Canada;France;Hungary;Italy;Latvia;Poland;Slovakia;Spain;Ukraine;United Kingdom;United States;
      2016   Phase 2   EUCTR2016-001684-36-HU   Bulgaria;Canada;Czech Republic;France;Hungary;Italy;Latvia;Poland;Slovakia;Spain;Ukraine;United Kingdom;United States;
      2016   Phase 2   EUCTR2016-001684-36-BG   Bulgaria;Canada;France;Hungary;Italy;Latvia;Poland;Slovakia;Spain;Ukraine;United Kingdom;United States;
GI-270384   
   GlaxoSmithKline
      2004   Phase 1   NCT00457171   Netherlands;
GLPG0974   
   Galapagos NV
      2013   Phase 2   NCT01829321   Belgium;Czech Republic;Latvia;Slovakia;
      2013   Phase 2   EUCTR2012-005521-73-BE   Belgium;Czech Republic;Latvia;
      2013   -   EUCTR2012-005521-73-LV   Czech Republic;Latvia;
      2013   -   EUCTR2012-005521-73-CZ   Belgium;Czech Republic;Latvia;
GLPG1205   
   Galapagos NV
      2015   Phase 2   EUCTR2014-001893-32-CZ   Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation;
      2015   -   EUCTR2014-001893-32-PL   Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation;
      2014   Phase 2   NCT02337608   Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation;
      2014   -   EUCTR2014-001893-32-HU   Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation;
      2014   -   EUCTR2014-001893-32-DE   Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation;
      2014   -   EUCTR2014-001893-32-BE   Belgium;Czech Republic;Germany;Hungary;Poland;Russian Federation;
GLPG3970   
   Galapagos NV
      2020   Phase 2   NCT04577794   Georgia;Moldova, Republic of;Poland;Ukraine;
      2020   Phase 2   EUCTR2020-000659-11-PL   Georgia;Moldova, Republic of;Poland;Ukraine;
GLYCYRRHIZA GLABRA ROOT   
   Steigerwald Arzneimittelwerk GmbH
      2014   -   EUCTR2013-000891-13-DE   Germany;
GM-CSF, fosfomycin and metronidazole   
   Zealand University Hospital
      2021   Phase 1/Phase 2   NCT04979832   Denmark;
GS-4875   
   GILEAD SCIENCES INCORPORATED
      2020   Phase 2   EUCTR2019-001430-33-IT   Australia;Austria;Belgium;Canada;Czechia;France;Germany;Italy;Poland;Russian Federation;Switzerland;United Kingdom;United States;
   Gilead Sciences, Inc.
      2020   Phase 2   EUCTR2019-001430-33-PL   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Italy;Poland;Russian Federation;Switzerland;United Kingdom;United States;
      2020   Phase 2   EUCTR2019-001430-33-GB   Australia;Austria;Belgium;Canada;Czechia;France;Germany;Italy;Poland;Russian Federation;Switzerland;United Kingdom;United States;
      2020   Phase 2   EUCTR2019-001430-33-FR   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Italy;Poland;Russian Federation;Switzerland;United Kingdom;United States;
      2020   Phase 2   EUCTR2019-001430-33-DE   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Italy;Poland;Russian Federation;Switzerland;United Kingdom;United States;
      2020   Phase 2   EUCTR2019-001430-33-AT   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Italy;Poland;Russian Federation;Switzerland;United Kingdom;United States;
GS-5745   
   Gilead Sciences
      2013   Phase 1   NCT01831427   Belgium;Canada;Hungary;Moldova, Republic of;Netherlands;Romania;United States;
   Gilead Sciences, Inc
      2016   Phase 2;Phase 3   EUCTR2014-005217-24-SE   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
      2016   Phase 2;Phase 3   EUCTR2014-005217-24-IS   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
      2016   Phase 2;Phase 3   EUCTR2014-005217-24-HR   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
      2016   Phase 2;Phase 3   EUCTR2014-005217-24-ES   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
      2016   Phase 2;Phase 3   EUCTR2014-005217-24-DE   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
      2016   Phase 2;Phase 3   EUCTR2014-005217-24-BG   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
      2016   Phase 2;Phase 3   EUCTR2014-005217-24-BE   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
      2015   Phase 2;Phase 3   EUCTR2014-005217-24-SK   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
      2015   Phase 2;Phase 3   EUCTR2014-005217-24-NL   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
      2015   Phase 2;Phase 3   EUCTR2014-005217-24-LV   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
      2015   Phase 2;Phase 3   EUCTR2014-005217-24-IE   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
      2015   Phase 2;Phase 3   EUCTR2014-005217-24-HU   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
      2015   Phase 2;Phase 3   EUCTR2014-005217-24-GB   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
      2015   Phase 2;Phase 3   EUCTR2014-005217-24-CZ   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
      2015   Phase 2;Phase 3   EUCTR2014-005217-24-AT   Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Germany;Hong Kong;Hungary;Iceland;India;Iran, Islamic Republic of;Ireland;Israel;Korea, Republic of;Latvia;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Philippines;Romania;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
GS-5745 IV   
   Gilead Sciences
      2014   Phase 1   NCT02209987   New Zealand;
GS-5745 SC   
   Gilead Sciences
      2014   Phase 1   NCT02209987   New Zealand;
GS-6034   
   GILEAD SCIENCES INCORPORATED
      2018   Phase 3   EUCTR2016-002765-58-IT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2016-001392-78-IT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
   Galapagos NV
      2017   Phase 3   EUCTR2016-002765-58-SE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-002765-58-DE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-002765-58-AT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
   Gilead Sciences, Inc
      2017   Phase 3   EUCTR2016-002765-58-SK   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
   Gilead Sciences, Inc.
      2018   Phase 2   EUCTR2017-000402-38-SE   Australia;Austria;Belgium;Canada;Czech Republic;Germany;Hungary;India;Italy;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sri Lanka;Sweden;Ukraine;United Kingdom;United States;
      2018   Phase 2   EUCTR2017-000402-38-PT   Australia;Austria;Belgium;Canada;Germany;India;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Taiwan;Ukraine;United Kingdom;United States;
      2018   Phase 2   EUCTR2017-000402-38-NL   Australia;Austria;Belgium;Canada;France;Germany;India;Italy;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Spain;Sri Lanka;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2018   Phase 2   EUCTR2017-000402-38-GB   Australia;Austria;Belgium;Canada;Germany;India;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Ukraine;United Kingdom;United States;
      2018   Phase 2   EUCTR2017-000402-38-ES   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;India;Italy;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sri Lanka;Sweden;Ukraine;United Kingdom;United States;
      2018   Phase 2   EUCTR2017-000402-38-DE   Australia;Austria;Belgium;Canada;Germany;India;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Taiwan;Ukraine;United Kingdom;United States;
      2018   Phase 2   EUCTR2017-000402-38-BE   Australia;Austria;Belgium;Canada;France;Germany;India;Italy;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Spain;Sri Lanka;Sweden;Switzerland;Ukraine;United Kingdom;United States;
      2018   Phase 2   EUCTR2017-000402-38-AT   Australia;Austria;Belgium;Canada;Germany;India;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-002765-58-PT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-002765-58-NL   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-002765-58-IS   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-002765-58-HU   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-002765-58-HR   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-002765-58-GR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-002765-58-FR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-002765-58-ES   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-002765-58-CZ   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-002765-58-BG   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2016-002765-58-BE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-SK   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-SE   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-PT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-NO   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-NL   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-IS   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-HU   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-HR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-GR   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-ES   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-DE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-BG   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-BE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sri Lanka;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2017   Phase 2;Phase 3   EUCTR2016-001392-78-AT   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2016-002765-58-GB   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
      2016   Phase 2;Phase 3   EUCTR2016-001392-78-GB   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Ukraine;United Kingdom;United States;
GSK1399686   
   GlaxoSmithKline
      2009   Phase 2   NCT01036022   Belgium;Canada;Germany;Norway;Sweden;
   GlaxoSmithKline Research and Development Ltd
      2009   Phase 2   EUCTR2009-011608-51-BE   Belgium;Germany;Sweden;
      2009   -   EUCTR2009-011608-51-SE   Germany;Sweden;
   GlaxoSmithKline Research and Development Ltd.
      2009   -   EUCTR2009-011608-51-DE   Germany;Sweden;
GSK1605786   
   GlaxoSmithKline
      2013   Phase 2   NCT01658605   Belgium;Netherlands;United Kingdom;
GSK1605786A   
   GlaxoSmithKline Research & Development Ltd
      2012   Phase 2   EUCTR2011-002818-37-BE   Belgium;Netherlands;United Kingdom;
      2012   -   EUCTR2011-002818-37-NL   Netherlands;United Kingdom;
      2012   -   EUCTR2011-002818-37-GB   Netherlands;United Kingdom;
GSK2586184   
   GlaxoSmithKline
      2013   Phase 1   NCT02000453   Netherlands;
GSK2831781   
   GlaxoSmithKline Research & Development Limited
      2020   Phase 2   EUCTR2018-003278-28-BG   Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Hungary;India;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovakia;South Africa;Ukraine;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-003278-28-PL   Bulgaria;Canada;Czech Republic;Estonia;France;Hungary;India;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovakia;South Africa;Ukraine;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-003278-28-NL   Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Hungary;India;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Ukraine;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-003278-28-HU   Bulgaria;Canada;Czech Republic;Estonia;France;Hungary;India;Korea, Republic of;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Ukraine;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-003278-28-GB   Bulgaria;Canada;Czech Republic;Estonia;France;Hungary;India;Israel;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Ukraine;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-003278-28-FR   Bulgaria;Canada;Czech Republic;Estonia;France;Hungary;India;Korea, Republic of;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Ukraine;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-003278-28-CZ   Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Hungary;India;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Russian Federation;Serbia;Slovenia;South Africa;Ukraine;United Kingdom;United States;
GSK2831781 - Double Blind Phase   
   GlaxoSmithKline
      2019   Phase 2   NCT03893565   Belgium;Bulgaria;Canada;Czechia;Estonia;France;Hungary;India;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Slovakia;South Africa;Ukraine;United Kingdom;United States;
GSK2831781 - Open Label phase   
   GlaxoSmithKline
      2019   Phase 2   NCT03893565   Belgium;Bulgaria;Canada;Czechia;Estonia;France;Hungary;India;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Slovakia;South Africa;Ukraine;United Kingdom;United States;
GSK2982772   
   GlaxoSmithKline
      2016   Phase 2   NCT02903966   Germany;Netherlands;Poland;Russian Federation;Sweden;United Kingdom;United States;
   GlaxoSmithKline Research & Development Ltd
      2017   Phase 2   EUCTR2016-001833-29-PL   Germany;Netherlands;Poland;Sweden;United Kingdom;
      2017   Phase 2   EUCTR2016-001833-29-NL   Germany;Netherlands;Poland;Sweden;United Kingdom;
      2016   Phase 2   EUCTR2016-001833-29-SE   Germany;Netherlands;Poland;Russian Federation;Sweden;United Kingdom;United States;
      2016   Phase 2   EUCTR2016-001833-29-GB   Germany;Netherlands;Poland;Sweden;United Kingdom;
GSK2982772A, where A denotes the free base   
   GlaxoSmithKline Research & Development Ltd
      2017   Phase 2   EUCTR2016-001833-29-PL   Germany;Netherlands;Poland;Sweden;United Kingdom;
      2017   Phase 2   EUCTR2016-001833-29-NL   Germany;Netherlands;Poland;Sweden;United Kingdom;
      2016   Phase 2   EUCTR2016-001833-29-SE   Germany;Netherlands;Poland;Russian Federation;Sweden;United Kingdom;United States;
      2016   Phase 2   EUCTR2016-001833-29-GB   Germany;Netherlands;Poland;Sweden;United Kingdom;
GWP42003   
   GW Pharma Ltd.
      2013   Phase 2   EUCTR2011-003208-19-CZ   Czech Republic;United Kingdom;
      2011   Phase 2   EUCTR2011-003208-19-GB   Czech Republic;United Kingdom;
   GW Research Ltd
      2012   Phase 2   NCT01562314   Czech Republic;United Kingdom;
Ganciclovir   
   Department of Gastroenterology and Hepatology, Kyoto University Hospital
      2016   -   JPRN-UMIN000022588   Japan;
   Graduate School of Medicine, Kyoto University, Gastroenterology and Hepatology
      2007   -   JPRN-UMIN000013925   Japan;
Gastro-resistant phosphatidylcholine granules   
   Dr. Falk Pharma GmbH
      2016   Phase 3   EUCTR2013-001205-84-HU   Austria;Belgium;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
      2016   Phase 3   EUCTR2013-001205-84-BE   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
      2015   Phase 3   EUCTR2013-001205-84-SK   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
      2015   Phase 3   EUCTR2013-001205-84-PL   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
      2015   Phase 3   EUCTR2013-001205-84-LV   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
      2015   Phase 3   EUCTR2013-001205-84-DE   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
      2015   Phase 3   EUCTR2013-001205-84-AT   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
      2014   Phase 3   EUCTR2012-003702-27-SK   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
      2014   Phase 3   EUCTR2012-003702-27-PL   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
      2014   Phase 3   EUCTR2012-003702-27-NL   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
      2014   Phase 3   EUCTR2012-003702-27-LV   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
      2014   Phase 3   EUCTR2012-003702-27-LT   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
      2014   Phase 3   EUCTR2012-003702-27-HU   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
      2014   Phase 3   EUCTR2012-003702-27-DE   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
      2014   Phase 3   EUCTR2012-003702-27-CZ   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
      2014   Phase 3   EUCTR2012-003702-27-BE   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
      2014   Phase 3   EUCTR2012-003702-27-AT   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
Gastroscopy   
   Tel-Aviv Sourasky Medical Center
      2015   Phase 2   NCT04434872   Israel;
Glutamine   
   The Second Hospital of Nanjing Medical University
      2019   -   NCT03917095   China;
Gold   
   Peking University First Hospital
      2018   -   ChiCTR1800019676   China;
   Xijing Hospital of Digestive Diseases, Fourth Military Medical University
      2012   -   ChiCTR1900023689   China;
Golimumab   
   Guy's and St Thomas' NHS Foundation Trust
      2017   Phase 4   NCT03124121   United Kingdom;
      2017   Phase 4   EUCTR2017-001374-42-GB   United Kingdom;
   Hospital San Carlos, Madrid
      2019   -   NCT03773445   Spain;
   Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
      2016   -   NCT03018925   Spain;
   Istituto Clinico Humanitas
      2015   Phase 4   NCT02412085   Italy;
   JANSSEN PHARMACEUTICAL K.K
      2008   Phase 3   JPRN-JapicCTI-090740   -
      2008   Phase 2-3   JPRN-JapicCTI-090739   -
   Janssen Biologics B.V.
      2014   -   EUCTR2012-004366-18-BE   Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
      2013   Phase 1   EUCTR2012-004366-18-DK   Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
      2013   Phase 1   EUCTR2012-004366-18-DE   Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
      2013   Phase 1   EUCTR2012-004366-18-AT   Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
      2013   -   EUCTR2012-004366-18-NL   Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
      -   Phase 1   EUCTR2012-004366-18-FR   Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
   Janssen Pharmaceutical K.K.
      2013   Phase 3   NCT01863771   Japan;
   Janssen Research & Development, LLC
      2022   Phase 2   NCT05242484   United States;
      2018   Phase 3   NCT03596645   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
      2013   Phase 2   NCT01988961   Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Hungary;Netherlands;Poland;Russian Federation;Ukraine;United States;
      2013   Phase 1   NCT01900574   Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
      2007   Phase 3   NCT00488631   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Former Serbia and Montenegro;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Nauru;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United Kingdom;United States;
      2007   Phase 2/Phase 3   NCT00487539   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United Kingdom;United States;
   Janssen Scientific Affairs, LLC
      2013   Phase 4   NCT01804166   United States;
   Kliniken im Naturpark Altmuehltal
      2014   Phase 4   NCT02186886   Germany;
   MSD
      2014   Phase 4   EUCTR2013-004583-56-GB   United Kingdom;
   Merck Sharp & Dohme Corp.
      2015   Phase 4   NCT02318667   Portugal;
      2014   Phase 4   NCT02092285   United Kingdom;
Golimumab (GLM)   
   University College Dublin
      2016   Phase 4   NCT02687724   Ireland;
Golimumab (Optimization)   
   Centre Hospitalier Universitaire de Saint Etienne
      2017   Phase 2   NCT03182166   France;
Golimumab 1 mg per kg   
   Janssen Research & Development, LLC
      2007   Phase 2/Phase 3   NCT00488774   Australia;Austria;Belgium;Bulgaria;Canada;Former Serbia and Montenegro;France;Germany;Hungary;India;Israel;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Sweden;Ukraine;United Kingdom;United States;
Golimumab 2 mg per kg   
   Janssen Research & Development, LLC
      2007   Phase 2/Phase 3   NCT00488774   Australia;Austria;Belgium;Bulgaria;Canada;Former Serbia and Montenegro;France;Germany;Hungary;India;Israel;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Sweden;Ukraine;United Kingdom;United States;
Golimumab 4 mg per kg   
   Janssen Research & Development, LLC
      2007   Phase 2/Phase 3   NCT00488774   Australia;Austria;Belgium;Bulgaria;Canada;Former Serbia and Montenegro;France;Germany;Hungary;India;Israel;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Sweden;Ukraine;United Kingdom;United States;
Golimumab 50 mg in patients <80 kg and Golimumab 100 mg in patients >80 kg   
   Hospital de Manises
      2018   Phase 4   NCT03669029   Spain;
Golimumab Dose 1   
   Janssen Research & Development, LLC
      2018   Phase 2   NCT03662542   Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States;
Golimumab Dose 2   
   Janssen Research & Development, LLC
      2018   Phase 2   NCT03662542   Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States;
Golimumab Liquid in Vial   
   Centocor BV
      2008   -   EUCTR2006-003397-94-SE   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2008   -   EUCTR2006-003397-94-NL   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2008   -   EUCTR2006-003397-94-LT   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2008   -   EUCTR2006-003397-94-BG   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2007   Phase 2;Phase 3   EUCTR2006-003397-94-SK   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
      2007   Phase 2;Phase 3   EUCTR2006-003397-94-HU   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
      2007   Phase 2;Phase 3   EUCTR2006-003397-94-FR   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
      2007   -   EUCTR2006-003397-94-LV   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2007   -   EUCTR2006-003397-94-DE   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2007   -   EUCTR2006-003397-94-BE   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2007   -   EUCTR2006-003397-94-AT   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
Golimumab Liquid in prefilled syringe   
   Centocor BV
      2010   -   EUCTR2006-003398-28-CZ   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2008   -   EUCTR2006-003399-37-LT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2008   -   EUCTR2006-003398-28-SE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2008   -   EUCTR2006-003398-28-NL   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2008   -   EUCTR2006-003398-28-LT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2008   -   EUCTR2006-003398-28-DK   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2008   -   EUCTR2006-003398-28-BG   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2007   Phase 3   EUCTR2006-003399-37-FR   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
      2007   Phase 2;Phase 3   EUCTR2006-003398-28-SK   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
      2007   Phase 2;Phase 3   EUCTR2006-003398-28-FR   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
      2007   -   EUCTR2006-003398-28-LV   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2007   -   EUCTR2006-003398-28-HU   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2007   -   EUCTR2006-003398-28-DE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2007   -   EUCTR2006-003398-28-BE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2007   -   EUCTR2006-003398-28-AT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
   Janssen Biologics B.V.
      2010   -   EUCTR2006-003399-37-CZ   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
      2008   -   EUCTR2006-003399-37-SE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
      2008   -   EUCTR2006-003399-37-DK   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
      2008   -   EUCTR2006-003399-37-BG   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
      2007   -   EUCTR2006-003399-37-LV   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
      2007   -   EUCTR2006-003399-37-HU   Australia;Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;India;Israel;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Sweden;Ukraine;
      2007   -   EUCTR2006-003399-37-DE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
      2007   -   EUCTR2006-003399-37-BE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
      2007   -   EUCTR2006-003399-37-AT   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
   Janssen Biologics BV
      2008   -   EUCTR2006-003399-37-NL   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
      2007   Phase 3   EUCTR2006-003399-37-SK   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
Golimumab Prefilled Syringe   
   David Drobne
      2020   Phase 4   NCT04156984   Slovenia;
Golimumab treatment optimization.   
   Hospital de Manises
      2018   Phase 4   NCT03669029   Spain;
Gralise   
   Shirley Ryan AbilityLab
      2012   Phase 4   NCT01678911   United States;
Granulated mesalamine   
   Bausch Health Americas, Inc.
      2004   Phase 3   NCT00767728   United States;
      2004   Phase 3   NCT00744016   United States;
Grapefruit   
   Department of Rheumatology and Clinical Immunology, Kyoto University Hospital
      2014   -   JPRN-UMIN000013546   Japan;
Group 1- Control Diet   
   Prof. Arie Levine
      2020   -   NCT03980405   Israel;
Group 2- UCD Diet   
   Prof. Arie Levine
      2020   -   NCT03980405   Israel;
Guaiazulene   
   Mie University Graduate School of Medicine, Gastrointestinal and Pediatric Surgery
      2013   -   JPRN-UMIN000013266   Japan;
Guselkum   
   Janssen-Cilag International NV
      2020   Phase 2;Phase 3   EUCTR2018-004002-25-ES   Argentina;Australia;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Russian Federation;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 2;Phase 3   EUCTR2018-004002-25-FR   Argentina;Australia;Belgium;Bulgaria;Canada;China;Czech Republic;France;Germany;Hong Kong;Hungary;Israel;Italy;Japan;Korea, Republic of;Malaysia;Poland;Portugal;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Guselkumab   
   Janssen Pharmaceutical K.K.
      2020   Phase 2-3   JPRN-JapicCTI-194980   Japan, Asia except Japan, North America, Europe;
   Janssen Research & Development, LLC
      2022   Phase 2   NCT05242484   United States;
      2019   Phase 2/Phase 3   NCT04033445   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Malaysia;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
   Janssen-Cilag International NV
      2021   Phase 2;Phase 3   EUCTR2018-004002-25-SK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Malaysia;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 2;Phase 3   EUCTR2018-004002-25-LV   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Netherlands;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 2;Phase 3   EUCTR2018-004002-25-NL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Malaysia;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 2;Phase 3   EUCTR2018-004002-25-GB   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 2;Phase 3   EUCTR2018-004002-25-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungary;Ireland;Israel;Italy;Japan;Jordan;Korea, Republic of;Latvia;Malaysia;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Slovakia;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-001510-15-PL   Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States;
      2019   Phase 2   EUCTR2018-001510-15-DE   Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States;
Guselkumab Dose 1   
   Janssen Research & Development, LLC
      2018   Phase 2   NCT03662542   Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States;
Guselkumab Dose 2   
   Janssen Research & Development, LLC
      2018   Phase 2   NCT03662542   Argentina;Australia;Brazil;Germany;Mexico;Poland;Russian Federation;Ukraine;United States;
H02AB   
   GETECCU (Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa)
      2009   -   EUCTR2007-003815-30-PT   Portugal;Spain;
HE3286   
   Harbor Therapeutics
      2008   Phase 1/Phase 2   NCT00628433   United States;
HF2   
   Sheba Medical Center
      2019   Phase 1/Phase 2   NCT03720002   Israel;
HGS1025   
   Human Genome Sciences Inc.
      2011   Phase 1   NCT01434576   -
HM201   
   Syneos Health
      2021   Early Phase 1   NCT05088369   -
HMPL-004   
   Hutchison MediPharma Enterprises Limited
      2008   -   EUCTR2007-005166-12-DE   Germany;
   Hutchison Medipharma Limited
      2013   Phase 3   NCT01882764   United States;
   Nutrition Science Partners Limited
      2014   -   EUCTR2013-003060-31-PL   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2014   -   EUCTR2013-003060-31-LV   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2014   -   EUCTR2013-003060-31-LT   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2014   -   EUCTR2013-003060-31-HU   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2014   -   EUCTR2013-003060-31-CZ   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2014   -   EUCTR2013-003060-31-BG   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2013   Phase 3   EUCTR2013-002116-27-CZ   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
      2013   -   EUCTR2013-002116-27-LV   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
      2013   -   EUCTR2013-002116-27-LT   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
      2013   -   EUCTR2013-002116-27-HU   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
      2013   -   EUCTR2013-002116-27-BG   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
HMPL-004 1800 mg/day   
   Hutchison Medipharma Limited
      2013   Phase 3   NCT01805791   United States;
HMPL-004 2400 mg/day   
   Hutchison Medipharma Limited
      2013   Phase 3   NCT01805791   United States;
HMPL-004 high dose   
   Hutchison Medipharma Limited
      2008   Phase 2   NCT00659802   United States;
HMPL-004 low dose   
   Hutchison Medipharma Limited
      2008   Phase 2   NCT00659802   United States;
HMPL004-6599   
   Nutrition Science Partners Limited
      2018   Phase 1   NCT03597971   Australia;
HUMIRA   
   Abbott GmbH Co. KG
      2007   -   EUCTR2006-002781-20-IT   Austria;Czech Republic;Germany;Hungary;Italy;Sweden;
   GETAID
      2019   Phase 4   EUCTR2018-003490-10-FR   France;
HUMIRA - 40 MG SOLUZIONE INIETTABILE USO SOTTOCUTANEO 1 SIRINGA PRERIEMPITA 0.8 ML + 1 TAMPONE IMBEVUTO DI ALCOL IN UN BLISTER   
   TAKEDA DEVELOPMENT CENTRE EUROPE LTD
      2015   Phase 3   EUCTR2015-000939-33-IT   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
HUMIRA 40Mg Solution for Injection   
   Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
      2019   Phase 4   NCT04131322   Spain;
HUMIRA ®   
   Fundación Publica Andaluza para la Gestión de Salud en Sevilla (FISEVI)
      2019   Phase 4   EUCTR2019-000717-37-ES   Spain;
Hemay007   
   Tianjin Hemay Pharmaceutical Co.,Ltd
      2019   Phase 2   NCT03977480   China;
Herbal treatment (SA100)   
   Stanford University
      2014   Phase 1   NCT02442960   United States;
Hextend   
   Spectrum Health Hospitals
      2007   Phase 3   NCT00467922   United States;
Hgd40   
   sterna biologicals GmbH & Co. KG
      2014   Phase 2   EUCTR2013-004599-36-DE   Germany;
High Dose Budesonide   
   Bausch Health Americas, Inc.
      2022   Phase 4   NCT04314375   -
High Dose MT-1303   
   Bausch Health Americas, Inc.
      2021   Phase 2   NCT04857112   United States;
High Protein and Low Fiber Diet   
   Mayo Clinic
      2021   -   NCT04933162   United States;
High dose   
   Holy Stone Healthcare Co., Ltd
      2016   Phase 2   NCT02493712   Italy;Taiwan;
HuM291   
   Facet Biotech
      2007   Phase 3   NCT00502294   -
   PDL BioPharma , Inc.
      2006   -   EUCTR2005-003482-17-IT   Greece;Ireland;Italy;Spain;United Kingdom;
   PDL BioPharma, Inc
      2007   -   EUCTR2005-003707-37-BE   Austria;Belgium;
      2007   -   EUCTR2005-003707-37-AT   Austria;Belgium;
      2006   Phase 2;Phase 3   EUCTR2005-002063-87-SK   Austria;Belgium;Czech Republic;Germany;Hungary;Slovakia;
      2006   Phase 2   EUCTR2005-003481-42-IE   Austria;Czech Republic;Germany;Greece;Hungary;Ireland;Slovakia;Spain;
      2006   -   EUCTR2005-004105-28-NL   France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
      2006   -   EUCTR2005-003481-42-ES   Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;
      2006   -   EUCTR2005-002063-87-DE   Belgium;Czech Republic;Germany;Hungary;
   PDL BioPharma, Inc.
      2007   -   EUCTR2005-004105-28-GR   France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
      2007   -   EUCTR2005-004105-28-FR   France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
      2007   -   EUCTR2005-003482-17-GR   Greece;Ireland;Italy;Spain;United Kingdom;
      2007   -   EUCTR2005-003482-17-GB   Greece;Ireland;Italy;Spain;United Kingdom;
      2007   -   EUCTR2005-003481-42-GR   Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;
      2006   Phase 2   EUCTR2005-004105-28-IE   France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
      2006   Phase 2   EUCTR2005-003482-17-IE   Greece;Ireland;Italy;Spain;United Kingdom;
      2006   -   NCT00355901   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Italy;Netherlands;Norway;Ukraine;United States;
      2006   -   EUCTR2005-004105-28-GB   France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
      2006   -   EUCTR2005-004105-28-DE   France;Germany;Greece;Hungary;Ireland;Netherlands;United Kingdom;
      2006   -   EUCTR2005-003482-17-ES   Greece;Ireland;Italy;Spain;United Kingdom;
      2006   -   EUCTR2005-003481-42-HU   Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;
      2006   -   EUCTR2005-003481-42-DE   Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;
      2006   -   EUCTR2005-003481-42-CZ   Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;
      2006   -   EUCTR2005-002063-87-CZ   Belgium;Czech Republic;Germany;Hungary;
   Protein Design Labs, Inc
      2006   Phase 2   EUCTR2005-003481-42-SK   Austria;Czech Republic;Germany;Greece;Hungary;Ireland;Slovakia;Spain;
      2006   -   EUCTR2005-003481-42-AT   Austria;Czech Republic;Germany;Greece;Hungary;Ireland;Slovakia;Spain;
   Protein Design Labs, Inc.
      2006   -   EUCTR2005-002063-87-HU   Belgium;Czech Republic;Germany;Hungary;
      2006   -   EUCTR2005-002063-87-BE   Belgium;Czech Republic;Germany;Hungary;
      2005   -   EUCTR2005-002063-87-AT   Austria;Belgium;Czech Republic;Germany;Hungary;
Hulio   
   University Medical Center Groningen
      2021   Phase 4   EUCTR2020-001811-26-BE   Belgium;Netherlands;
      2020   Phase 4   EUCTR2020-001811-26-NL   Netherlands;
Human Anti-TNF IgG1 Monoclonal Antibody   
   Centocor BV
      2010   -   EUCTR2006-003398-28-CZ   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2008   -   EUCTR2006-003399-37-LT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2008   -   EUCTR2006-003398-28-SE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2008   -   EUCTR2006-003398-28-NL   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2008   -   EUCTR2006-003398-28-LT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2008   -   EUCTR2006-003398-28-DK   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2008   -   EUCTR2006-003398-28-BG   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2008   -   EUCTR2006-003397-94-SE   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2008   -   EUCTR2006-003397-94-NL   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2008   -   EUCTR2006-003397-94-LT   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2008   -   EUCTR2006-003397-94-BG   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2007   Phase 3   EUCTR2006-003399-37-FR   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
      2007   Phase 2;Phase 3   EUCTR2006-003398-28-SK   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
      2007   Phase 2;Phase 3   EUCTR2006-003398-28-FR   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
      2007   Phase 2;Phase 3   EUCTR2006-003397-94-SK   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
      2007   Phase 2;Phase 3   EUCTR2006-003397-94-HU   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
      2007   Phase 2;Phase 3   EUCTR2006-003397-94-FR   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
      2007   -   EUCTR2006-003398-28-LV   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2007   -   EUCTR2006-003398-28-HU   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2007   -   EUCTR2006-003398-28-DE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2007   -   EUCTR2006-003398-28-BE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2007   -   EUCTR2006-003398-28-AT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2007   -   EUCTR2006-003397-94-LV   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2007   -   EUCTR2006-003397-94-DE   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2007   -   EUCTR2006-003397-94-BE   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2007   -   EUCTR2006-003397-94-AT   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
   Janssen Biologics B.V.
      2010   -   EUCTR2006-003399-37-CZ   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
      2008   -   EUCTR2006-003399-37-SE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
      2008   -   EUCTR2006-003399-37-DK   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
      2008   -   EUCTR2006-003399-37-BG   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
      2007   -   EUCTR2006-003399-37-LV   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
      2007   -   EUCTR2006-003399-37-HU   Australia;Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;India;Israel;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Sweden;Ukraine;
      2007   -   EUCTR2006-003399-37-DE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
      2007   -   EUCTR2006-003399-37-BE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
      2007   -   EUCTR2006-003399-37-AT   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
   Janssen Biologics BV
      2008   -   EUCTR2006-003399-37-NL   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
      2007   Phase 3   EUCTR2006-003399-37-SK   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
Human Anti-TNFalfa   
   Centocor BV
      2010   -   EUCTR2006-003398-28-CZ   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2008   -   EUCTR2006-003399-37-LT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2008   -   EUCTR2006-003398-28-SE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2008   -   EUCTR2006-003398-28-NL   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2008   -   EUCTR2006-003398-28-LT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2008   -   EUCTR2006-003398-28-DK   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2008   -   EUCTR2006-003398-28-BG   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2008   -   EUCTR2006-003397-94-SE   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2008   -   EUCTR2006-003397-94-NL   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2008   -   EUCTR2006-003397-94-LT   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2008   -   EUCTR2006-003397-94-BG   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2007   Phase 3   EUCTR2006-003399-37-FR   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
      2007   Phase 2;Phase 3   EUCTR2006-003398-28-SK   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
      2007   Phase 2;Phase 3   EUCTR2006-003398-28-FR   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
      2007   Phase 2;Phase 3   EUCTR2006-003397-94-SK   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
      2007   Phase 2;Phase 3   EUCTR2006-003397-94-HU   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
      2007   Phase 2;Phase 3   EUCTR2006-003397-94-FR   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
      2007   -   EUCTR2006-003398-28-LV   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2007   -   EUCTR2006-003398-28-HU   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2007   -   EUCTR2006-003398-28-DE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2007   -   EUCTR2006-003398-28-BE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2007   -   EUCTR2006-003398-28-AT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2007   -   EUCTR2006-003397-94-LV   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2007   -   EUCTR2006-003397-94-DE   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2007   -   EUCTR2006-003397-94-BE   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
      2007   -   EUCTR2006-003397-94-AT   Austria;Belgium;Bulgaria;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Sweden;
   Janssen Biologics B.V.
      2010   -   EUCTR2006-003399-37-CZ   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
      2008   -   EUCTR2006-003399-37-SE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
      2008   -   EUCTR2006-003399-37-DK   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
      2008   -   EUCTR2006-003399-37-BG   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
      2007   -   EUCTR2006-003399-37-LV   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
      2007   -   EUCTR2006-003399-37-HU   Australia;Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;India;Israel;Latvia;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Sweden;Ukraine;
      2007   -   EUCTR2006-003399-37-DE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
      2007   -   EUCTR2006-003399-37-BE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
      2007   -   EUCTR2006-003399-37-AT   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
   Janssen Biologics BV
      2008   -   EUCTR2006-003399-37-NL   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;India;Israel;Japan;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Ukraine;United States;
      2007   Phase 3   EUCTR2006-003399-37-SK   Austria;Belgium;Bulgaria;Czech Republic;Denmark;France;Germany;Hungary;Latvia;Lithuania;Netherlands;Slovakia;Sweden;
Human anti-IP10 monoclonal antibody   
   Bristol-Myers Squibb International Corporation
      2011   Phase 2   EUCTR2010-022506-41-BE   Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
      2011   -   EUCTR2010-022506-41-PL   Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
      2011   -   EUCTR2010-022506-41-IT   Australia;Austria;Brazil;Canada;Germany;Hungary;Italy;Mexico;Poland;South Africa;United States;
      2011   -   EUCTR2010-022506-41-HU   Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
      2011   -   EUCTR2010-022506-41-DE   Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
      2011   -   EUCTR2010-022506-41-AT   Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
Human anti-TNF-alpha monoclonal antibody   
   Janssen Biologics B.V.
      2014   -   EUCTR2012-004366-18-BE   Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
      2013   Phase 1   EUCTR2012-004366-18-DK   Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
      2013   Phase 1   EUCTR2012-004366-18-DE   Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
      2013   Phase 1   EUCTR2012-004366-18-AT   Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
      2013   -   EUCTR2012-004366-18-NL   Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
      -   Phase 1   EUCTR2012-004366-18-FR   Austria;Belgium;Canada;Denmark;France;Germany;Israel;Netherlands;Poland;United States;
Humanized recombinant IgG4 monoclonal antibody against CD-127   
   OSE Immunotherapeutics
      2020   Phase 2   EUCTR2020-001398-59-LV   Belarus;Belgium;Bulgaria;Croatia;France;Georgia;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Ukraine;
      2020   Phase 2   EUCTR2020-001398-59-HR   Belarus;Belgium;Bulgaria;Croatia;France;Georgia;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Ukraine;
      2020   Phase 2   EUCTR2020-001398-59-BG   Belarus;Belgium;Bulgaria;Croatia;Georgia;Hungary;Latvia;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;
      2020   Phase 2   EUCTR2020-001398-59-BE   Belarus;Belgium;Bulgaria;Croatia;Georgia;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Ukraine;
Humira   
   Abbott GmbH & Co. KG
      2008   -   EUCTR2006-002782-40-DE   Austria;Czech Republic;Denmark;France;Germany;Hungary;Portugal;
      2008   -   EUCTR2006-002782-40-AT   Austria;Czech Republic;Denmark;France;Germany;Hungary;Portugal;
      2008   -   EUCTR2006-002781-20-SE   Austria;Czech Republic;Germany;Hungary;Italy;Sweden;
      2008   -   EUCTR2006-002781-20-AT   Austria;Czech Republic;Germany;Hungary;Italy;Sweden;
      2007   Phase 3   EUCTR2006-002782-40-FR   Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Portugal;Spain;
      2007   Phase 3   EUCTR2006-002781-20-SK   Austria;Belgium;Czech Republic;Germany;Hungary;Italy;Slovakia;Sweden;
      2007   -   EUCTR2006-002782-40-PT   Austria;Czech Republic;Denmark;France;Germany;Hungary;Portugal;
      2007   -   EUCTR2006-002782-40-HU   Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Portugal;Spain;
      2007   -   EUCTR2006-002782-40-ES   Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Portugal;Spain;
      2007   -   EUCTR2006-002782-40-DK   Austria;Czech Republic;Denmark;France;Germany;Hungary;Portugal;
      2007   -   EUCTR2006-002782-40-CZ   Austria;Czech Republic;Denmark;France;Germany;Hungary;Portugal;
      2007   -   EUCTR2006-002782-40-BE   Austria;Belgium;Czech Republic;Denmark;France;Germany;Hungary;Portugal;Spain;
      2007   -   EUCTR2006-002781-20-HU   Austria;Czech Republic;Germany;Hungary;Italy;Sweden;
      2007   -   EUCTR2006-002781-20-DE   Austria;Czech Republic;Germany;Hungary;Italy;Sweden;
      2007   -   EUCTR2006-002781-20-CZ   Austria;Czech Republic;Germany;Hungary;Italy;Sweden;
      2007   -   EUCTR2006-002781-20-BE   Austria;Belgium;Czech Republic;Germany;Hungary;Italy;Sweden;
   F. Hoffmann-La Roche Ltd
      2019   Phase 3   EUCTR2013-004279-11-FR   Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States;
      2019   Phase 3   EUCTR2013-004277-27-HU   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States;
      2019   Phase 3   EUCTR2013-004277-27-CZ   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States;
      2015   Phase 3   EUCTR2013-004279-11-BG   Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States;
      2015   Phase 3   EUCTR2013-004277-27-BG   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States;
      2014   Phase 3   EUCTR2013-004279-11-SK   Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States;
      2014   Phase 3   EUCTR2013-004279-11-EE   Argentina;Australia;Brazil;Bulgaria;Estonia;France;Hong Kong;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States;
      2014   Phase 3   EUCTR2013-004277-27-LV   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States;
      2014   Phase 3   EUCTR2013-004277-27-LT   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States;
      2014   Phase 3   EUCTR2013-004277-27-HR   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States;
      2014   Phase 3   EUCTR2013-004277-27-GR   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Czech Republic;Greece;Hungary;Latvia;Lithuania;Malaysia;New Zealand;Poland;Russian Federation;Turkey;Ukraine;United States;
   Helse More og Romsdal Hospital Trust
      2016   Phase 4   EUCTR2016-001409-18-NO   Norway;
   Region Örebro län
      2021   Phase 4   EUCTR2019-002942-19-DK   Denmark;
   Royal Liverpool University Hospital
      2012   -   EUCTR2011-006084-22-GB   United Kingdom;
   Takeda Development Centre Europe, Ltd.
      2016   Phase 3   EUCTR2015-000939-33-PT   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000939-33-PL   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000939-33-NL   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000939-33-HU   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000939-33-HR   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000939-33-ES   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-000939-33-SK   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-000939-33-LV   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-000939-33-LT   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-000939-33-GB   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-000939-33-EE   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-000939-33-DK   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-000939-33-DE   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-000939-33-CZ   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-000939-33-BG   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-000939-33-BE   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
   University Medical Center Groningen
      2021   Phase 4   EUCTR2020-001811-26-BE   Belgium;Netherlands;
      2020   Phase 4   EUCTR2020-001811-26-NL   Netherlands;
Humira (adalimumab original)   
   Fundación Publica Andaluza para la Gestión de Salud en Sevilla (FISEVI)
      2019   Phase 4   EUCTR2019-000717-37-ES   Spain;
Humira 20 mg solution for injection in pre-filled syringe (20 mg/0.2mL)   
   AbbVie Deutschland GmbH & Co. KG
      2015   Phase 3   EUCTR2015-001346-29-SK   Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
      -   Phase 3   EUCTR2015-001346-29-PL   Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
Humira 40 mg solution for injection in pre-filled syringe   
   ABBOTT GMBH & Co. KG
      2012   -   EUCTR2011-002411-29-IT   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Ireland;Israel;Italy;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
   AbbVie Deutschland GmbH & Co. KG
      2013   -   EUCTR2011-002411-29-SK   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      2013   -   EUCTR2011-002411-29-PL   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      2013   -   EUCTR2011-002411-29-CZ   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      2012   -   EUCTR2011-002411-29-SE   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      2012   -   EUCTR2011-002411-29-PT   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      2012   -   EUCTR2011-002411-29-IE   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      2012   -   EUCTR2011-002411-29-FI   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      2012   -   EUCTR2011-002411-29-DK   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      2012   -   EUCTR2011-002411-29-DE   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      2012   -   EUCTR2011-002411-29-BE   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      2012   -   EUCTR2011-002411-29-AT   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      2009   Phase 3   EUCTR2007-004157-28-SE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
      2008   Phase 3   EUCTR2007-004157-28-NL   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
      2008   Phase 3   EUCTR2007-004157-28-HU   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
      2008   Phase 3   EUCTR2007-004157-28-DE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
      2008   Phase 3   EUCTR2007-004157-28-CZ   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
      2008   Phase 3   EUCTR2007-004157-28-BE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
      2008   Phase 3   EUCTR2007-004157-28-AT   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Sweden;Switzerland;
   Abbott GmbH & Co. KG
      2012   -   EUCTR2011-002411-29-GR   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      2012   -   EUCTR2011-002411-29-ES   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
      2009   Phase 3   EUCTR2007-004157-28-PT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;
      2008   Phase 3   EUCTR2007-004157-28-SK   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;
      2008   Phase 3   EUCTR2007-004157-28-FR   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;
   Abbvie Deutschland GmbH & Co. KG
      2012   -   EUCTR2011-002411-29-GB   Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Ireland;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
Humira 40 mg solution for injection in pre-filled syringe (40 mg/0.4 mL)   
   AbbVie Deutschland GmbH & Co. KG
      2015   Phase 3   EUCTR2015-001346-29-SK   Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
      -   Phase 3   EUCTR2015-001346-29-PL   Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
Humira 40 mg solution for injection in pre-filled syringes   
   Odense University Hospital
      2011   Phase 3   EUCTR2011-004268-31-DK   Denmark;
Humira 40 mg/0.8 ml solution for injection   
   AbbVie Deutschland GmbH & Co. KG
      2019   Phase 3   EUCTR2013-001682-16-DK   Austria;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
      2015   Phase 3   EUCTR2013-001682-16-BE   Belgium;Canada;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Spain;Switzerland;United States;
      2014   Phase 3   EUCTR2013-001682-16-SK   Austria;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
      2014   Phase 3   EUCTR2013-001682-16-PL   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
      2014   Phase 3   EUCTR2013-001682-16-NL   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
      2014   Phase 3   EUCTR2013-001682-16-IT   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
      2014   Phase 3   EUCTR2013-001682-16-HU   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
      2014   Phase 3   EUCTR2013-001682-16-ES   Austria;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
      2014   Phase 3   EUCTR2013-001682-16-DE   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
      2014   Phase 3   EUCTR2013-001682-16-CZ   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Italy;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
      2014   Phase 3   EUCTR2013-001682-16-AT   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Hungary;Israel;Japan;Netherlands;Poland;Slovakia;Spain;Switzerland;United States;
   AbbVie Inc.
      -   -   EUCTR2014-004559-29-Outside-EU/EEA   Japan;
Humira 40 mg/0.8 ml solution for injection for paediatric use   
   AbbVie Deutschland GmbH & Co. KG
      2017   Phase 3   EUCTR2015-001346-29-CZ   Austria;Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-001346-29-HU   Australia;Canada;Hungary;Israel;New Zealand;Spain;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-001346-29-GB   Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Spain;Sweden;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-001346-29-ES   Australia;Belgium;Canada;Czech Republic;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-001346-29-BE   Australia;Belgium;Canada;Czech Republic;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-001346-29-SK   Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
      2014   Phase 3   EUCTR2013-003032-77-IT   Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;Switzerland;United Kingdom;United States;
      2014   Phase 3   EUCTR2013-003032-77-HU   Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States;
      2014   Phase 3   EUCTR2013-003032-77-GB   Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States;
      -   Phase 3   EUCTR2015-001346-29-SE   Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Spain;Sweden;United Kingdom;United States;
      -   Phase 3   EUCTR2015-001346-29-PL   Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
      -   Phase 3   EUCTR2015-001346-29-AT   Austria;Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Spain;Sweden;United Kingdom;United States;
   Abbvie Deutschland GmbH & Co. KG
      2015   Phase 3   EUCTR2013-003032-77-PL   Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States;
      2014   Phase 3   EUCTR2013-003032-77-SK   Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States;
      2014   Phase 3   EUCTR2013-003032-77-ES   Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;Switzerland;United Kingdom;United States;
      2014   Phase 3   EUCTR2013-003032-77-CZ   Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States;
      2014   Phase 3   EUCTR2013-003032-77-BE   Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;Switzerland;United Kingdom;United States;
      2014   Phase 3   EUCTR2013-003032-77-AT   Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;United Kingdom;United States;
      -   Phase 3   EUCTR2013-003032-77-FR   Australia;Austria;Belgium;Canada;Czech Republic;France;Hungary;Israel;Italy;New Zealand;Poland;Slovakia;Spain;Switzerland;United Kingdom;United States;
Humira 80 mg solution for injection in pre-filled syringe (80 mg/0.8 mL)   
   AbbVie Deutschland GmbH & Co. KG
      2015   Phase 3   EUCTR2015-001346-29-SK   Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
      -   Phase 3   EUCTR2015-001346-29-PL   Belgium;Canada;Czech Republic;European Union;Hungary;Israel;Japan;New Zealand;Poland;Slovakia;Spain;Sweden;United Kingdom;United States;
Humira®   
   Samsung Bioepis Co., Ltd.
      2014   Phase 3   EUCTR2013-005013-13-BG   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom;
      2014   -   EUCTR2013-005013-13-PL   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom;
      2014   -   EUCTR2013-005013-13-LT   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom;
      2014   -   EUCTR2013-005013-13-CZ   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom;
Hydrocortisone   
   Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
      2016   Phase 4   NCT02425852   France;
Hydrogen   
   411th Hospital of PLA
      2013   -   ChiCTR-TRC-13003530   China;
   Juntendo University Hospital
      2020   -   JPRN-UMIN000042017   Japan;
Hydroxocobalamin with Butyrate   
   Joshua Korzenik
      2020   Phase 2   NCT04259060   United States;
Hydroxychloroquine   
   Icahn School of Medicine at Mount Sinai
      2022   Phase 1/Phase 2   NCT05119140   United States;
Hyperbaric oxygen   
   Dartmouth-Hitchcock Medical Center
      2013   Phase 2/Phase 3   NCT02144350   United States;
IBD98-M Delayed-release Capsules   
   Holy Stone Healthcare Co., Ltd.
      2015   Phase 2   EUCTR2015-001022-42-IT   Italy;
IDOFORM®Travel   
   Oslo University Hospital
      2020   Phase 1   NCT04241029   Norway;
IM90838   
   Immunic AG
      2020   Phase 2   EUCTR2017-003703-22-PT   Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
      2020   Phase 2   EUCTR2017-003703-22-BG   Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
      2019   Phase 2   EUCTR2017-003703-22-PL   Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
      2019   Phase 2   EUCTR2017-003703-22-HR   Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
      2018   Phase 2   EUCTR2017-003703-22-NL   Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
      2018   Phase 2   EUCTR2017-003703-22-GB   Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Germany;Macedonia, the former Yugoslav Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
      2018   Phase 2   EUCTR2017-003703-22-ES   Belgium;Czech Republic;Germany;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
IMU-838   
   Immunic AG
      2020   Phase 2   EUCTR2017-003703-22-PT   Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
      2020   Phase 2   EUCTR2017-003703-22-BG   Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
      2019   Phase 2   EUCTR2017-003703-22-PL   Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
      2019   Phase 2   EUCTR2017-003703-22-HR   Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
      2018   Phase 2   NCT03341962   Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Georgia;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 2   EUCTR2017-003703-22-NL   Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Germany;Netherlands;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
      2018   Phase 2   EUCTR2017-003703-22-GB   Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Germany;Macedonia, the former Yugoslav Republic of;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
      2018   Phase 2   EUCTR2017-003703-22-ES   Belgium;Czech Republic;Germany;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
INCB039110   
   Incyte Corporation
      2020   Phase 2   EUCTR2018-004491-35-RO   Czechia;Germany;Poland;Romania;United States;
      2019   Phase 2   EUCTR2018-004491-35-PL   Czech Republic;Germany;Poland;Romania;United States;
ITACITINIB ADIPATE   
   Incyte Corporation
      2020   Phase 2   EUCTR2018-004491-35-RO   Czechia;Germany;Poland;Romania;United States;
      2019   Phase 2   EUCTR2018-004491-35-PL   Czech Republic;Germany;Poland;Romania;United States;
IV Corticosteroid   
   Connecticut Children's Medical Center
      2012   Phase 4   NCT01536535   Canada;United States;
Iberogast N   
   Steigerwald Arzneimittelwerk GmbH
      2014   -   EUCTR2013-000891-13-DE   Germany;
Imolope   
   Department of surgery, Odense University Hospital
      2014   Phase 4   EUCTR2014-004740-35-DK   Denmark;
Impact   
   Hospices Civils de Lyon
      2018   -   NCT03504930   France;
   Lawson Health Research Institute
      2016   -   NCT02742597   Canada;
Imuran   
   SCHERING-PLOUGH
      2007   -   EUCTR2006-002670-22-IT   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
Imurek 25mg Filmtabletten   
   Essex Pharma GmbH
      2009   -   EUCTR2009-010065-23-DE   Germany;
Imurek 50mg Filmtabletten   
   Essex Pharma GmbH
      2009   -   EUCTR2009-010065-23-DE   Germany;
Imurel   
   Hvidovre Hospital
      2016   Phase 3   EUCTR2016-002433-30-DK   Denmark;
   Region Örebro län
      2021   Phase 4   EUCTR2019-002942-19-DK   Denmark;
   SOIBD (The Swedish Organisation for the study of Inflammatory Bowel Diseases)
      2018   Phase 4   EUCTR2016-004112-35-SE   Sweden;
Infectofos   
   Center for Surgical Science
      2021   Phase 1;Phase 2   EUCTR2020-000609-10-DK   Denmark;
Inflectra   
   CHU Amiens-Picardie
      2020   Phase 4   EUCTR2020-004391-18-FR   France;
   CUB- Hopital Erasme
      2016   Phase 4   EUCTR2015-004618-10-BE   Belgium;
   Celltrion, Inc.
      2020   Phase 3   EUCTR2019-003849-15-HR   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States;
      2020   Phase 3   EUCTR2019-003849-15-GR   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States;
      2020   Phase 3   EUCTR2019-003849-15-FR   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States;
      2020   Phase 3   EUCTR2019-003849-15-ES   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States;
      2020   Phase 3   EUCTR2019-003849-15-CZ   Austria;Belarus;Bulgaria;Croatia;Czech Republic;Czechia;France;Greece;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;
      2020   Phase 3   EUCTR2019-003849-15-BG   Austria;Belarus;Bulgaria;Croatia;Czech Republic;Czechia;France;Greece;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;
      2020   Phase 3   EUCTR2019-003849-15-AT   Austria;Belarus;Brazil;Bulgaria;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States;
   Centre Hospitalier Universitaire de Rennes
      2018   Phase 4   EUCTR2018-002673-21-FR   France;
   Erasmus Medical Center
      2019   Phase 4   EUCTR2018-004587-61-NL   Netherlands;
   Pfizer
      2018   -   NCT03801928   Canada;United States;
   UMC Amsterdam location AMC
      2021   Phase 4   EUCTR2018-003524-36-NO   France;Ireland;Netherlands;Norway;United Kingdom;
      2020   Phase 4   EUCTR2018-003524-36-IE   Ireland;Netherlands;
   University Medical Center Groningen
      2021   Phase 4   EUCTR2020-001811-26-BE   Belgium;Netherlands;
      2020   Phase 4   EUCTR2020-001811-26-NL   Netherlands;
Inflectra 100 mg powder for concentrate for solution for infusion   
   Santeon
      2015   Phase 4   EUCTR2015-001954-14-NL   Netherlands;
Infliximab   
   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
      2019   Phase 4   NCT03937609   Netherlands;
   Alimentiv Inc.
      2018   -   NCT03765450   Canada;United States;
   Austin Health
      2016   Phase 4   NCT02770040   Australia;
   CENTOCOR
      2007   -   EUCTR2006-000410-20-IT   Belgium;Denmark;Italy;Netherlands;
   Centocor BV
      2007   -   EUCTR2006-000410-20-DK   Belgium;Denmark;Italy;Netherlands;
      2007   -   EUCTR2006-000410-20-BE   Belgium;Denmark;Italy;Netherlands;
   Centocor, Inc.
      2006   Phase 3   NCT00336492   Belgium;Canada;Denmark;Netherlands;United States;
      2002   Phase 3   NCT00096655   -
      2002   Phase 3   NCT00036439   Belgium;United States;
   Chiba University Hospital
      2012   Phase 2   JPRN-UMIN000015297   Japan;
      2012   Phase 2   JPRN-UMIN000007806   Japan;
   Children's Hospital of Fudan University
      2021   Phase 4   NCT04999228   -
   Department of Gastroenterology and Hepatology, Kyoto University Hospital
      2011   -   JPRN-UMIN000006141   Japan;
   Department of Internal Medicine, Division of Gastroenterology and Hepatology, Keio University School of Medicine
      2013   Phase 4   JPRN-UMIN000010612   Japan;
   Department of Internal Medicine,Juntendo University
      2014   -   JPRN-UMIN000013033   Japan;
   Essex Pharma GmbH
      2009   -   EUCTR2009-010065-23-DE   Germany;
   Fukuoka University Chikushi Hospital
      2021   -   JPRN-UMIN000043165   Japan;
   GETECCU (Grupo Español para el estudio de la enfermedad de Crohn y la colitis ulcerosa)
      2008   -   EUCTR2006-005299-42-ES   Belgium;Finland;France;Spain;
   Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
      2016   Phase 4   NCT02425852   France;
   Grupo de Estudo da Doença Inflamatória Intestinal
      2011   Phase 4   NCT01408810   Portugal;
   Hikma Pharmaceuticals LLC
      2018   -   NCT03452501   Saudi Arabia;
   Hiroshima University Hospital, Department of Endoscopy
      2014   -   JPRN-UMIN000015068   Japan;
   Hoffmann-La Roche
      2014   Phase 3   NCT02136069   Austria;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Norway;Philippines;Portugal;Romania;Singapore;South Africa;Spain;Sweden;Switzerland;United Kingdom;Vietnam;
   Hyogo College of Medicine
      2014   Phase 1   JPRN-UMIN000014275   Japan;
   Hyogo college of medicine
      2013   -   JPRN-UMIN000013371   Japan;
   Inflammatory bowel disease center, Hyogo college of medicine
      2013   Phase 1   JPRN-UMIN000013370   Japan;
   Istituto Clinico Humanitas
      2017   Phase 4   NCT03151525   Italy;
   Janssen Research & Development, LLC
      2018   Phase 3   NCT03596645   Belgium;Brazil;France;Israel;Italy;Korea, Republic of;Netherlands;Poland;Spain;Taiwan;United States;
      2004   -   NCT00207688   Argentina;Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Israel;Netherlands;New Zealand;Switzerland;United Kingdom;United States;
   Janssen Scientific Affairs, LLC
      2013   Phase 4   NCT01804166   United States;
   Keio University Gastroenterology and Hepatology
      2016   -   JPRN-UMIN000024936   Japan;
   Merck Sharp & Dohme Corp.
      2009   Phase 3   NCT00984568   Germany;
      2007   -   NCT00705484   Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States;
   Naganuma Makoto
      2021   -   JPRN-jRCT1031200329   Japan;
   Nagoya University Graduate School of Medicine, Department of Gastroentrology and hepatology
      2015   -   JPRN-UMIN000018745   Japan;
   Rennes University Hospital
      2019   Phase 4   NCT03679546   France;
   Royal Liverpool University Hospital
      2012   -   EUCTR2011-006084-22-GB   United Kingdom;
   SCHERING-PLOUGH
      2007   -   EUCTR2006-002670-22-IT   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
   Schering-Plough Research Institute, a division of Schering Corporation
      2008   Phase 3   EUCTR2006-002670-22-SK   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
      2008   Phase 3   EUCTR2006-002670-22-GB   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
      2007   Phase 3   EUCTR2006-002670-22-FR   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
      2007   Phase 3   EUCTR2006-002670-22-ES   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
      2007   Phase 3   EUCTR2006-002670-22-BE   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
      2007   -   EUCTR2006-002670-22-PT   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
      2007   -   EUCTR2006-002670-22-HU   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
      2007   -   EUCTR2006-002670-22-DE   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
      2007   -   EUCTR2006-002670-22-CZ   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
   Schneider Children's Medical Center, Israel
      2018   -   NCT03209232   Israel;
   Sixth Affiliated Hospital, Sun Yat-sen University
      2021   -   NCT04879966   China;
   Tohoku University Graduate School of Medicine (Tohoku University Hospital)
      2012   -   JPRN-UMIN000007341   Japan;
   University Hospitals Cleveland Medical Center
      2008   -   NCT00791557   United States;
   University Southampton Hospital NHS Foundation Trust
      2018   Phase 4   EUCTR2018-001546-33-GB   United Kingdom;
   University of California, San Francisco
      2013   Phase 1   NCT01971814   United States;
   University of Toyama
      2017   -   JPRN-UMIN000027465   Japan;
   University of Western Ontario, Canada
      2014   Phase 4   NCT01960426   United States;
   Xian-Janssen Pharmaceutical Ltd.
      2012   Phase 3   NCT01551290   China;
   Yokohama City University Medical Center
      2014   Phase 2   JPRN-UMIN000013716   Japan;
Infliximab (IFX)   
   Merck Sharp & Dohme Corp.
      2007   Phase 3   NCT00537316   Argentina;Belgium;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Ukraine;United Kingdom;
Infliximab [infliximab biosimilar 3]   
   Pfizer
      2019   -   NCT03884439   Japan;
Infliximab and adalimumab   
   Regionshospitalet Viborg, Skive
      2009   -   NCT02322008   -
Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab   
   Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
      2019   Phase 4   NCT03885713   Spain;
Infliximab therapeutic drug monitoring   
   Imelda GI Clinical Research Center
      2018   Phase 4   NCT04775732   Belgium;
Infliximab, adalimumab, certolizumab pegol   
   Oslo University Hospital
      2013   -   NCT02073526   Norway;
Infusion of Saline   
   Guangzhou First People's Hospital
      2019   Phase 2/Phase 3   NCT03804931   China;
Innovator infliximab   
   Diakonhjemmet Hospital
      2014   Phase 4   NCT02148640   Norway;
Inositol   
   National Cancer Institute (NCI)
      2010   Phase 1/Phase 2   NCT01111292   United States;
Interferon-beta-1a, 44 microgram   
   EMD Serono
      2001   Phase 2   NCT00303381   Germany;Israel;Netherlands;Singapore;Spain;Sweden;Switzerland;United Kingdom;
Interferon-beta-1a, 66 microgram   
   EMD Serono
      2001   Phase 2   NCT00303381   Germany;Israel;Netherlands;Singapore;Spain;Sweden;Switzerland;United Kingdom;
Interleukin-2 (aldesleukin).   
   Scott Snapper
      2015   Phase 1   NCT02200445   United States;
Intestinal flora capsule   
   Third Military Medical University
      2021   -   NCT05030064   China;
Iron sulphate 200mg coated tablets   
   Barts Health NHS Trust
      2011   Phase 4   EUCTR2010-023797-39-GB   United Kingdom;
Iron supplement 300-600 mg/day   
   University Health Network, Toronto
      2002   Phase 2   NCT00152841   Canada;
Iron(III)- hydroxide dextran complex   
   Barts Health NHS Trust
      2011   Phase 4   EUCTR2010-023797-39-GB   United Kingdom;
Itacitinib   
   Incyte Corporation
      2018   Phase 2   NCT03627052   United States;
JNJ-54781532 150 mg once daily   
   Janssen Research & Development, LLC
      2013   Phase 2   NCT01959282   Australia;Belgium;Bulgaria;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
JNJ-54781532 25 mg once daily   
   Janssen Research & Development, LLC
      2013   Phase 2   NCT01959282   Australia;Belgium;Bulgaria;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
JNJ-54781532 75 mg once daily   
   Janssen Research & Development, LLC
      2013   Phase 2   NCT01959282   Australia;Belgium;Bulgaria;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
JNJ-54781532 75 mg twice daily   
   Janssen Research & Development, LLC
      2013   Phase 2   NCT01959282   Australia;Belgium;Bulgaria;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
JNJ-54781532-AAD-   
   Janssen-Cilag International NV
      2014   Phase 2   EUCTR2013-000263-88-RO   Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
      2014   Phase 2   EUCTR2013-000263-88-DE   Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
      2014   Phase 2   EUCTR2013-000263-88-BG   Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
      2014   -   EUCTR2013-000263-88-PL   Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
      2014   -   EUCTR2013-000263-88-NL   Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
      2014   -   EUCTR2013-000263-88-HU   Belgium;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
      2014   -   EUCTR2013-000263-88-BE   Australia;Belgium;Bulgaria;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Romania;Russian Federation;Ukraine;United States;
JNJ-66525433   
   Janssen Research & Development, LLC
      2020   Phase 1   NCT04457960   Georgia;Germany;Moldova, Republic of;
JNJ-72537634   
   Vedanta Biosciences, Inc.
      2021   Phase 2   EUCTR2021-001280-24-LT   Czechia;Hungary;Lithuania;Netherlands;Poland;Russian Federation;Ukraine;United States;
      2021   Phase 2   EUCTR2021-001280-24-HU   Czechia;Hungary;Lithuania;Netherlands;Poland;Russian Federation;Ukraine;United States;
JNJ-78934804   
   Janssen Research & Development, LLC
      2022   Phase 2   NCT05242484   United States;
Janus Kinase Inhibitor   
   Alimentiv Inc.
      2020   -   NCT04576000   Belgium;Canada;Italy;Netherlands;Spain;United States;
Janus kinase Inhibitor   
   Alimentiv Inc.
      2020   Phase 4   EUCTR2019-003780-21-NL   Belgium;Canada;Italy;Netherlands;Spain;United States;
K(D)PT   
   DR. AUGUST WOLFF GMBH & CO. KG
      2012   -   EUCTR2011-002462-20-IT   Czech Republic;Germany;Hungary;Italy;Poland;Slovakia;
   Dr. August Wolff GmbH & Co. KG Arzneimittel
      2011   Phase 2   EUCTR2010-023494-19-SE   Sweden;
KBL697   
   KoBioLabs
      2021   Phase 2   NCT04898348   -
KHK4083   
   Kyowa Kirin Co., Ltd.
      2016   Phase 1   NCT02985593   Japan;
   Kyowa Kirin Pharmaceutical Development, Inc.
      2016   Phase 2   NCT02647866   Czech Republic;Czechia;Hungary;Poland;Puerto Rico;Romania;Russian Federation;Serbia;United States;
      2016   Phase 2   EUCTR2015-001555-69-PL   Czech Republic;Hungary;Poland;Romania;Russian Federation;Serbia;United States;
      2016   Phase 2   EUCTR2015-001555-69-HU   Czech Republic;Hungary;Poland;Russian Federation;Serbia;United States;
      2016   Phase 2   EUCTR2015-001555-69-CZ   Czech Republic;Hungary;Poland;Russian Federation;Serbia;United States;
KRP203   
   Novartis Pharmaceuticals
      2010   Phase 2   NCT01375179   Belgium;Germany;Hungary;Sweden;Switzerland;United Kingdom;
   Novartis Services AG
      2010   -   EUCTR2010-019970-33-SE   Belgium;Germany;Hungary;Sweden;United Kingdom;
      2010   -   EUCTR2010-019970-33-DE   Belgium;Germany;Hungary;Sweden;United Kingdom;
KRP203A   
   Novartis Services AG
      2011   -   EUCTR2010-019970-33-GB   Belgium;Germany;Hungary;Sweden;United Kingdom;
      2010   Phase 2   EUCTR2010-019970-33-BE   Belgium;Germany;Hungary;Sweden;United Kingdom;
      2010   -   EUCTR2010-019970-33-SE   Belgium;Germany;Hungary;Sweden;United Kingdom;
      2010   -   EUCTR2010-019970-33-HU   Belgium;Germany;Hungary;Sweden;United Kingdom;
Kamillenblüten 3ml/10ml   
   Steigerwald Arzneimittelwerk GmbH
      2014   -   EUCTR2013-000891-13-DE   Germany;
Kappaproct   
   INDEX PHARMACEUTICALS
      2012   -   EUCTR2011-003130-14-IT   Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom;
   InDex Pharmaceuticals
      2011   Phase 3   NCT01493960   Czech Republic;France;Germany;Hungary;Italy;Poland;United Kingdom;
   InDex Pharmaceuticals AB
      2012   -   EUCTR2011-003130-14-CZ   Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom;
      2011   Phase 3   EUCTR2011-003130-14-GB   Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom;
      2011   -   EUCTR2011-003130-14-PL   Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom;
      2011   -   EUCTR2011-003130-14-HU   Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom;
      2011   -   EUCTR2011-003130-14-DE   Czech Republic;Germany;Hungary;Italy;Poland;United Kingdom;
      2006   -   EUCTR2006-001846-15-SE   Sweden;
KdPT   
   Dr August Wolff GmbH & Co KG Arzneimittel
      2012   -   EUCTR2011-002462-20-SK   Czech Republic;Germany;Hungary;Italy;Poland;Slovakia;
      2011   -   EUCTR2011-002462-20-PL   Czech Republic;Germany;Hungary;Italy;Poland;
      2011   -   EUCTR2011-002462-20-HU   Czech Republic;Germany;Hungary;Italy;Poland;
      2011   -   EUCTR2011-002462-20-DE   Czech Republic;Germany;Hungary;Italy;Poland;
      2011   -   EUCTR2011-002462-20-CZ   Czech Republic;Germany;Hungary;Italy;Poland;
Kremezin®, Spherical Adsorptive Carbon   
   Ocera Therapeutics, Inc.
      2007   -   EUCTR2005-005363-28-HU   Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom;
      2007   -   EUCTR2005-005363-28-AT   Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom;
      2006   Phase 3   EUCTR2005-005363-28-GB   Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom;
      2006   -   EUCTR2005-005363-28-DE   Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom;
      2006   -   EUCTR2005-005363-28-CZ   Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom;
      2006   -   EUCTR2005-005363-28-BE   Austria;Belgium;Czech Republic;Germany;Hungary;United Kingdom;
Kyo-Dophilus   
   University of California, Irvine
      2007   Phase 1   NCT00578799   United States;
Kümmel 2ml/10ml   
   Steigerwald Arzneimittelwerk GmbH
      2014   -   EUCTR2013-000891-13-DE   Germany;
L-Lysyl-D-Prolyl-L-Threonine Acetate   
   Dr August Wolff GmbH & Co KG Arzneimittel
      2012   -   EUCTR2011-002462-20-SK   Czech Republic;Germany;Hungary;Italy;Poland;Slovakia;
      2011   -   EUCTR2011-002462-20-PL   Czech Republic;Germany;Hungary;Italy;Poland;
      2011   -   EUCTR2011-002462-20-HU   Czech Republic;Germany;Hungary;Italy;Poland;
      2011   -   EUCTR2011-002462-20-DE   Czech Republic;Germany;Hungary;Italy;Poland;
      2011   -   EUCTR2011-002462-20-CZ   Czech Republic;Germany;Hungary;Italy;Poland;
L-Lysyl-D-Prolyl-LThreonine acetate, lyophilisate   
   DR. AUGUST WOLFF GMBH & CO. KG
      2012   -   EUCTR2011-002462-20-IT   Czech Republic;Germany;Hungary;Italy;Poland;Slovakia;
LC51-0255   
   LG Chem
      2020   Phase 2   NCT04096573   -
LDP-02   
   Millennium Pharmaceuticals, Inc.
      2009   -   EUCTR2008-002782-32-AT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
LT-02   
   Dr. Falk Pharma GmbH
      2016   Phase 3   EUCTR2013-001205-84-HU   Austria;Belgium;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
      2016   Phase 3   EUCTR2013-001205-84-BE   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
      2015   Phase 3   EUCTR2013-001205-84-SK   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
      2015   Phase 3   EUCTR2013-001205-84-PL   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
      2015   Phase 3   EUCTR2013-001205-84-LV   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
      2015   Phase 3   EUCTR2013-001205-84-DE   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
      2015   Phase 3   EUCTR2013-001205-84-AT   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
      2014   Phase 3   NCT02280629   Germany;
      2014   Phase 3   NCT02142725   Germany;
      2014   Phase 3   EUCTR2012-003702-27-SK   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
      2014   Phase 3   EUCTR2012-003702-27-PL   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
      2014   Phase 3   EUCTR2012-003702-27-NL   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
      2014   Phase 3   EUCTR2012-003702-27-LV   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
      2014   Phase 3   EUCTR2012-003702-27-LT   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
      2014   Phase 3   EUCTR2012-003702-27-HU   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
      2014   Phase 3   EUCTR2012-003702-27-DE   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
      2014   Phase 3   EUCTR2012-003702-27-CZ   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
      2014   Phase 3   EUCTR2012-003702-27-BE   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
      2014   Phase 3   EUCTR2012-003702-27-AT   Austria;Belgium;Czech Republic;Germany;Hungary;Israel;Latvia;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;
   Lipid Therapeutics GmbH
      2009   Phase 2   NCT01011322   Germany;Lithuania;Romania;
   Prometheus Laboratories
      2016   Phase 3   NCT02849951   United States;
LT-02 (modified-release PC pellets)   
   Lipid Therapeutics GmbH
      2009   -   EUCTR2008-007952-90-LT   Germany;Lithuania;
      2009   -   EUCTR2008-007952-90-DE   Germany;Lithuania;
LX1606   
   Lexicon Pharmaceuticals, Inc.
      2012   -   EUCTR2011-003532-32-LT   Belgium;Lithuania;Poland;Slovakia;United States;
      2011   -   EUCTR2011-003532-32-SK   Belgium;Lithuania;Poland;Slovakia;United States;
LY3074828   
   ELI LILLY & COMPANY, LILLY CORPORATE CENTER
      2019   Phase 3   EUCTR2017-004092-31-IT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-003238-96-IT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-003229-14-IT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;
   Eli Lilly Cork Limited
      2018   Phase 3   EUCTR2017-003229-14-HU   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-003229-14-DK   Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
   Eli Lilly Japan K.K.
      2018   Phase 3   JPRN-JapicCTI-184062   Japan, Asia except Japan, North America, South America, Europe, Oceania, Middle East;
      2016   Phase 2   JPRN-JapicCTI-163356   Japan, North America, Europe, Oceania;
      -   Phase 3   JPRN-JapicCTI-184217   -
      -   Phase 3   JPRN-JapicCTI-184216   -
   Eli Lilly and Company
      2021   Phase 3   EUCTR2019-001653-99-LV   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2019-001653-99-LT   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2019-001653-99-DE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2019-001653-99-BE   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2019-001653-99-FR   Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2017-004092-31-RO   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2017-004092-31-AT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2017-004092-31-PL   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2017-004092-31-HU   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2017-004092-31-HR   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2017-004092-31-FR   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2017-004092-31-DE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2017-003238-96-HR   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2019   Phase 3   EUCTR2017-003229-14-HR   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-004092-31-NL   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-004092-31-LV   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-004092-31-LT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-004092-31-GB   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-004092-31-DK   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-004092-31-BE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-003238-96-SK   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-003238-96-NL   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-003238-96-LV   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-003238-96-LT   Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-003238-96-HU   Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-003238-96-GB   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-003238-96-ES   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-003238-96-DK   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-003238-96-DE   Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-003238-96-CZ   Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-003238-96-BE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-003238-96-AT   Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-003229-14-SK   Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-003229-14-LV   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-003229-14-LT   Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-003229-14-GB   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-003229-14-ES   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-003229-14-DE   Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-003229-14-CZ   Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-003229-14-BE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-003229-14-AT   Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 2   EUCTR2015-003123-57-PL   Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States;
      2016   Phase 2   EUCTR2015-003123-57-NL   Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States;
      2016   Phase 2   EUCTR2015-003123-57-HU   Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States;
      2016   Phase 2   EUCTR2015-003123-57-GB   Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States;
      2016   Phase 2   EUCTR2015-003123-57-DK   Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States;
      2016   Phase 2   EUCTR2015-003123-57-CZ   Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States;
      2016   Phase 2   EUCTR2015-003123-57-BE   Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States;
      2015   Phase 2   EUCTR2015-003123-57-LT   Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States;
   Lilly S.A.
      2019   Phase 3   EUCTR2017-004092-31-ES   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
LY3471851   
   Eli Lilly and Company
      2021   Phase 2   NCT04677179   Argentina;Australia;Belgium;Brazil;Canada;China;Czechia;France;Georgia;Germany;Hungary;India;Israel;Japan;Korea, Republic of;Latvia;Poland;Romania;Russian Federation;Slovakia;Ukraine;United Kingdom;United States;
      2021   Phase 2   EUCTR2020-003017-35-SK   Argentina;Australia;Belgium;Brazil;Canada;China;Czech Republic;Czechia;France;Georgia;Germany;Hungary;India;Israel;Japan;Korea, Republic of;Latvia;Poland;Romania;Russian Federation;Slovakia;Ukraine;United Kingdom;United States;
      2021   Phase 2   EUCTR2020-003017-35-HU   Argentina;Australia;Belgium;Brazil;Canada;China;Czech Republic;Czechia;France;Georgia;Germany;Hungary;India;Israel;Japan;Korea, Republic of;Latvia;Poland;Romania;Russian Federation;Slovakia;Ukraine;United Kingdom;United States;
      2021   Phase 2   EUCTR2020-003017-35-CZ   Argentina;Australia;Belgium;Brazil;Canada;China;Czech Republic;Czechia;France;Georgia;Germany;Hungary;India;Israel;Japan;Korea, Republic of;Latvia;Poland;Romania;Russian Federation;Slovakia;Ukraine;United Kingdom;United States;
      2021   Phase 2   EUCTR2020-003017-35-BE   Argentina;Australia;Belgium;Brazil;Canada;China;Czech Republic;Czechia;France;Georgia;Germany;Hungary;India;Israel;Japan;Korea, Republic of;Latvia;Poland;Romania;Russian Federation;Slovakia;Ukraine;United Kingdom;United States;
LYC-30937   
   Lycera Corp.
      2016   Phase 1   NCT02818543   Hungary;
LYC-30937-EC   
   Lycera Corp.
      2017   Phase 2   EUCTR2016-003633-26-PL   Canada;Czech Republic;Hungary;Netherlands;Poland;Serbia;United States;
      2017   Phase 2   EUCTR2016-003633-26-NL   Canada;Czech Republic;Hungary;Netherlands;Poland;Serbia;United States;
      2017   Phase 2   EUCTR2016-003633-26-CZ   Canada;Czech Republic;Hungary;Netherlands;Poland;Serbia;United States;
      2016   Phase 2   NCT02764229   Czechia;Hungary;Netherlands;Poland;Serbia;United States;
      2016   Phase 2   NCT02762500   Canada;Czech Republic;Czechia;Hungary;Netherlands;Poland;Serbia;United States;
      2016   Phase 2   EUCTR2016-003633-26-HU   Canada;Czech Republic;Hungary;Netherlands;Poland;Serbia;United States;
      2016   Phase 2   EUCTR2016-000518-31-PL   Canada;Czech Republic;Hungary;Netherlands;Poland;Serbia;United States;
      2016   Phase 2   EUCTR2016-000518-31-NL   Canada;Czech Republic;Hungary;Netherlands;Poland;Serbia;United States;
      2016   Phase 2   EUCTR2016-000518-31-HU   Canada;Czech Republic;Hungary;Netherlands;Poland;Serbia;United States;
      2016   Phase 2   EUCTR2016-000518-31-CZ   Canada;Czech Republic;Hungary;Netherlands;Poland;Serbia;United States;
LYS006   
   Novartis Pharma AG
      2021   Phase 2   EUCTR2019-003113-34-SK   Bulgaria;Czechia;Germany;Hungary;Norway;Poland;Russian Federation;Slovakia;United States;
      2020   Phase 2   EUCTR2019-003113-34-NO   Bulgaria;Czechia;Germany;Hungary;Norway;Poland;Russian Federation;Slovakia;United States;
      2020   Phase 2   EUCTR2019-003113-34-HU   Bulgaria;Czechia;Germany;Hungary;Norway;Poland;Russian Federation;Slovakia;United States;
      2020   Phase 2   EUCTR2019-003113-34-DE   Czech Republic;Germany;Hungary;Norway;United States;
   Novartis Pharmaceuticals
      2020   Phase 2   NCT04074590   Bulgaria;Czechia;Germany;Hungary;Norway;Poland;Russian Federation;Slovakia;United Kingdom;United States;
Lactated Ringers   
   Spectrum Health Hospitals
      2007   Phase 3   NCT00467922   United States;
Lactobacillus GG   
   Children's Hospital Medical Center, Cincinnati
      2011   Phase 2   NCT00895336   United States;
Lactobacillus casei   
   Jiangnan University
      2020   Phase 0   ChiCTR2000033953   China;
Lactobacillus casei DG   
   University of Padova
      2016   -   NCT03136419   Italy;
Lactobacillus plantarum   
   Jiangnan University
      2020   Phase 0   ChiCTR2000033953   China;
Lactobacillus reuteri   
   Uppsala University
      2017   Phase 2   NCT03798210   Sweden;
Lactobacillus rhamnosus GG ATCC 53103   
   San Giovanni Addolorata Hospital
      2019   Phase 1/Phase 2   NCT04102852   Italy;
Lactobacillus salivarius UCC118   
   University College Cork
      2002   Phase 2/Phase 3   NCT00510978   Ireland;
Lactobacilus acidophilus & bifidobacterium animalis/lactis   
   Hvidovre University Hospital
      2004   Phase 2   NCT00268164   Denmark;
Lactose in water   
   University Hospitals, Leicester
      2007   -   NCT00403923   United Kingdom;
Leucine   
   Showa Inan General Hospital
      2020   -   NCT04535882   Japan;
Levocarnitine   
   SIGMA-TAU
      2005   -   EUCTR2005-003471-20-IT   Italy;Lithuania;
Levocarnitine propyl hydrochloride   
   SIGMA-TAU
      2012   -   EUCTR2011-004765-32-IT   Belgium;Czech Republic;Italy;Netherlands;
   Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
      2012   Phase 3   EUCTR2011-004770-28-ES   Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
      2012   Phase 3   EUCTR2011-004765-32-BE   Belgium;Czech Republic;Italy;Netherlands;Slovakia;
      2012   -   EUCTR2011-004770-28-PL   Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
      2012   -   EUCTR2011-004770-28-LV   Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
      2012   -   EUCTR2011-004770-28-LT   Austria;France;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
      2012   -   EUCTR2011-004770-28-HU   Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
      2012   -   EUCTR2011-004770-28-AT   Austria;Germany;Hungary;Latvia;Lithuania;Poland;Spain;
      2012   -   EUCTR2011-004765-32-SK   Belgium;Czech Republic;Italy;Netherlands;Slovakia;
      2012   -   EUCTR2011-004765-32-NL   Belgium;Czech Republic;Israel;Italy;Netherlands;Russian Federation;
      2012   -   EUCTR2011-004765-32-CZ   Belgium;Czech Republic;Italy;Netherlands;
Linaclotide   
   University of Virginia
      2015   Phase 4   NCT02465385   United States;
Lixacol   
   Palau Pharma S.A.
      2009   Phase 2   EUCTR2008-004610-27-SK   Belgium;Hungary;Slovakia;Spain;
      2009   -   EUCTR2008-004610-27-HU   Belgium;Hungary;Spain;
      2008   -   EUCTR2008-004610-27-BE   Belgium;Hungary;Spain;
Loperamide   
   Odense University Hospital
      2014   Phase 3   NCT02266849   Denmark;
Loperamide hydrochloride   
   University of Leeds
      2020   Phase 2;Phase 3   EUCTR2019-003220-21-GB   United Kingdom;
Losartan   
   Takeda
      2016   Phase 4   NCT02760615   United States;
Low Dose Budesonide   
   Bausch Health Americas, Inc.
      2022   Phase 4   NCT04314375   -
Low Dose MT-1303   
   Bausch Health Americas, Inc.
      2021   Phase 2   NCT04857112   United States;
Low FODMAP   
   Vendsyssel Hospital
      2018   -   NCT02469220   Denmark;
Low Protein and High Fiber Diet   
   Mayo Clinic
      2021   -   NCT04933162   United States;
Low dose   
   Holy Stone Healthcare Co., Ltd
      2016   Phase 2   NCT02493712   Italy;Taiwan;
Low dose naltrexone   
   Santa Barbara Cottage Hospital
      2013   Phase 2   NCT01810185   United States;
Lumbar puncture   
   Shire
      2012   Phase 1   NCT01387594   Austria;Belgium;France;Germany;Netherlands;
Lusvertikimab   
   OSE Immunotherapeutics
      2020   Phase 2   EUCTR2020-001398-59-BG   Belarus;Belgium;Bulgaria;Croatia;Georgia;Hungary;Latvia;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;
      2020   Phase 2   EUCTR2020-001398-59-BE   Belarus;Belgium;Bulgaria;Croatia;Georgia;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Ukraine;
Lysine-D-Proline-Threonine   
   Dr. August Wolff GmbH & Co. KG Arzneimittel
      2011   Phase 2   EUCTR2010-023494-19-SE   Sweden;
Lysine-D-proline-threonine   
   DR. AUGUST WOLFF GMBH & CO. KG
      2012   -   EUCTR2011-002462-20-IT   Czech Republic;Germany;Hungary;Italy;Poland;Slovakia;
MATRICARIA RECUTITA L. FLOS   
   Steigerwald Arzneimittelwerk GmbH
      2014   -   EUCTR2013-000891-13-DE   Germany;
MD-0901   
   MOCHIDA PHARMACEUTICAL CO., LTD
      2018   Phase 2-3   JPRN-JapicCTI-173803   Japan;
      2018   Phase 2-3   JPRN-JapicCTI-173802   Japan;
   MOCHIDA PHARMACEUTICAL CO., LTD.
      2013   Phase 3   JPRN-JapicCTI-142475   -
      2010   Phase 3   JPRN-JapicCTI-101381   -
      2010   Phase 3   JPRN-JapicCTI-101380   -
MDX-1100   
   Bristol-Myers Squibb
      2008   Phase 2   NCT00656890   Canada;Czech Republic;Hungary;Latvia;Romania;Russian Federation;Ukraine;United States;
   Bristol-Myers Squibb Company
      2008   -   EUCTR2007-002544-25-LV   Czech Republic;Hungary;Latvia;
   Bristol-Myers Squibb International Corporation
      2011   Phase 2   EUCTR2010-022506-41-BE   Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
      2011   -   EUCTR2010-022506-41-PL   Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
      2011   -   EUCTR2010-022506-41-HU   Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
      2011   -   EUCTR2010-022506-41-DE   Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
      2011   -   EUCTR2010-022506-41-AT   Australia;Austria;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Mexico;Netherlands;Poland;South Africa;United States;
      2008   -   EUCTR2007-002544-25-HU   Czech Republic;Hungary;Latvia;
      2008   -   EUCTR2007-002544-25-CZ   Czech Republic;Hungary;Latvia;
MDX-1100 (anti-CXCL10 human monoclonal antibody)   
   Bristol-Myers Squibb
      2006   Phase 1   NCT00295282   United States;
MEDI7183 high dose   
   AstraZeneca
      2013   Phase 2   NCT01959165   Japan;
MEDI7183 low dose   
   AstraZeneca
      2013   Phase 2   NCT01959165   Japan;
MEDI7183 medium dose   
   AstraZeneca
      2013   Phase 2   NCT01959165   Japan;
MELISSAE FOLII DRY AQUEOUS EXTRACT   
   Steigerwald Arzneimittelwerk GmbH
      2014   -   EUCTR2013-000891-13-DE   Germany;
MENTHA × PIPERITA L. FOLIUM   
   Steigerwald Arzneimittelwerk GmbH
      2014   -   EUCTR2013-000891-13-DE   Germany;
MESENCHYMAL CELLS   
   Leiden University Medical Center
      2018   Phase 2   EUCTR2017-003524-75-NL   Netherlands;
MET-2   
   NuBiyota
      2019   Phase 1   NCT03832400   Canada;
METHOTREXATE DISODIUM   
   UMC Amsterdam location AMC
      2020   Phase 4   EUCTR2018-003524-36-IE   Ireland;Netherlands;
METHYLPREDNISOLONE SODIUM HEMISUCCINATE   
   GETECCU (Grupo Español de Trabajo en Enfermedad de Crohn y Colitis ulcerosa)
      2017   Phase 4   EUCTR2016-001170-15-ES   Spain;
MEZAVANT   
   GIULIANI
      2009   -   EUCTR2008-007292-25-IT   Italy;
MH002   
   MRM Health NV
      2021   Phase 1;Phase 2   EUCTR2020-004355-33-CZ   Belgium;Czech Republic;
      2021   Phase 1;Phase 2   EUCTR2020-004355-33-BE   Belgium;
MK-6194   
   Merck Sharp & Dohme Corp.
      2021   Phase 1   NCT04924114   Georgia;Germany;Moldova, Republic of;Ukraine;United Kingdom;United States;
MK-8259   
   MSD Belgium BVBA/SPRL
      2014   -   EUCTR2014-000656-29-BE   Belgium;
MLN0002   
   Academic Medical Center/ Gastroenterology
      2015   Phase 4   EUCTR2014-005443-40-BE   Belgium;Hungary;Netherlands;
   MILLENNIUM PHARMACEUTICALS, INC.
      2009   Phase 3   EUCTR2008-002784-14-IT   Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2009   -   EUCTR2008-002782-32-IT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
   Millennium Pharmaceuticals, Inc.
      2009   Phase 3   EUCTR2008-002784-14-PT   Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2009   Phase 3   EUCTR2008-002784-14-IE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2009   Phase 3   EUCTR2008-002784-14-GR   Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2009   Phase 3   EUCTR2008-002784-14-FR   Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2009   Phase 3   EUCTR2008-002784-14-ES   Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2009   Phase 3   EUCTR2008-002784-14-EE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2009   Phase 3   EUCTR2008-002782-32-IS   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
      2009   Phase 3   EUCTR2008-002782-32-GB   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
      2009   Phase 3   EUCTR2008-002782-32-FR   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
      2009   Phase 3   EUCTR2008-002782-32-BE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
      2009   -   EUCTR2008-002784-14-MT   Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2009   -   EUCTR2008-002783-33-MT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
      2009   -   EUCTR2008-002783-33-AT   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;
      2009   -   EUCTR2008-002782-32-PT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
      2009   -   EUCTR2008-002782-32-NL   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
      2009   -   EUCTR2008-002782-32-MT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
      2009   -   EUCTR2008-002782-32-IE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
      2009   -   EUCTR2008-002782-32-HU   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
      2009   -   EUCTR2008-002782-32-GR   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
      2009   -   EUCTR2008-002782-32-ES   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
      2009   -   EUCTR2008-002782-32-EE   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
      2009   -   EUCTR2008-002782-32-DK   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
      2009   -   EUCTR2008-002782-32-DE   Australia;Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;
      2009   -   EUCTR2008-002782-32-CZ   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
      2009   -   EUCTR2008-002782-32-BG   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
      2009   -   EUCTR2008-002782-32-AT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
      2008   -   EUCTR2008-002782-32-LV   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Spain;United Kingdom;
   TAKEDA DEVELOPMENT CENTER AMERICAS INC.
      2021   Phase 3   EUCTR2020-004300-34-IT   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
   TAKEDA DEVELOPMENT CENTRE EUROPE LTD
      2015   Phase 3   EUCTR2015-000939-33-IT   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
   Takeda Development Center Americas, Inc.
      2021   Phase 3   EUCTR2020-004300-34-SK   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-004300-34-LT   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-004300-34-HU   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-004300-34-HR   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-004300-34-GR   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-004300-34-ES   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2020-004300-34-CZ   Australia;Austria;Belgium;Bosnia and Herzegovina;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Lithuania;New Zealand;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2020-004300-34-BE   Australia;Belgium;Canada;China;Croatia;Czech Republic;Czechia;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Poland;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom;United States;
   Takeda Development Centre Europe Ltd
      2009   Phase 3   EUCTR2008-002784-14-IS   Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hungary;Iceland;Ireland;Italy;Latvia;Malta;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
   Takeda Development Centre Europe Ltd.
      2010   Phase 3   EUCTR2008-002784-14-SE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2010   Phase 3   EUCTR2008-002784-14-GB   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;United Kingdom;
      2009   Phase 3   EUCTR2008-002784-14-SK   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2009   Phase 3   EUCTR2008-002784-14-NL   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2009   Phase 3   EUCTR2008-002784-14-DE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2009   Phase 3   EUCTR2008-002784-14-CZ   Australia;Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;
      2009   Phase 3   EUCTR2008-002784-14-BG   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2009   Phase 3   EUCTR2008-002784-14-BE   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2009   Phase 3   EUCTR2008-002784-14-AT   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2008   Phase 3   EUCTR2008-002784-14-LV   Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
   Takeda Development Centre Europe ltd.
      2009   Phase 3   EUCTR2008-002784-14-HU   Australia;Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Hong Kong;Hungary;Iceland;India;Ireland;Israel;Italy;Korea, Republic of;Latvia;Malaysia;Malta;Netherlands;New Zealand;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
   Takeda Development Centre Europe, Ltd.
      2018   Phase 2   EUCTR2017-002231-41-PL   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
      2018   Phase 2   EUCTR2017-002231-41-NL   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
      2018   Phase 2   EUCTR2017-002231-41-BE   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
      2018   Phase 2   EUCTR2017-002182-21-PL   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
      2018   Phase 2   EUCTR2017-002182-21-NL   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
      2018   Phase 2   EUCTR2017-002182-21-BE   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
      2017   Phase 2   EUCTR2017-002231-41-HU   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
      2017   Phase 2   EUCTR2017-002231-41-GB   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
      2017   Phase 2   EUCTR2017-002231-41-DE   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
      2017   Phase 2   EUCTR2017-002182-21-HU   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
      2017   Phase 2   EUCTR2017-002182-21-GB   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
      2017   Phase 2   EUCTR2017-002182-21-FR   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
      2017   Phase 2   EUCTR2017-002182-21-DE   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000939-33-PT   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000939-33-PL   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000939-33-NL   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000939-33-HU   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000939-33-HR   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000939-33-ES   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-000939-33-SK   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-000939-33-LV   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-000939-33-LT   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-000939-33-GB   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-000939-33-EE   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-000939-33-DK   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-000939-33-DE   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-000939-33-CZ   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-000939-33-BG   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-000939-33-BE   Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 2   EUCTR2017-002231-41-FR   Belgium;Canada;France;Germany;Hungary;Israel;Netherlands;Poland;Ukraine;United Kingdom;United States;
MLN0002 (Vedolizumab)   
   TAKEDA PHARMACEUTICAL COMPANY LTD.
      2014   Phase 3   JPRN-JapicCTI-142403   Japan;
MLN0002 SC   
   TAKEDA DEVELOPMENT CENTRE EUROPE LTD
      2016   Phase 3   EUCTR2015-000482-31-IT   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Montenegro;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000480-14-IT   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
   Takeda Development Centre Europe, Ltd.
      2016   Phase 3   EUCTR2015-000482-31-SK   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000482-31-SE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000482-31-NL   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000482-31-LT   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000482-31-HU   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000482-31-HR   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000482-31-GB   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000482-31-ES   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000482-31-DK   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000482-31-DE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000482-31-CZ   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000482-31-BG   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000482-31-BE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000480-14-SK   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000480-14-SE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000480-14-NL   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000480-14-LT   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000480-14-HU   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000480-14-HR   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000480-14-GB   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000480-14-ES   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000480-14-DK   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000480-14-DE   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000480-14-CZ   Argentina;Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Denmark;Estonia;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000480-14-BG   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000480-14-BE   Australia;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
MLN002   
   Takeda Development Centre Europe Limited
      2016   Phase 4   EUCTR2016-000678-40-CZ   Australia;Bulgaria;Czech Republic;Estonia;Hungary;India;Italy;Korea, Republic of;Latvia;Malaysia;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Taiwan;Turkey;Ukraine;
MMX Mesalamine   
   Shire
      2010   Phase 1   NCT01130844   Australia;Poland;Slovakia;United Kingdom;United States;
      2007   Phase 4   NCT00446849   United States;
MMX Mesalamine/Mesalazine   
   Shire Development Inc
      2010   Phase 4   EUCTR2009-017044-13-FR   Belgium;Czech Republic;France;Germany;Hungary;Ireland;Spain;United Kingdom;
      2010   -   EUCTR2009-017044-13-DE   Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
   Shire Development Inc.
      2010   Phase 4   EUCTR2009-017044-13-ES   Belgium;Czech Republic;France;Germany;Hungary;Ireland;Spain;United Kingdom;
   Shire Development LLC
      2010   Phase 4   EUCTR2009-017044-13-GB   Belgium;Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
      2010   Phase 4   EUCTR2009-017044-13-BE   Belgium;Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
      2010   -   EUCTR2009-017044-13-IE   Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
      2010   -   EUCTR2009-017044-13-HU   Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
      2010   -   EUCTR2009-017044-13-CZ   Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
MMX Mesalamine/Mesalazine (High Dose)   
   Shire
      2014   Phase 3   NCT02093663   Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;United Kingdom;United States;
MMX Mesalamine/Mesalazine (Low Dose)   
   Shire
      2014   Phase 3   NCT02093663   Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;United Kingdom;United States;
MMX mesalamine/ mesalazine   
   Shire
      2010   Phase 4   NCT01124149   Belgium;Brazil;Canada;Colombia;Czech Republic;Czechia;France;Germany;Hungary;India;Ireland;Poland;Romania;South Africa;Spain;United Kingdom;United States;
MONOCLONAL ANTIBODY ANTI-IGG1   
   BOEHRINGER-INGELHEIM ITALIA S.P.A.
      2018   Phase 2;Phase 3   EUCTR2017-004230-28-IT   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
      2018   Phase 2   EUCTR2018-000334-35-IT   Australia;Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
   Boehringer Ingelheim BV Netherlands
      2017   Phase 2   EUCTR2016-004572-21-NL   Denmark;Germany;Netherlands;Norway;Spain;United Kingdom;
   Boehringer Ingelheim Denmark A/S
      2019   Phase 2;Phase 3   EUCTR2017-004230-28-DK   Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
   Boehringer Ingelheim España, S.A.
      2018   Phase 2;Phase 3   EUCTR2017-004230-28-ES   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
      2018   Phase 2   EUCTR2018-000334-35-ES   Austria;Belgium;Canada;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;United Kingdom;United States;
      2017   Phase 2   EUCTR2016-004572-21-ES   Denmark;Germany;Netherlands;Norway;Spain;
   Boehringer Ingelheim International GmbH
      2019   Phase 2;Phase 3   EUCTR2017-004230-28-HU   Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
      2019   Phase 2;Phase 3   EUCTR2017-004230-28-GR   Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
      2019   Phase 2;Phase 3   EUCTR2017-004230-28-CZ   Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
   Boehringer Ingelheim LImited
      2018   Phase 2   EUCTR2018-000334-35-GB   Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
   Boehringer Ingelheim Limited
      2018   Phase 2;Phase 3   EUCTR2017-004230-28-GB   Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
      2017   Phase 2   EUCTR2017-000100-20-GB   Belgium;Germany;United Kingdom;
      2017   Phase 2   EUCTR2016-004572-21-GB   Denmark;Germany;Netherlands;Norway;Spain;United Kingdom;
   Boehringer Ingelheim Norway KS
      2019   Phase 2   EUCTR2018-000334-35-NO   Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
      2017   Phase 2   EUCTR2016-004572-21-NO   Denmark;Germany;Netherlands;Norway;Spain;United Kingdom;
   Boehringer Ingelheim Pharma GmbH & Co. KG
      2018   Phase 2;Phase 3   EUCTR2017-004230-28-DE   Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
      2018   Phase 2   EUCTR2018-000334-35-DE   Australia;Austria;Belgium;Canada;Czechia;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
      2017   Phase 2   EUCTR2017-000100-20-DE   Belgium;Germany;United Kingdom;
      2017   Phase 2   EUCTR2016-004572-21-DK   Denmark;Germany;Netherlands;Norway;Spain;United Kingdom;
      2017   Phase 2   EUCTR2016-004572-21-DE   Denmark;Germany;Netherlands;Norway;Spain;United Kingdom;
   Boehringer Ingelheim RCV GmbH & Co KG
      2018   Phase 2;Phase 3   EUCTR2017-004230-28-AT   Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
   Boehringer Ingelheim RCV GmbH&Co. KG
      2019   Phase 2   EUCTR2018-000334-35-PL   Australia;Austria;Belgium;Canada;Czechia;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
      2019   Phase 2   EUCTR2018-000334-35-HU   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
      2018   Phase 2   EUCTR2018-000334-35-AT   Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
   Boehringer Ingelheim bv
      2018   Phase 2;Phase 3   EUCTR2017-004230-28-NL   Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
   Boehringer Ingelheim bv Netherlands
      2019   Phase 2   EUCTR2018-000334-35-NL   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
   SCS Boehringer Ingelheim Comm. V
      2018   Phase 2;Phase 3   EUCTR2017-004230-28-BE   Argentina;Australia;Austria;Belgium;Canada;China;Czech Republic;Denmark;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Spain;Taiwan;United Kingdom;United States;
      2018   Phase 2   EUCTR2018-000334-35-BE   Austria;Belgium;Canada;Germany;Hungary;Italy;Japan;Korea, Republic of;Netherlands;Norway;Poland;Russian Federation;Spain;United Kingdom;United States;
      2017   Phase 2   EUCTR2017-000100-20-BE   Belgium;Germany;United Kingdom;
MS-20 oral solution   
   National Taiwan University Hospital
      2021   -   NCT04908644   -
MSB11022   
   Fresenius Kabi SwissBioSim GmbH
      2019   Phase 1   NCT04018599   United States;
MSC   
   Leiden University Medical Center
      2018   Phase 2   EUCTR2017-003524-75-NL   Netherlands;
MT-1303   
   Salix Pharmaceuticals, Inc.
      2021   Phase 2   EUCTR2020-005232-30-SK   Australia;Belarus;Belgium;Bulgaria;Czechia;Estonia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia;Taiwan;Ukraine;United States;
      2021   Phase 2   EUCTR2020-005232-30-HU   Australia;Belarus;Belgium;Bulgaria;Czechia;Estonia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia;Taiwan;Ukraine;United States;
      2021   Phase 2   EUCTR2020-005232-30-EE   Australia;Belarus;Belgium;Bulgaria;Czechia;Estonia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia;Taiwan;Ukraine;United States;
      2021   Phase 2   EUCTR2020-005232-30-DE   Australia;Belarus;Belgium;Bulgaria;Czechia;Estonia;France;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Moldova, Republic of;New Zealand;Poland;Russian Federation;Serbia;Slovakia;Taiwan;Ukraine;United States;
      2021   Phase 2   EUCTR2020-005232-30-BG   Australia;Belarus;Belgium;Bulgaria;Canada;Estonia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia;Taiwan;Ukraine;United States;
MTX 12.5   
   University of Western Ontario, Canada
      2013   Phase 4   NCT01716039   -
MTX 25   
   University of Western Ontario, Canada
      2013   Phase 4   NCT01716039   -
Maltodextrin   
   Capital Medical University
      2020   Phase 0   ChiCTR2000032498   China;
   Jiangnan University
      2020   Phase 0   ChiCTR2000033953   China;
   University of Alberta
      2016   -   NCT02865707   Canada;
Maltose   
   Honda Takashi
      2018   -   JPRN-jRCTs041190010   Japan;
Mango polyphenolics   
   Texas A&M University
      2014   -   NCT02227602   United States;
Mare´s milk   
   University of Jena
      2000   -   NCT00940576   Germany;
Maximal oral 5ASA   
   University of Aarhus
      2012   -   NCT01534312   Denmark;
Melatonin   
   Emory University
      2009   Phase 2   NCT00790478   United States;
Melissenblätter 15ml/10ml   
   Steigerwald Arzneimittelwerk GmbH
      2014   -   EUCTR2013-000891-13-DE   Germany;
Melitracen   
   Guiyang 1st People's Hospital
      2018   -   ChiCTR1800016438   China;
Mercaptopurine (Puri-Nethol)   
   Academic Medical Centre
      2016   Phase 3   EUCTR2015-005260-41-NL   Netherlands;
Mercaptopurine (Purinethol)   
   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
      2016   Phase 3   NCT02910245   Netherlands;
Mesalamin   
   Tillotts Pharma AG
      2009   Phase 3   NCT01059344   Belarus;India;Turkey;Ukraine;
Mesalamine   
   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
      2016   Phase 3   NCT02910245   Netherlands;
   Altheus Therapeutics, Inc.
      2009   Phase 1   NCT01020708   United States;
   Beijing Friendship Hospital, Capital Medical University
      2019   -   ChiCTR1900021229   China;
   Department of Gastroenterology, Jinan Central Hospital
      2018   -   ChiCTR2100043797   China;
   Dr. Falk Pharma GmbH
      2014   Phase 3   NCT02280629   Germany;
   EMET Pharmaceuticals, LLC
      2008   Phase 3   NCT01045018   -
      2008   -   EUCTR2007-004732-23-PL   Estonia;Latvia;Poland;
   Ferring Pharmaceuticals
      2021   -   NCT04499495   Korea, Republic of;
      2016   Phase 3   NCT02522780   Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Poland;Russian Federation;Serbia;Switzerland;Ukraine;United States;
      2015   Phase 3   NCT02522767   Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Poland;Russian Federation;Serbia;Switzerland;Ukraine;United States;
   Icahn School of Medicine at Mount Sinai
      2022   Phase 1/Phase 2   NCT05119140   United States;
   James Lewis
      2008   Phase 4   NCT00652145   United States;
   VSL Pharmaceuticals
      2017   -   NCT03415711   Italy;
   Warner Chilcott
      2006   Phase 3   NCT00350415   Belarus;Canada;Croatia;Czech Republic;Estonia;Former Serbia and Montenegro;Hungary;Latvia;Lithuania;Poland;Puerto Rico;Romania;Russian Federation;Serbia;Ukraine;United States;
      2005   Phase 1   NCT00254618   United States;
      2001   Phase 3   NCT00577473   United States;
   Wolfson Medical Center
      2010   Phase 4   NCT01201122   Israel;
   Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai
      2020   Phase 0   ChiCTR2000037261   China;
Mesalamine Delayed Release Tablets   
   EMET Pharmaceuticals LLC
      2008   -   EUCTR2007-004732-23-LV   Estonia;Latvia;Poland;
      2007   -   EUCTR2007-004732-23-EE   Estonia;Latvia;Poland;
Mesalamine Enema   
   Altheus Therapeutics, Inc.
      2012   Phase 2   NCT01586533   United States;
Mesalamine Granules   
   Dayanand Medical College and Hospital
      2018   Phase 3   NCT03716388   India;
Mesalamine Once-Daily   
   Warner Chilcott
      2007   Phase 3   NCT00505778   Canada;Puerto Rico;United States;
Mesalamine Twice-Daily   
   Warner Chilcott
      2007   Phase 3   NCT00505778   Canada;Puerto Rico;United States;
Mesalamine granules   
   Dr. Falk Pharma GmbH
      2005   Phase 3   NCT00746447   Germany;
Mesalamine, 5-ASA   
   Holy Stone Healthcare Co., Ltd.
      2015   Phase 2   EUCTR2015-001022-42-IT   Italy;
Mesalamine, 5-aminosalicylic acid [5-ASA]   
   Ferring International PharmaScience Center U.S., Inc.
      2017   Phase 3   EUCTR2015-002558-11-BG   Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States;
      2017   Phase 3   EUCTR2015-002557-35-BG   Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States;
      2016   Phase 3   EUCTR2015-002558-11-LV   Belarus;Belgium;Bulgaria;Canada;Hungary;Ireland;Latvia;Lithuania;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States;
      2016   Phase 3   EUCTR2015-002558-11-HU   Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States;
      2016   Phase 3   EUCTR2015-002557-35-LV   Belarus;Belgium;Bulgaria;Canada;Hungary;Ireland;Latvia;Lithuania;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States;
      2016   Phase 3   EUCTR2015-002557-35-HU   Belgium;Bulgaria;Canada;Hungary;Latvia;Mexico;Russian Federation;Serbia;Switzerland;Ukraine;United States;
      2015   Phase 3   EUCTR2015-002558-11-BE   Belgium;Bulgaria;Canada;Czech Republic;Hungary;Israel;Korea, Republic of;Latvia;New Zealand;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;United States;
      2015   Phase 3   EUCTR2015-002557-35-BE   Belgium;Bulgaria;Canada;Czech Republic;Hungary;Israel;Latvia;Poland;Russian Federation;Slovakia;Switzerland;Ukraine;United States;
Mesalazine   
   Affiliated Hospital of Inner Mongolia Medical University
      2017   -   ChiCTR-IPR-17010306   China;
   Affiliated Hospital of Jiangnan University
      2021   -   ChiCTR2100046446   China;
   Affiliated Hospital of Nanjing University of Traditional Chinese Medicine (Jiangsu Province Traditional Chinese Medicine Hospital)
      2014   -   ChiCTR1800016668   China;
   Beijing Hospital of Traditional Chinese Medicine affiliated to Capital Medical University
      2020   Phase 2   ChiCTR2000028869   China;
   Cardiff and Vale NHS Trust
      2006   Phase 3   EUCTR2005-002784-91-GB   United Kingdom;
   Chengdu University of Traditional Chinese Medicine
      2020   Phase 0   ChiCTR2000039161   China;
      2020   Phase 0   ChiCTR2000038888   China;
   Chiba University Hospital
      2013   Phase 2   JPRN-UMIN000010906   Japan;
   Chinese University of Hong Kong
      2015   -   NCT02537210   China;Hong Kong;
   Connecticut Children's Medical Center
      2012   Phase 4   NCT01536535   Canada;United States;
   Department of Gastroenterology and Hepatology, Kyoto University Hospital
      2013   -   JPRN-UMIN000010127   Japan;
   Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University
      2017   -   JPRN-UMIN000026175   Japan;
   Department of anorectal surgery, Dongzhimen Hospital, Beijing University of Chinese Medicine
      2014   -   ChiCTR-IOR-15006812   China;
   Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine
      2011   -   JPRN-UMIN000011236   Japan;
   Dongfang Hospital Affiliated to Beijing University of Traditional Chinese Medicine
      2014   -   ChiCTR-OCH-14004615   China;
   Dongfang Hospital of Beijing University of Chinese Medicine
      2019   Phase 0   ChiCTR1900023159   China;
   Dongfang hospital, Beijing univetsity of Chinese Medicine
      2015   -   ChiCTR-IOR-15007194   China;
   Dr. Falk Pharma GmbH
      2007   Phase 3   NCT00747110   Germany;
      2005   Phase 3   NCT00449722   Germany;
   Ferring BV
      2005   Phase 3   EUCTR2004-004565-15-CZ   Czech Republic;Denmark;Finland;Germany;Norway;Sweden;
      2005   -   EUCTR2004-004565-15-SE   Czech Republic;Denmark;Finland;Germany;Norway;Sweden;
      2005   -   EUCTR2004-004565-15-NO   Czech Republic;Denmark;Finland;Germany;Norway;Sweden;
      2005   -   EUCTR2004-004565-15-FI   Czech Republic;Denmark;Finland;Germany;Norway;Sweden;
      2005   -   EUCTR2004-004565-15-DK   Czech Republic;Denmark;Finland;Germany;Norway;Sweden;
      -   -   EUCTR2004-004565-15-DE   Czech Republic;Denmark;Finland;Germany;Norway;Sweden;
   Ferring Pharmaceuticals
      2015   -   NCT02368743   France;
      2015   -   NCT02261636   Netherlands;
      2012   -   NCT01517607   Germany;
   Flemming Bendtsen
      2019   Phase 4   NCT04133194   Denmark;
   GIULIANI
      2009   -   EUCTR2008-007292-25-IT   Italy;
      2004   -   EUCTR2004-000916-25-IT   Italy;
   Guiyang 1st People's Hospital
      2018   -   ChiCTR1800016438   China;
   Hyogo College of Medicine
      2018   -   JPRN-UMIN000034016   Japan;
   Jiangsu Province Hospital of Chinese Medicine
      2020   Phase 0   ChiCTR2000035099   China;
      2019   Phase 4   ChiCTR1900023158   China;
   Kitasato University Kitasato Institute Hospital
      2016   -   JPRN-UMIN000022954   Japan;
   MOCHIDA PHARMACEUTICAL CO., LTD
      2018   Phase 2-3   JPRN-JapicCTI-173803   Japan;
      2018   Phase 2-3   JPRN-JapicCTI-173802   Japan;
   MOCHIDA PHARMACEUTICAL CO., LTD.
      2013   Phase 3   JPRN-JapicCTI-142475   -
   Nanjing Hospital of Chinese Medicine
      2019   Phase 3   ChiCTR1900025900   China;
   Palau Pharma S.A.
      2009   Phase 2   EUCTR2008-004610-27-SK   Belgium;Hungary;Slovakia;Spain;
      2009   -   EUCTR2008-004610-27-HU   Belgium;Hungary;Spain;
      2008   Phase 2   NCT00808977   Belgium;Hungary;Slovakia;Spain;
      2008   -   EUCTR2008-004610-27-BE   Belgium;Hungary;Spain;
   Peking University First Hospital
      2019   Phase 0   ChiCTR1900024591   China;
   Procter & Gamble Pharmaceuticals
      2005   Phase 2   EUCTR2004-004077-29-SK   Czech Republic;Germany;Lithuania;Slovakia;United Kingdom;
      2005   -   EUCTR2004-004077-29-LT   Czech Republic;Germany;Lithuania;United Kingdom;
      2005   -   EUCTR2004-004077-29-DE   Czech Republic;Germany;Lithuania;United Kingdom;
      2005   -   EUCTR2004-004077-29-CZ   Czech Republic;Germany;Lithuania;United Kingdom;
   Procter & Gamble Technical Centres Limited
      2006   -   EUCTR2006-001310-32-LV   Czech Republic;Estonia;Hungary;Latvia;Lithuania;
      2006   -   EUCTR2006-001310-32-LT   Czech Republic;Estonia;Hungary;Latvia;Lithuania;
      2006   -   EUCTR2006-001310-32-HU   Czech Republic;Estonia;Hungary;Latvia;Lithuania;
      2006   -   EUCTR2006-001310-32-EE   Czech Republic;Estonia;Hungary;Latvia;Lithuania;
      2006   -   EUCTR2006-001310-32-CZ   Czech Republic;Estonia;Hungary;Latvia;Lithuania;
   Procter & Gamble Technical Centres Ltd
      2005   -   EUCTR2004-004077-29-GB   Czech Republic;Germany;Lithuania;United Kingdom;
   Saitama Medical Center, Saitama Medical University
      2013   -   JPRN-UMIN000010340   Japan;
      2012   -   JPRN-UMIN000008352   Japan;
   Shire Development Inc
      2012   -   EUCTR2011-000164-10-SK   Slovakia;United Kingdom;United States;
   Shire Development LLC
      2013   Phase 1   EUCTR2011-000164-10-GB   Australia;Poland;Slovakia;United Kingdom;United States;
   Shire Pharmaceutical Development Inc
      2004   -   EUCTR2004-000733-12-CZ   Czech Republic;
   Shire Pharmaceutical Development Inc.
      2005   -   EUCTR2004-000734-36-CZ   Czech Republic;
   Shire Pharmaceutical Development Ltd
      2009   -   EUCTR2004-004184-29-DK   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2008   Phase 3   EUCTR2004-004184-29-NL   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2007   -   EUCTR2004-004184-29-SE   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2007   -   EUCTR2004-004184-29-PT   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2005   Phase 3   EUCTR2004-004184-29-HU   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2005   Phase 3   EUCTR2004-004184-29-GB   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2005   -   EUCTR2004-004184-29-ES   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2005   -   EUCTR2004-004184-29-DE   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2005   -   EUCTR2004-004184-29-CZ   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
   Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
      2021   Phase 0   ChiCTR2100048176   China;
   Shuguang Hospital affiliated to Shanghai University of traditional Chinese Medicine
      2020   Phase 0   ChiCTR2000037220   China;
      2020   Phase 0   ChiCTR2000035497   China;
   Southern Medical University, Nanfang Hospital, Department of Gastroenterology
      2015   -   ChiCTR-ICR-15007188   China;
   The 900th Hospital of PLA
      2018   Phase 4   ChiCTR2000038316   China;
   The Affiliated Hospital of Nanjing University of Traditional Chinese Medicine
      2006   Phase 1 study   ChiCTR-TRC-08000048   China;
   The First Affiliated Hospital of Guangzhou University of Chinese Medicine
      2021   -   ChiCTR2100048502   China;
      2019   -   ChiCTR1900024086   China;
   The Second Hospital of Nanjing Medical University
      2019   -   NCT03917095   China;
   Tillotts Pharma AG
      2010   Phase 3   NCT01257399   China;
      2010   Phase 3   NCT01257386   China;
   UMC Utrecht
      2009   -   EUCTR2009-010921-38-NL   Netherlands;
   University Medical Center Groningen
      2010   -   EUCTR2010-018557-35-NL   Netherlands;
   Xiangya Hospital of Central South University
      2020   -   ChiCTR2000028767   China;
   Yanling Wei
      2015   Phase 2   NCT02335281   China;
   Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of TCM
      2020   Phase 0   ChiCTR2000036950   China;
   Zeria Pharmaceutical Co., Ltd.
      2013   Phase 3   JPRN-JapicCTI-132135   -
      -   Phase 2   JPRN-JapicCTI-121943   -
   Zeria Pharmaceutical Co.,LTD.
      2005   Phase 3   JPRN-C000000289   Japan;
      2005   Phase 3   JPRN-C000000288   Japan;
Mesalazine (3,600 mg)   
   Ferring Pharmaceuticals
      2018   Phase 3   NCT03412682   Japan;
Mesalazine (Asacol®)   
   Cardiff and Vale University Health Board
      2006   Phase 3   NCT00708656   United Kingdom;
Mesalazine - TID 2x   
   Dr. Falk Pharma GmbH
      2013   Phase 3   NCT01745770   Germany;
Mesalazine 1000 mg gastro-resistant tablets   
   Dr. Falk Pharma GmbH
      2013   Phase 3   EUCTR2012-001830-32-DE   Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
      2013   -   EUCTR2012-001830-32-PL   Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
      2013   -   EUCTR2012-001830-32-LT   Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
      2012   Phase 3   EUCTR2012-001830-32-LV   Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
      2012   Phase 3   EUCTR2012-001830-32-HU   Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
Mesalazine 250Mg Tablet and nitazoxanide 500Mg Oral Tablet   
   Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan
      2015   Phase 1/Phase 2   NCT03441893   -
Mesalazine 4G Enema   
   Institute for Clinical and Experimental Medicine
      2017   Phase 2   NCT03104036   Czech Republic;Czechia;
Mesalazine 500 mg gastro-resistant tablets (Salofa   
   Dr. Falk Pharma GmbH
      2013   Phase 3   EUCTR2012-001830-32-DE   Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
      2013   -   EUCTR2012-001830-32-PL   Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
      2013   -   EUCTR2012-001830-32-LT   Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
      2012   Phase 3   EUCTR2012-001830-32-LV   Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
Mesalazine 500 mg gastro-resistant tablets (Salofalk® 500 mg)   
   Dr. Falk Pharma GmbH
      2013   Phase 3   EUCTR2012-001830-32-DE   Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
      2013   -   EUCTR2012-001830-32-PL   Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
      2013   -   EUCTR2012-001830-32-LT   Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
      2012   Phase 3   EUCTR2012-001830-32-LV   Germany;Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
      2012   Phase 3   EUCTR2012-001830-32-HU   Hungary;Latvia;Lithuania;Poland;Russian Federation;Ukraine;
Mesalazine Enema   
   Ferring Pharmaceuticals
      2015   Phase 3   NCT02368717   China;
Mesalazine enema   
   University Hospitals of Leicester NHS Trust
      2006   Phase 3   EUCTR2006-002036-25-GB   United Kingdom;
Mesalazine liquid enema   
   Ferring Pharmaceuticals
      2008   Phase 3   NCT00737789   Belgium;France;Netherlands;United Kingdom;
Mesalazine slow-release granules   
   Ferring Pharmaceuticals
      2008   Phase 3   NCT00737789   Belgium;France;Netherlands;United Kingdom;
Mesalazine tablet   
   Ajinomoto Pharmaceuticals Co., Ltd.
      -   Phase 2-3   JPRN-JapicCTI-101144   -
   MOCHIDA PHARMACEUTICAL CO., LTD.
      2010   Phase 3   JPRN-JapicCTI-101381   -
      2010   Phase 3   JPRN-JapicCTI-101380   -
Mesalazine with hydrocortisone sodium succinate   
   Xijing Hospital of Digestive Diseases
      2017   Phase 4   NCT03110198   China;
Mesalazinum   
   Shire Pharmaceutical Development Inc
      2004   -   EUCTR2004-000733-12-CZ   Czech Republic;
   Shire Pharmaceutical Development Inc.
      2005   -   EUCTR2004-000734-36-CZ   Czech Republic;
Metformin 500 mg TID Oral Tablet   
   National Hepatology & Tropical Medicine Research Institute
      2021   Phase 2   NCT04750135   Egypt;
Methotrexate   
   Centre Hospitalier Universitaire de Besancon
      2007   Phase 2   NCT00498589   Austria;Belgium;France;Israel;Italy;Netherlands;
   GETAID, Jean Minjoz Hospital
      2009   -   EUCTR2006-003607-40-FI   Austria;Belgium;Finland;Netherlands;
   Indiana University
      2015   -   NCT02413047   United States;
   University of North Carolina, Chapel Hill
      2012   Phase 2   NCT01393405   United States;
Methotrexate bellon 25mg/ml   
   Besancon University Hospital
      2008   -   EUCTR2006-003607-40-NL   Austria;Finland;Netherlands;
      2008   -   EUCTR2006-003607-40-BE   Austria;Belgium;Finland;Netherlands;
   Besancon University Hospitaö
      2008   -   EUCTR2006-003607-40-AT   Austria;Finland;Netherlands;
Methotrexate injection   
   Amsterdam UMC location AMC
      2019   Phase 4   EUCTR2018-003594-95-NL   Netherlands;
Methylene blue 25mg tablets   
   COSMO TECHNOLOGIES LTD
      2012   -   EUCTR2011-005693-36-IT   Italy;
Methylprednisolone   
   Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
      2018   Phase 4   NCT02921555   Spain;
Metoject   
   UMC Amsterdam location AMC
      2021   Phase 4   EUCTR2018-003524-36-NO   France;Ireland;Netherlands;Norway;United Kingdom;
      2020   Phase 4   EUCTR2018-003524-36-IE   Ireland;Netherlands;
      2019   Phase 4   EUCTR2018-003524-36-NL   Netherlands;
Metronidazole   
   Ari M Grinspan
      2021   Early Phase 1   NCT04968951   United States;
   Division of General Medicine, Department of Internal Medicine, Nihon University School of Medicine
      2013   Phase 3   JPRN-UMIN000009811   Japan;
   Hamilton Health Sciences Corporation
      2016   Phase 2   NCT02606032   Canada;
   Hokkaido University Hospital
      2016   -   JPRN-UMIN000024520   Japan;
   Ishikawa Dai
      2017   -   JPRN-jRCTs031180415   Japan;
   Japan UC Antibiotics-therapy Study Group(JUCASG)
      2003   Phase 2   JPRN-C000000078   Japan;
   Juntendo university school of medicine Department of gastroenterology
      2015   -   JPRN-UMIN000018642   Japan;
      2014   -   JPRN-UMIN000014152   Japan;
   Juntendo university school of medicineDepartment of gastroenterology
      2017   -   JPRN-UMIN000025846   Japan;
   National Center for Child Health and Development
      2016   -   JPRN-UMIN000026485   Japan;
   Postgraduate Institute of Medical Education and Research
      2019   Phase 2   NCT03794765   India;
   Shiga University of Medical Science
      2015   -   JPRN-UMIN000017844   Japan;
   University of Dundee
      2006   -   NCT00355602   United Kingdom;
Metronidazole capsule   
   FORMAC Pharmaceuticals NV
      2009   -   EUCTR2009-015136-14-BE   Belgium;
Mezavant 1200 mg magensaftresistente Retardtabletten   
   Medizinische Universität Wien, Universitätsklinik für Innere Medizin 3, Abteilung für Gastroenterologie und Hepatologie
      2012   Phase 2   EUCTR2012-002023-15-AT   Austria;
Mezavant Gastro-resistant, prolonged release tablets   
   Shire Development LLC
      2018   Phase 3   EUCTR2013-001744-65-DE   Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;Sweden;United Kingdom;United States;
      2018   Phase 3   EUCTR2013-001744-65-BE   Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;Sweden;United Kingdom;United States;
   Shire Devlopment LLC
      2014   Phase 3   EUCTR2013-001744-65-SK   Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;Sweden;United Kingdom;United States;
      2014   Phase 3   EUCTR2013-001744-65-PL   Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;Sweden;United Kingdom;United States;
Mezavant XL 1200 mg gastro-resistant prolonged release tablets   
   Shire Pharmaceutical Development Ltd
      2009   -   EUCTR2004-004184-29-DK   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2008   Phase 3   EUCTR2004-004184-29-NL   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2007   -   EUCTR2004-004184-29-SE   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2007   -   EUCTR2004-004184-29-PT   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2005   Phase 3   EUCTR2004-004184-29-GB   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
Mezavant XL 1200 mg gastro-resistant, prolonged release tablets.   
   Shire Pharmaceutical Development Ltd
      2005   Phase 3   EUCTR2004-004184-29-HU   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
      2005   -   EUCTR2004-004184-29-CZ   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
Mezavant XL 1200mg gastro-resistant, prolonged release tablets   
   Shire Development LLC
      2013   Phase 1   EUCTR2011-000164-10-GB   Australia;Poland;Slovakia;United Kingdom;United States;
Mezavant XL Gastro-resistant, prolonged release tablets   
   Shire Development Inc
      2010   Phase 4   EUCTR2009-017044-13-FR   Belgium;Czech Republic;France;Germany;Hungary;Ireland;Spain;United Kingdom;
      2010   -   EUCTR2009-017044-13-DE   Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
   Shire Development Inc.
      2010   Phase 4   EUCTR2009-017044-13-ES   Belgium;Czech Republic;France;Germany;Hungary;Ireland;Spain;United Kingdom;
   Shire Development LLC
      2014   Phase 3   EUCTR2013-001744-65-GB   Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;Sweden;United Kingdom;United States;
      2010   Phase 4   EUCTR2009-017044-13-GB   Belgium;Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
      2010   Phase 4   EUCTR2009-017044-13-BE   Belgium;Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
      2010   -   EUCTR2009-017044-13-IE   Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
      2010   -   EUCTR2009-017044-13-HU   Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
      2010   -   EUCTR2009-017044-13-CZ   Canada;Colombia;Czech Republic;France;Germany;Hungary;India;Ireland;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States;
   Shire Devlopment LLC
      2015   Phase 3   EUCTR2013-001744-65-NL   Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;United Kingdom;United States;
      2014   Phase 3   EUCTR2013-001744-65-HU   Belgium;Canada;Germany;Hungary;Israel;Netherlands;Poland;Slovakia;United Kingdom;United States;
Microbiote fécal   
   AP-HP/DRCD
      2022   Phase 2   EUCTR2020-000311-71-FR   France;
Midazolam   
   Janssen Research & Development, LLC
      2018   Phase 1   NCT03358706   Austria;Belgium;Denmark;Germany;Sweden;United Kingdom;United States;
   Takeda
      2016   Phase 4   NCT02760615   United States;
Mirikizumab   
   ELI LILLY & COMPANY, LILLY CORPORATE CENTER
      2019   Phase 3   EUCTR2017-004092-31-IT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
   Eli Lilly Japan K.K.
      2018   Phase 3   JPRN-JapicCTI-184062   Japan, Asia except Japan, North America, South America, Europe, Oceania, Middle East;
      2016   Phase 2   JPRN-JapicCTI-163356   Japan, North America, Europe, Oceania;
      -   Phase 3   JPRN-JapicCTI-184217   -
      -   Phase 3   JPRN-JapicCTI-184216   -
   Eli Lilly and Company
      2021   Phase 3   NCT04844606   Israel;Japan;Korea, Republic of;United States;
      2020   Phase 2   NCT04004611   Canada;Israel;Japan;Korea, Republic of;United States;
      2018   Phase 3   NCT03524092   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   NCT03519945   Argentina;Australia;Austria;Belgium;Canada;China;Croatia;Czechia;Denmark;France;Georgia;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   NCT03518086   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czechia;Denmark;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States;
      2016   Phase 2   EUCTR2015-003123-57-PL   Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States;
      2016   Phase 2   EUCTR2015-003123-57-DK   Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States;
      2016   Phase 2   EUCTR2015-003123-57-CZ   Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States;
      2016   Phase 2   EUCTR2015-003123-57-BE   Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States;
      2015   Phase 2   NCT02589665   Australia;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Puerto Rico;Romania;Russian Federation;Ukraine;United Kingdom;United States;
      2015   Phase 2   EUCTR2015-003123-57-LT   Australia;Belgium;Canada;Czech Republic;Denmark;France;Georgia;Hungary;Japan;Lithuania;Moldova, Republic of;Netherlands;Poland;Romania;Russian Federation;Ukraine;United Kingdom;United States;
   Yoshimoto Yusuke
      2021   Phase 3   JPRN-jRCT2031210210   Japan;United States;
Mirikizumab IV   
   Eli Lilly and Company
      2021   Phase 3   NCT04469062   -
Mirikizumab SC   
   Eli Lilly and Company
      2021   Phase 3   NCT04469062   -
MitoQ   
   University of Edinburgh
      2021   Phase 2   NCT04276740   -
Modified Gegen Qinlian Decoction   
   Xiyuan Hospital of China Academy of Chinese Medical Sciences
      2019   Early Phase 1   NCT04057547   China;
Modified-release phosphatidylcholine   
   Lipid Therapeutics GmbH
      2009   -   EUCTR2008-007952-90-LT   Germany;Lithuania;
      2009   -   EUCTR2008-007952-90-DE   Germany;Lithuania;
Molgramostim   
   Center for Surgical Science
      2021   Phase 1;Phase 2   EUCTR2020-000609-10-DK   Denmark;
Mongersen   
   Celgene Corporation
      2016   Phase 2   EUCTR2015-003364-36-SK   Bulgaria;Canada;Hungary;Poland;Slovakia;United States;
      2016   Phase 2   EUCTR2015-003364-36-HU   Bulgaria;Canada;Hungary;Poland;Slovakia;United States;
      2016   Phase 2   EUCTR2015-003364-36-BG   Bulgaria;Canada;Hungary;Poland;Slovakia;United States;
MultiStem high dose   
   Pfizer
      2011   Phase 2   NCT01240915   Belgium;Canada;Germany;Hungary;Italy;Slovakia;Sweden;United States;
MultiStem low dose   
   Pfizer
      2011   Phase 2   NCT01240915   Belgium;Canada;Germany;Hungary;Italy;Slovakia;Sweden;United States;
Multiple dose- Group B   
   Pfizer
      2005   Phase 1   NCT00928681   Belgium;Czech Republic;Denmark;Germany;Norway;Slovakia;Spain;
Multiple dose-Group B   
   Pfizer
      2005   Phase 1   NCT00928681   Belgium;Czech Republic;Denmark;Germany;Norway;Slovakia;Spain;
Mycodigest supplement   
   Tel-Aviv Sourasky Medical Center
      2018   -   NCT04329481   Israel;
Myrrhinil-Intest®   
   REPHA GmbH
      2008   -   EUCTR2007-007928-18-DE   Germany;
N.d.   
   IRCCS ISTITUTO CLINICO HUMANITAS
      2021   Phase 4   EUCTR2020-003420-16-IT   Austria;Belgium;France;Germany;Italy;Portugal;Spain;Sweden;Switzerland;United Kingdom;
NAND (Neoandrographolide)   
   Nutrition Science Partners Limited
      2014   -   EUCTR2013-003060-31-PL   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2014   -   EUCTR2013-003060-31-LV   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2014   -   EUCTR2013-003060-31-LT   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2014   -   EUCTR2013-003060-31-HU   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2014   -   EUCTR2013-003060-31-CZ   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2014   -   EUCTR2013-003060-31-BG   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
      2013   Phase 3   EUCTR2013-002116-27-CZ   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
      2013   -   EUCTR2013-002116-27-LV   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
      2013   -   EUCTR2013-002116-27-LT   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
      2013   -   EUCTR2013-002116-27-HU   Bulgaria;Czech Republic;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Ukraine;United States;
      2013   -   EUCTR2013-002116-27-BG   Bulgaria;Czech Republic;Hungary;Latvia;Lithuania;Poland;Ukraine;United States;
NEORAL   
   GETAID
      2008   -   EUCTR2006-005299-42-BE   Belgium;Finland;France;Spain;
      2007   -   EUCTR2006-005299-42-FR   Belgium;Finland;France;Spain;
NO   
   Peking Union Medical College Hospital
      2019   -   ChiCTR2000029648   China;
   University of Texas at Austin
      2021   -   NCT04898530   United States;
      2021   -   NCT04617184   United States;
NX-13   
   Landos Biopharma Inc.
      2020   Phase 1   NCT04458805   Australia;
NX-13 250mg IR   
   Landos Biopharma Inc.
      2021   Phase 1   NCT04862741   Ukraine;United States;
NX-13 500mg IR   
   Landos Biopharma Inc.
      2021   Phase 1   NCT04862741   Ukraine;United States;
NX-13 500mg MR   
   Landos Biopharma Inc.
      2021   Phase 1   NCT04862741   Ukraine;United States;
Nanocort   
   Enceladus Pharmaceuticals
      2011   -   EUCTR2010-020448-37-NL   Belgium;Netherlands;
      2010   Phase 2   EUCTR2010-020448-37-BE   Belgium;Netherlands;
Narrow Band Imaging   
   London North West Healthcare NHS Trust
      2006   -   NCT00292175   United Kingdom;
Natura-alpha capsule   
   Natrogen Therapeutics International, Inc
      2010   Phase 2   NCT01216280   United States;
Neomycin   
   University of Dundee
      2006   -   NCT00355602   United Kingdom;
Neoral Soft Gelatin Capsules   
   Swansea University
      2008   Phase 3   EUCTR2008-001968-36-GB   United Kingdom;
Niclosamide   
   First Wave Bio, Inc.
      2018   Phase 1/Phase 2   NCT03521232   Italy;
Nicolon   
   S.L.A. PHARMA (UK) LTD
      2007   -   EUCTR2006-006052-35-IT   Italy;
Nivolumab   
   Alliance Foundation Trials, LLC.
      2019   Phase 1   NCT03656627   United States;
   National Cancer Institute (NCI)
      2019   Phase 1   NCT03816345   Canada;United States;
Nolpitantium Besylate   
   SANOFI-SYNTHELABO
      2005   -   EUCTR2004-001677-26-IT   Czech Republic;Estonia;Hungary;Italy;Spain;Sweden;
Nolpitantium besylate   
   Sanofi
      2005   Phase 2   NCT00232258   Argentina;Belgium;Brazil;Canada;Chile;Czech Republic;Estonia;France;Hungary;Italy;Russian Federation;Singapore;South Africa;Spain;Sweden;United States;
   Sanofi-Synthelabo Recherche
      2005   Phase 2   EUCTR2004-001677-26-HU   Czech Republic;Estonia;Hungary;Italy;Spain;Sweden;
      2005   -   EUCTR2004-001677-26-SE   Czech Republic;Estonia;Hungary;Italy;Spain;Sweden;
      2005   -   EUCTR2004-001677-26-ES   Czech Republic;Estonia;Hungary;Italy;Spain;Sweden;
      2005   -   EUCTR2004-001677-26-EE   Czech Republic;Estonia;Hungary;Italy;Spain;Sweden;
   sanofi-aventis recherche & developpement
      2004   -   EUCTR2004-001677-26-CZ   Czech Republic;Estonia;Hungary;Italy;Spain;Sweden;
Non as of yet   
   Lexicon Pharmaceuticals, Inc.
      2011   -   EUCTR2011-003532-32-SK   Belgium;Lithuania;Poland;Slovakia;United States;
None   
   Bridge Biotherapeutics, Inc.
      2021   Phase 2   EUCTR2020-003556-33-PL   Korea, Republic of;New Zealand;Poland;Ukraine;United States;
None given   
   Shire Pharmaceutical Development Ltd
      2005   -   EUCTR2004-004184-29-DE   Czech Republic;Denmark;Germany;Hungary;Netherlands;Portugal;Spain;Sweden;United Kingdom;
Normal Saline Enema   
   McMaster Children's Hospital
      2015   Phase 1   NCT02487238   Canada;
Nutrition supplement   
   Baptist Memorial Health Care Corporation
      2018   -   NCT03594708   United States;
Nutritional dietary intervention   
   Hospital Galdakao-Usansolo
      2020   -   NCT04188990   Spain;
Nuvion®   
   Facet Biotech
      2007   Phase 3   NCT00502294   -
   PDL BioPharma, Inc.
      2006   -   NCT00355901   Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Hungary;Ireland;Italy;Netherlands;Norway;Ukraine;United States;
OPC-6535   
   Otsuka Maryland Research Institute, Inc.
      2005   Phase 3   EUCTR2005-003724-19-HU   Czech Republic;Hungary;
      2005   -   EUCTR2005-003724-19-CZ   Czech Republic;Hungary;
      2004   -   EUCTR2004-000611-25-IE   Hungary;Ireland;
      2004   -   EUCTR2004-000611-25-HU   Hungary;Ireland;
   Otsuka Pharmaceutical Development & Commercialization, Inc.
      2004   Phase 3   NCT00092508   United States;
OPC-6535 Tablets (drug)   
   Otsuka Pharmaceutical Development & Commercialization, Inc.
      2003   Phase 3   NCT00064454   United States;
      2003   Phase 3   NCT00064441   United States;
OPC-6535(Tetomilast)   
   Otsuka Pharmaceutical Co., Ltd.
      2006   Phase 2   NCT00317356   Japan;
OPRX-106   
   Protalix
      2016   Phase 2   NCT02768974   Israel;
OPRX-106 (plant cells expressing TNFR-Fc)   
   Protalix Biotherapeutics Ltd.
      2016   Phase 2   EUCTR2016-000509-35-BG   Bulgaria;Israel;Serbia;
ORE1001   
   Ore Pharmaceuticals, Inc.
      2009   Phase 1/Phase 2   NCT01039597   Canada;India;
OSE-127   
   OSE Immunotherapeutics
      2020   Phase 2   NCT04882007   Belarus;Belgium;Bulgaria;Croatia;Georgia;Hungary;Latvia;Poland;Russian Federation;South Africa;Ukraine;
      2020   Phase 2   EUCTR2020-001398-59-LV   Belarus;Belgium;Bulgaria;Croatia;France;Georgia;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Ukraine;
      2020   Phase 2   EUCTR2020-001398-59-HR   Belarus;Belgium;Bulgaria;Croatia;France;Georgia;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Ukraine;
      2020   Phase 2   EUCTR2020-001398-59-BG   Belarus;Belgium;Bulgaria;Croatia;Georgia;Hungary;Latvia;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;
      2020   Phase 2   EUCTR2020-001398-59-BE   Belarus;Belgium;Bulgaria;Croatia;Georgia;Hungary;Latvia;Lithuania;Poland;Russian Federation;Serbia;Ukraine;
OST-122   
   ONCOSTELLAE S.L.
      2020   Phase 1;Phase 2   EUCTR2019-004090-50-ES   Spain;
   Oncostellae S.L
      2020   Phase 1/Phase 2   NCT04353791   Spain;
Omeprazole   
   Brigham and Women's Hospital
      2011   Phase 1/Phase 2   NCT01287195   United States;
   Janssen Research & Development, LLC
      2018   Phase 1   NCT03358706   Austria;Belgium;Denmark;Germany;Sweden;United Kingdom;United States;
   Takeda
      2016   Phase 4   NCT02760615   United States;
Ondansetron hydrochloride dihydrate   
   University of Leeds
      2020   Phase 2;Phase 3   EUCTR2019-003220-21-GB   United Kingdom;
Ontamalimab   
   SHIRE HUMAN GENETIC THERAPIES, INC
      2018   Phase 3   EUCTR2017-000599-27-IT   Australia;Austria;Brazil;Croatia;Czech Republic;Czechia;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-000574-11-IT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-000573-37-IT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
   Shire
      2018   Phase 3   NCT03290781   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   NCT03283085   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   NCT03259334   Australia;Austria;Brazil;Croatia;Czechia;Germany;Israel;Italy;Japan;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;South Africa;United Kingdom;United States;
      2017   Phase 3   NCT03259308   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Estonia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;New Zealand;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States;
   Shire Human Genetic Therapies, Inc.
      2018   Phase 3   EUCTR2017-000572-28-BG   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Estonia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States;
   Shire Human Genetic Therapies, Inc.
      2018   Phase 3   EUCTR2017-000599-27-NL   Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-000599-27-LT   Australia;Austria;Brazil;Croatia;Czech Republic;Czechia;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-000599-27-HR   Australia;Austria;Brazil;Croatia;Czech Republic;Czechia;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-000599-27-GB   Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-000599-27-DE   Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-000599-27-CZ   Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-000574-11-PT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-000574-11-NL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-000574-11-LT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-000574-11-IE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-000574-11-HU   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-000574-11-HR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-000574-11-GB   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-000574-11-EE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-000574-11-DE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-000574-11-BG   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-000574-11-BE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-000573-37-PT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-000573-37-NL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-000573-37-LT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-000573-37-IE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-000573-37-HU   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-000573-37-HR   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-000573-37-GB   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-000573-37-EE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-000573-37-DE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-000573-37-CZ   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-000573-37-BG   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2017-000572-28-PT   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States;
      2018   Phase 3   EUCTR2017-000572-28-HU   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States;
      2018   Phase 3   EUCTR2017-000572-28-BE   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Mexico;Portugal;Slovakia;Spain;Switzerland;Ukraine;United States;
      2017   Phase 3   EUCTR2017-000599-27-AT   Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
      2017   Phase 3   EUCTR2017-000574-11-SK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2017-000574-11-AT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2017-000573-37-SK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2017-000573-37-AT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2017-000572-28-SK   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Estonia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States;
      -   Phase 3   EUCTR2017-000599-27-PL   Australia;Austria;Brazil;Croatia;Czech Republic;Germany;Greece;Israel;Italy;Japan;Lithuania;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;United Kingdom;United States;
      -   Phase 3   EUCTR2017-000574-11-PL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2017-000574-11-CZ   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2017-000573-37-PL   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Korea, Republic of;Lebanon;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2017-000572-28-IE   Argentina;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;France;Greece;Hungary;Ireland;Japan;Korea, Republic of;Lebanon;Mexico;Portugal;Slovakia;Spain;Switzerland;Turkey;Ukraine;United States;
Oral 5-ASA+/-topical 5-ASA+IV corticosteroids / PO Methylprednisolone   
   Sheba Medical Center
      2013   Phase 4   NCT01941589   China;France;Greece;Israel;Italy;Korea, Republic of;Serbia;
Oral Corticosteroids   
   Connecticut Children's Medical Center
      2012   Phase 4   NCT01536535   Canada;United States;
Oral Iron   
   American University of Beirut Medical Center
      2019   Phase 3   NCT05225545   Lebanon;
Oral OKT3   
   Brigham and Women's Hospital
      2011   Phase 1/Phase 2   NCT01287195   United States;
Orencia   
   Bristol-Myers Squibb International Corporation
      2007   Phase 3   EUCTR2006-003604-19-GB   Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
      2007   -   EUCTR2006-003604-19-IT   Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
      2007   -   EUCTR2006-003604-19-DE   Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
      2007   -   EUCTR2006-003604-19-CZ   Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
      2007   -   EUCTR2006-003604-19-BE   Belgium;Czech Republic;France;Germany;Ireland;Italy;Poland;United Kingdom;
Originator (legacy) drug   
   McGill University Health Centre/Research Institute of the McGill University Health Centre
      2018   -   NCT03729674   Canada;
Oseltamivir   
   Xiangya Hospital of Central South University
      2020   -   ChiCTR2000028767   China;
Other Biologic Therapies   
   Janssen Scientific Affairs, LLC
      2021   -   NCT04372108   United States;
Overencapsulated Azathioprine (Imuran) 50 mg Tablet   
   Schering-Plough Research Institute, a division of Schering Corporation
      2008   Phase 3   EUCTR2006-002670-22-SK   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
      2008   Phase 3   EUCTR2006-002670-22-GB   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
      2007   Phase 3   EUCTR2006-002670-22-ES   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
      2007   Phase 3   EUCTR2006-002670-22-BE   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Slovakia;Spain;United Kingdom;
      2007   -   EUCTR2006-002670-22-PT   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
      2007   -   EUCTR2006-002670-22-HU   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
      2007   -   EUCTR2006-002670-22-DE   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
      2007   -   EUCTR2006-002670-22-CZ   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom;
Overencapsulated mesalazine tablets   
   GlaxoSmithKline Research and Development Ltd
      2009   Phase 2   EUCTR2009-011608-51-BE   Belgium;Germany;Sweden;
      2009   -   EUCTR2009-011608-51-SE   Germany;Sweden;
   GlaxoSmithKline Research and Development Ltd.
      2009   -   EUCTR2009-011608-51-DE   Germany;Sweden;
Oxygen   
   Dartmouth-Hitchcock Medical Center
      2017   Phase 2   NCT03494764   United States;
Ozanimod   
   Bristol-Myers Squibb
      2021   Phase 2/Phase 3   NCT05076175   France;Japan;United States;
   CELGENE INTERNATIONAL II SàRL
      2016   Phase 3   EUCTR2015-001600-64-IT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Mexico;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-000319-41-IT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
   Celgene
      2019   Phase 3   NCT03915769   Japan;
      2012   Phase 2   NCT01647516   Australia;Belgium;Bulgaria;Canada;Greece;Hungary;Israel;Korea, Republic of;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;Ukraine;United States;
   Celgene International II Sàrl
      2018   Phase 3   EUCTR2015-001600-64-LV   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2015-001600-64-GR   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2015-001600-64-ES   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2015-001600-64-AT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2015-001600-64-HR   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-001600-64-GB   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-001600-64-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-000319-41-GB   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
   Celgene International II Sàrl (CIS II)
      2018   Phase 3   EUCTR2015-000319-41-LV   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2015-000319-41-GR   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2015-000319-41-ES   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2018   Phase 3   EUCTR2015-000319-41-AT   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2017   Phase 3   EUCTR2015-000319-41-HR   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2016   Phase 3   EUCTR2015-000319-41-NL   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-000319-41-SK   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-000319-41-DE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-000319-41-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Netherlands;New Zealand;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      2015   Phase 3   EUCTR2015-000319-41-BE   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2015-001600-64-PL   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2015-000319-41-PL   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Ukraine;United Kingdom;United States;
      -   Phase 3   EUCTR2015-000319-41-BG   Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
   Celgene International II Sárl (CIS II)
      2015   Phase 3   EUCTR2015-001600-64-HU   Arge